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il'.bstract
Recent investigations have shown enhal1ced or aberral1t
expression of major histocompatibility system (MHC)
antigens on cells lines derived from human hepatocellUlar
carcinoma (HCe) in vitro and HCC in vivo. The
present s".:udyundertook to furth-=r clarify the biological
significance of MHC antigel1 expression in BCC and to
elucidate the role of potential :modulatil1g agel1t::.of
antigen e.xp::;ession, These studies have utilised several
hepatic tumour ...derived cell 1il1es as in vit:r:o:model
systems. The cell lines included PLC/PRF/5 (Alexander cell
line), Hep 3E, Hep G2, TONG PHC, HA22T/VGH, HA59T/VGH and
Mahlavu. T~vo cell lines, 1<562 and Raji, wet'e used as
negative and pos itivu controls respectively. The cell line
K562, a B-lympr-oid clerived cell line, expresses negligible
amounts of MH': complex whUe Raji, al1 erythromyeloid
clerived cell lil1e, expresses both MRC Class I and II
antigens as well as their respective invariant chains,
B2-microSlobUlin and ri. The eXl?ression of sU:t'faceMRC was
quantitatively assessed by the indirect immul1ofluorescence
indirewc im:munofluorescel1ce (lIF) assay. The results of
this assay, Lnddcatied that all hepatic tumour-derived cell
lines exhibit spontianeous NHC Class I surface antigel")'s
\<lhileonly two poorly clifferentiated cell lines I HA2 2T /VGH
and HA59T/VGI-t, display MHC Class :n antiger.s. The Validity
of tt.e assignmel1t of Raji and K562 as positive and negative
ii
control cell lines was confirmed by this assay. The
quantitative asSessment of MHC surface antigen e:x:pressidn
was achieved by the enzyme-linked immunosorbent assay
(EI,:tSl~). Dose response experLmerit.s performed on HCC ceLl,
lines confirmed spontaneous surface expression of MHC
Class X antigens and MHC Class II antigen expression on the
HA22T/VGH and HA59T/VGH ce.Ll,lines. rn addition, the
Alexander cell line displayed MHC Class II surface atltigens
using the ELISA but not the IIF technique. Th.e effects of
modulating agents such the interferdns alpha arid gamma,
sodium butyrate and clofazimil"leon MHC expression were then
investigated on the cell lines HA22T/VGH, HA59T/VGH and
TONG PHC. The results indicate that gamma interferon and
olofazimine a.remodulators of MHC Class II expression while
sodium butyrate Ufled at a physiological concentration
enhances MHC surface arrtLqen expre::::don. eDNA probes
directed against MHC class I, Class II and its associated
invariant chain were isolated and purified.
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1CHAPTER 1.
1.1. HISTORY OF THE .Hlic.
The elucidation or the structure and machand.sms of the
products of the Major HistocompatibHlt.y Complex (MHC) and.
the undp.rstanding of their crucial role in regulating the
immune 'response, has been an area{Jf intensive research
OV$l:' the past two decades (Gopas!it...U :1..989). In :1.5)38,
$o1"'1Irdiscovered ttle first eviCleno(;:lof a histooompa.tlbility
sYstem in the mouse (Klein 1986). The h.istoQompatibility
molecules could be recognised for two reasens, Firatly, it
was possible to proQuce ant.isera to the molecules and
secondlY t the molecules Were oapable of il'td.ucingrejection
in the (cells of) tissues of incompatible mice (Klein
1979). The above property govel:ns tissue comp~t.ibility
which is important in tissue tr~nspJ.antation (Klein 1S18tS).
Gorsr, Lyman and snell designated the moleCUleS as
histocolrtpatibility ant.i':1enand gave them the s6..:t:ialnumber
two (Klein J.97!;)). The term histocompatibility was coined
by Snell in 1948 (Marx 1980) to denote the aall sUrface
antigens that. Qetarmina whethal:'011El tissue is compatible
\.,ithanot.her, Gorer and snell designatad the gene coding
for the antigens a.s11"'2(H:l.$tocompatability....2) (Marx
1980). Dauseat was the first to damonstratill the axistencill
2of human leukocytes that carried group specific
characteristics that WElre called isoantigens (al.lo-
antigens). Dausset designated the leucocyte group as Mac
(Dausset 19M).
These antigens appeared to be genetically controlled as was
shcvn in studies on monozygotic twins (Dausset s Breoy
1957, Lalezal:'iS: 8paet 1959), families and in the
appearanoe of maternal aHaantigel1.t:!d.uring pregnancy (:i;>ayne
& ~olfS 195$). In 1958, Payne ana.Rolfs demonstrated the
existeneo of leukooyte factors in pregnant women who had
not received pl'ior blood transfusions by leukoag9'lutinin
formation in the mother. At the Same time, van Rood.
demonstrated l.eukocyte antibodieiS in Sl3ra from pregnant
W"men and. provided. data to Show the existence of a
leul<:.ocyteiSoahtigen Loeus Which he designated as four (van
~ood ID;.....aJ. 19$8). Thb locus was found, on the basis of a
procedure for testing leukocyte agglutination. V;ln RoOd
found that the loc:.t~swas occupied Py one of t\'lOallele.s,
4a or 4b (van ~ood & van :Le3uwel1:1.963). Family studi$$
proved that 4a ahd 4P were inherited as simp1e
Mendelian a1.1.tosomalco-dominant alleles (van Rood & van
Leeuwen 1963). \I'healleles 4a and 40 are now known aa
Bw4 a.nd BW6. Similarly I payne clefil'\eda diffcal:'entaJ.lelic
sy,:st.:emoalled r..A (Leukocyte Antigen) (Zmijeweld~...u
19'70). The two sys·t.el11sLA and Four were shown to be
3closelY linkeCl (Zmijewsk.i at sl 1970).
puring this time, in the 1960'S, the situation conceZ"ning
leukocyte antJ.cjens was highly confused. Manymore antigen
systems were iClentified anCl it was hot clfAar hoWtheY were
rel;:.ted or Lndeed whether they actually were relat~)d in any
way (Marx 1980). It was only in 1964 dU:i:'ihg'th~ first
Xntet'national !1LAWorkshop tlu\t the development of the !1J:JA
(Humanlleukacyte Antig'en) system was clarified (Bodmer
1977). Subsequertt workshops, organised biennia:J.l.y,
invol'!ed an exchange of sera, reagents and data from an
increasing num)J~lrat laboratories. -rne wor)t~.hops 1-6
starting 191$4 to 1975 defined the :aLA-A,B,Cloci as a
unive.rsal phenomenon (Bodmer 1977).
In 1968, th<J World :aealth C?rgani·sation (WHO) assigneQ the
name HL-A to the leUKooyte GrOUp4 system (Zmijewski I~.:t.....sl
1970). :t't: was thought that the H,l,"'Ahaplotype consisted of
one genetio determinant (or blank) from the J.JAserieS ano.
one trom tl'19 four series (Bodmer 1972). In 1975, during
the sixth workshop, the :aLA-Plocus was accepted as a
system identif iea by mixed J.ympbocyte cuJ.ture techniques.
li'ollow;l.ng tbot, in 3.975, the WHO announced that HHLA" was
to define the whole l:e9'ion while IiLA"'A, RU-13, litA.....C and
HLA"'Pwere to refer to the individual loci within 'bne "
entire reg'ion (Bodmer 1977).
4ThE) HU-D region, encoding class :0: antigens, was first
found using studies of Mixed Leukocyte CultUre (MLC) (BaCh
& Hirschorn 1964, Bain et al 1964). In the MLC or Mixed
L,ynlphocyte Reaction (:M'LR),lymphocytes of two individua'
<lIreincubated together and they respond by undergoing ..
~lllonalproliferation and lympho'k.ineproduction. fJ.'heamount
t:>f proliferation is a measure ()f incompatibility or
all.oreactivity between the lymphocyte po~ulations of two
individltals (l<orman et al 1985).
Am6s and. :aeoh suggested in 1968, that a genetic region
existed that encoded molecules stimulating proliferation in
MLC, that Itlaybe linked to but were different from the
HLA-A and -B loci, that is a region St1ch as HtA-D. (AmoS &
Bach 1968). 'llheypresented data that the HL.'l\...n relat$d
products could be reco';jni~ed by serology using an MLC (An\os
« Bach 19(8).
HLA is a codominant system as both alleles are expressed
equally on the cell ~1urface. Eaoh antigen is identified by
a letter for the locus which Clontrol.s it, followed by a
number defining the particulal. specificity of that locus.
The letter w followinl;, a loous symbol and preceding the
number, indicates that a specificity is only provisionallY
identified and is Undergoing intern1;l.tionalH\.,rorkshOj?"
5confirmation in which several laboratories participate to
identify a particUlar antigen (Barrett 1988). There are 24
known alleles at the A locus, 52 at the B locus and 11 at
the C locus. There are 20 alleles at the HLA-DR and S) at
the DQ Locus . All the above loci are identified
serologically by the cellular typing technique known as the
microcytoto){icity test (Barrett 1988). Twenty six alleles
have been recognised at the Dw locus and 6 at the DJ? locus.
(WHO Non\enclature committee 1988)
Table 1.l lists the HLA-A,B,C anci P locus antigens
identified to date (WHO Nomenclature committee 1988). The
listing of th,e specificities tabled. in Table 1.1 will be
updatad. as more und.efined alleles at the HLA-A loci and all
the alleles at the B,C I ow, DR loci aa well as the DJ? and
DQ loci are identified in the coming years.
1.2. THE STRUCTURE OF THE MHC
The loci controll.ing the two maj or sets o~ serologically
defined antigens, the :f:IT.JA-A,B,C(Class I) determinants ana.
the Ht.A-D region (Class II) determ.Lnants, haVe been shown
to be closely linked to each other on the short arm of
chromosome 6 (Bodmez' 1981) (Figure 1.1). situated on
cbz-omcscme 6 as well, the genes encoding fOL' severa.l
complement factors, C4A, 046, C2, and factor 6 (Bf) known
as :MHC Class :t:tI have also been identi:eied (Barrett 1988).
5confirmation in which several laboratories participate to
identify a particular antigen (Barrett 1,988). There are 2.4
known alleles at the A locus, 52 at the B locus and J.,l at
the C locus. There are 20 alleles at the HLA-OR and 9 at
the OQ loCUS. All the above loci are identified
serologicallY by the cellular typing technique known as the
microcytotoxicity test (Barrett 19(8), Twenty six alleleS
have been recognised at the Ow locus and 6 at the OP locus.
(WHO Nomenclature committee 1988)
Table 1.1 lists the HLA-A/B,C and D locus antigens
identified to date (WHO Nomenclature committee 198$). ~~he
listing of the Specificities tabled in Table 1.1 will be
updated as more undefined alleles at the HLA-A loci and all
the alleles at the B,C, Ow, OR l .:;;t as well as the DP and
OQ loci are identified in the coming years.
1. 2 • THE STRUCTURE OF THE MHo
The loci controlling the two :major Sets of serologically
def Lned antige11s, the HLA-A ,B,C (Class I) determinants and
the HLA-D region (Class II) determinants, have been ahown
to be closely linked to each other on the short azm Of
chromosome 6 (Bodmer 1987) (Figure 1.1). situated on
chromosome 6 as well, the genes encoding for several
~;;o:mPle:mentfactors I 04A, C4B, C2, and factor B (Bf) known
as MHC Class III have also been identified (Barrett 1988).
6The HLA and its murine ana.logue, the H-2 system, display
marked serological, functional and structural homologies
(Klein 1979). The B-2 comp Lex , located on chromosome 17
(Klein 1979) is divided into six regions CK, I, s, G, D and
'1') (Figure 1.1). The I regibh is divided into five
subregions (A, 13/ J, E and C). The. murine eguivalent to
HLA-A/B,C is H-2K, H-2L and H-20 (:MHCClass I). The
regions R-2 1A and lE/C encode biochemicallY identifi.ed Ia
polypeptides which ure equivalent to the BLA-O region
antigens (Klein 1979). A major feature of these genetic
regions is the high degree of pol.ymorphism expressed (Klein
1979, 130dmer & 130dmer 1978). The HLA region as a Whole,
though it may comprise only one-thousandth of the human
genome, Lnc.Ludas a thousand or more genes with a l.a.rge
series of multiple alleles at each of several different
although unrelated loci (Bodmer & )3odmer 1978).
The H-2K and 20 gene producns and the HLA-A/ 131 C antigens
have the same structure and are associated "lith
e2-microglobulin (B2:m) (see Fig. 1.2) (Klein 1979). The
class I antigens (human HU-A, St C and the mur Lne :a"'4K,"20
and -2L) are k.nown as the classic transplantation antigens
(KaUfman & strominger 1983). Also, homOlogous :moleCUles
with identical tissue distribution (primarily rest:ri.cted to
13 lymphocytes and macrophages) and havin; similar functions
RECOGNISl.:D
DR
DRl
DR2
DR3
DR4
DR5
DRw6
DR7
DRw8
DR9
DRwlO
DRW11(5)
DRw12 (5)
DRw13(w6)
DRW14 (ws)
DRw15(2)
DRw16(2)
DRw17(3)
DRw18(3)
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1.1: COMPLETE LISTING OF
BCD
B5 CWl DWl
B7 CW2 DW2
B8 CW3 DW3
B12 Cw4 Dw4
B13 Cw5 Dw5
B14 CW6 DW6
B15 Cw7 Dw7
B16 CWS DW8
B17 CW9(W3) Dw9
B18 Cwl0(W3) DwlO
B21 Cwll DWll(w7)
BW22 Dw12
B27 Dw13
B35 DW14
B37 Dw15
B38(16) DW16
B39(16) DW17(w7)
B40 DW18 (W6)
BW41 Dw19(W6)
BW42 Dw20
B44(12) Dw21
B45(12) Dw22
Bw46 Dw23
Bw47 DW24
BW48 Dw25
B49(21) DW26
Bw50 (21)
B51(5)
Bw52(5)
BW53
Bw54 (W22)
swss (W22)
BW56(W22)
BW57 (17)
BW58(17)
BW59
BW60(40)
BW61(40)
BW62(15)
Bw63 (15)
BW64(14)
Bw65(14)
Bw67
BW7l(W70)
Bw70
Bw72(w70)
Bw73
Bw75 (1::"')
Bw76(15)
Bw77(lS)
Bw4
Bw6
Nomenclature ccmmittee 1988
TABLE
A
Al
A2
A3
A9
A10
All
Aw19
A23(9)
A24
A2~(lO)
A26(10)
A28
A29(W19)
A30(W19)
A31(W19)
A32(w19)
AW33 (W19)
A34(lO)
Aw36
AW43
Aw66(lO)
Aw68(28)
AW69 (28)
Aw74 (W19)
HLA SPECIFICITIESa
DQ ~ DP
DQwl DPwl
DQw2 DPW2
DQW3 DPW3
DQW4 DPT,,4
DQW5(Wl) DPW5
DQW6(Wl) D:Pw6
DQW7(W3)
DQW8(W3)
DQw9 (W3)
DRW52
DRW53
Centromere K Arsv. EB Ea D L Qa T
Structural genes for the murine major histocompatibility are situated
-.on chromosome 17. The class I H2-K histocompatibility genes ,are
separated from the H2-D and H2-L genes.
Centromere
The structural genes tor the human major histocompatibility complex
are on chromosome 6. The class I genes HLA ..A, -8 and -C are
grouped, unlike the murine MHC..
II'Class I o Class II
Figu,re1.1 : Rodrawn from Banett (1981)
9were found in antigens encoded by the murine I regions, the
Ia antigens, and in man, by the HLA-D region (Humphreys et
al 1976).
Knowledge in the field of HLA molecUlar genetics has
progressed rapidly over the past few years (Jc~dan et al
1985). It has been shown using sequencing data, that the
HLA-A,B,C, D region products are members of the
immunoglobulin super-gene family (Bodmer 1987). Thlls, the
HLA (human and H-2 (murine) major histocompatibility
products have been called histoglobulins (Klein 1979).
1.2.1 MHC CLASS I
The HLA-A, B, C loci lie at the end of the HLA region on
chromosome 6 (See Fig 1.1). The typical HLA'-A, B, C gene
produces a moLecuLe with three extracel1ula); domains:
alphal, alpha2 and alpha3 of a molecular weight of 45 kDa
(Vega & strominger 1989). of these three domains alpha3 is
the most conserved, whereas alpha1 and alpha2 bear
polymorphic N-terminal determinants (Vega & st);ominger
1989). This W~$ observed from the elucidation of the
crystal structurl~ of HLA-1\.2(Bjorkman et al 1987a, 1987b).
1';'''1 molecule also consists of a transmembrane segment and a
8l-J.l.rtcy oplasmic oonserved immunoglobulinlike c-terminal
region or "tail" (See Fig 1..2) (Kaufman & st:t'ominger
1982). All these produots are non-convalently associated
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poly Ig receptor
mlgM
MHC MHC
Class!
Plasma----~------_4~----_+~--~~~----~----+_~.,nembrar
cytoplasm
Figure 1.2 :
Schematic'representation of MHC antigens and other membrane
proteins with homology to immunoglobulin constant domains (_)
and variable domains (IIIIIII\).
(redrawn .:.from Auffray and Strominger (1986) )
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with .B2-microglobulin (B2m)which is encoded for by a
singJ.e gene on chromosome 15 (Goodfellow et al 1975' T~e
B2-microglobulinr an ivariant Ot" highly consel;"V'ed12kOa
polypeptide, lies outside the cell membrane and associates
part.:i.cularly ~iith tho alpha3 domain as shown in Figure
1.2. (Bjorkman et al 1987a). The conserved
membrane-proxlmal alpha3 and 132mo.oma.i.nsalso exhibit a
similar tertiary structure that has been described for ·the
an'l:.i):)odydomains )the constant :region) of the
immunoglobulins (Bjorkman et.....s.l198,.~). The alpha3 and .B2m
domains are paired by a novel interaction not found betWeen
pairs of constant domains in the known antibody structures
(eg CHi and cr, in an Fab fragment) (Bjot'kmaI1at a:). 1987a).
there is a e;ignifican't amino acid sequence homology ):)etween
alpha3, B2mand .1E! constant regions of the immunoglobulins
(orr et al J.979, Tragardh ~ :1,979), The alpha1, alpha.3
and 132mdomains are stabilised bY an intrachain disulphide
bonds. (See Fig 1.2).
MHcCLASS!I
The MHCClaSS !I or HLA~Dregion is defined by its
complexity at both the genetic and serological. leVEnS
(Trowsd~].e et a). 1985, CressweH &t...l!1 1987). The
extensive review of Trowsdale eWl (19aS) Of genetic
stud.i.es on the characterisation and polymorphism of the
HLA-P region alpha and ,j chain geme, suggests that thElre
are at lea.st th:l:'Elel\\a.j or sets of pr(.)ductS: fILA-DR, ....OJ?
(formerly S6) a11Q""PQ(preViously DC) al.]. having a very
similar structure CrrowRdale ~. 19a5) •
'.
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Each antigen consists of a. heterodimer, having its own
alpha and a subunit. The HLA-D locus has revealed at J.east
6 alpha chain genes and at. :t.9ast7 a chain genes I nearl.y
all assigned to DR, DQ or D~ (Trowsdale &.'Ul 198$). iI'he
alpha and 13 chi"ins are transmembrane glycoproteins Of
approxi:mateJ.y 35kDa and 27kOa respectively (Trowsdale ~_CL!..
1985). Tha subunits are highly polymorphic and are
non ...convalently associated (steinhoff 1990). The alpha and
13 subunits have a short cytopJ.a"lmic immul1og10bulin ..lil<:e
conserved c-te:z:ominaltail (l(au:f:man& stromingar 1992). The
polypeptide SUbl.mits span the lipid )oilaye1.·and protrude
into the extracytoplas:m of the cell. (Walsh & Q't'umpton :l.~77 r
.'Kaufman & Strom:l.ngl';Jr1979). The N....terminus of the
extracytoPlasmic portiono of both chains is rE)cognisably
divided into two domains (Trowsd.ale ~ 1985). 8(.)t11.
domains of the B subunit (See Fig 1.2) contain an
intrachain sul1!lhydrylbond (Cresswell ~ 1981). Only
the membrane-Proximal alpha2 domain of the alpha subunit
has an internal disulphida bond (C:tesswoll ~ :).987) •
The membrane"'pl:"oxilllaldomains of both subunits alpha~ and
,82 exhibit a limited alnino acid $(9q:uencahomology wit.h the
inlmunoglobulin :family and al:'ehighly consel:'ved (l(a;ufmans
strominger 1983).
).3
THE ASSOCIATION OF MHC CLASS II W!TH A THIRD
Gt,';lcOPROTEIN.
1.2•.2 .1.1. Discovery of the HLA-D Region-Assooiatea.
Invariant chain.
In 1979, Jones et a1 by using 2-dimensional (2-d) gel
eleotropho:t;'esisof I-A and I"'E subregion antigen$ of the
H-2 complax detnonstratea.that all Ia antigen
immunopreoipitates contain three di$tinct polYl?eptic'le
chains (Jones et a:L1979). The third polypeptide Wa$
identified to be an invariant Ia ....t!lssociatedchain because
it lackedpolymorphisln at an isoelectriq point as
identified by 2....d gel eleotropho:t;'esis(Jones ~ 1979).
The Ia-associate('l invariant ohain was termed Ii indicating
Murine MHO Class II and 'i' for 'invariant'. Similar
findings were reported by Charron ana.McDevitt (1979) Who
also idt:sntifiedthe invariant chain to be of approxima'l.;.el.y
32 kDa (Ohart'on & McDevitt 1980).
Since 1980 many abbreviations have been used to desoribe
the HLA"P region-associated invariant chain, including :Ci
(Jones ~. ;1.979),p31 (Owen~. 1981), Gamma (l<viat st!;,
.al. t984r claasson « Peterson 19S3) ano. In (liong 198!S). :E'er
the purpose of this study, the name Ii will be u.Sed.
1.2.2.1.2 STRUCTURE OF Ii
::lineathe discovery of Ii, the :euneticnal rola of tha liLA...P
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region associated"'inva:t:'iant chain has been a subject of
intense investigation with :few answers having been pr.ovided
(tohg 198;5, H~hnmerlihg & Moreno :1,990). structurally, the
iriVarianc chain is a basic glycoprotein of approximately
3J.kDa "1r 4:!.kf)awhich originates from differential RNA
splicing (Yamamotoat al :L98Sa). :tt is encoded by a gene
no': linlt3d to the MHCgenes but IOdated on chromosome 1$ in
In;ioa and chz'omoaome 5 in humans (':?amamoto~ 1985b,
C. eeaon ..Wel&h at al 1984). 't.ne invariant chain is an
unusual, transmembrane glYcoprotein since it is inverted
Com~ICl.L~u to most membrane proteins (such as MHC Cl.).ss ,t:q
with the C-terminus in the extra"'oytoplasm (CreSSi'lell ~t Sl1
1gei~. No hO'l\\010gywith any known p:=ote1n, il'loluding the
immunoglobulin, MHCClass II I MHO Class :r Or the 'ff;J;Ic ClasS
:t-~.$sooie,ted invariant ohail"!, 134-rnioroglobulirl, is evident
in the primal.~YXi aminI' acid sequence (Cresswell et. (;\l
1987) •
Its uncommon configuration o·t a U-tet'mj,nl'l.l cytoplaa1tl;io
pOl:tion t.\nd an extracytoplasmic C....tel:t\l.;.,nal 'tail' is; !Shared
J;)ya limit.ed number of integra.l glyooproteills (Fi~ldS n _U
1981, D:do~arnsr « N:amon1982) such as the tr~nsfel'rin
t'eceptol: (MoClelland ~ 1984). cresswell (:1.985)
SU9gests that 'Che endooytic pathway followed by the latter
intersects the exocytio route taken by newly syn'l::held,',f;lt'
1-1'HC ClalSs :n antigans };lrior to t11). disac)ciation of thQ Xi
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chain before the class II molecule is expressed on the
plasma memprane. (See section 1.3.2.1 .•3.2. 1) This
intracellular il".lteractiol'lbetween class :n: molecules and
:foreign proteins may be important in Class II antigen
function (ct'esswell 198.5).
1. 3 THE FUNCTION 01)' THE HHc.
1.3.1 History of the ~unction of the NHC
In ;1..962,Gowans ~ postulated that the immune t'eSponse
may be initiated by the interactj,on of antigens and
lymphocytes. Miller (196.2)and Good ~_A1 (19Q2)
discovered that lyml:lhooytesdifferentiate into two claSSeS
of cells which are either derived from th~' t:.hy.mv,s(Tlyltipho-
cytes) or Bursa of Fabricus (13lymphoC)7\~es). warner at al
(1962) identified two distinct immunocompetent '.ymlJhoid-
derived populations and recognised th~t cells derived £l:'om
the thymus were responsible for cellular immune phenomena.
It was also demonstrated that immu:nogenicity is regulated
by h~l}?el.~':(.''''ce1l9and cytotoxic rr"'calls (na.j ewsky i:!; al
1969, Kap}? ~t ~l 1974). Katz and Bsnacar~af (1972)
}?ostuls:t.edthat, helper T"cr :!J.~ll i.'~li>ponseswerE'.!ragulated l:ly
Ir (il1\muna-responst':.)geMS in mioa. At this stac;re,it bad
Pecome increasingly obvious that the immune system was
oomplex and that T lymphooytee had a oritical role to play
in the regulation of immunity (13enacerraf 1981).
I .
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'I'hework of J3enacerraf, l<atz and. others on cellUlar
interactions between histoincompatible T and 13lymphocytes
showed that a dual specificity of thymus-derived
lymphocytes fol:' struc'tures coded by the MHC (self) an.d for
foreign antigens (non-s~lf) existed in mice (Katz et a1,
1910, Katz et ",,1 1971, Katz et g_l 1913a). In these studies
histoincompatible lymphocytes Were used in order to avoid
an alloqeneic effect (Katz et aJ. 1913a). The word
histoincompatible implies that lymphocytes Were derived
f:t'omdifferent· murine stains. FUrthermore it was shown
that the co"'opElrative'interaction of '1' and J3lymphooytes is
restricted by the H-2 gene complex (l<indr<'\tl& Schreffler
1972/ Katz et.al 1973b). Genes within the X-:r.egionof the
MHC appear to control the activity of helper 'r ....cells (Greel1
!it a.l 1966, Katz ~ 19730) ~"hils,t:Ia moleCUle ..) deter:mine
immune :t'er:>ponsiVel'leSS'coT-cell antigens (Kappler & Marraok
1978).
bEMONSTaATION OF THE FUNCTION OF THE MHC
Originally, Unanue & Askonas (1908) demonstrated that
macrophage""bound antigen exhibited enhanced imr(\Unoge11icity
which persistea long after the uptake of antigen by
macrophage. Unanue and Cerottini (1970) found that when
keyhole: limpet hemocyanin was used as an antig'en carrier it
was taken up by the macrophage, rapidl.y oatabol;i.sedand
eliminated from the o.eU. However, they demonstrated that
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the antigen still remained immunogenic by virtue of a :few
molecules of residual antigen bound to the plasma membr-ane
of the macrophage (Unanue & cerottini 1970). La't.erit was
demonstrated that the involvement ·of the membrane
glycoproteins encoded in the major histocompatibility gene
complex are essential for the development of an immune
response in most cellular interactions (Babbitt et &1 19$5,
Rosenthal & Shevach 1973a, 1973b).
1.3 .2.1 WT,1NCTIONOF MHc CLASS It
1.3 •.2. 1.1 Demonstration of Antigen Processing an,
presentation.
Rosenthal and shevach (1973a, 1973b)1 using a guinea pig as
a model, demcmstrated that macxophaqei: contt'ibut6 to the
sJ?eci:f:i..cityof a 1'-oe119 response after its activation by
macrophage-bound antigone. rJ.'heyalso demonstrated that the
.i:amolecule$, are essential :ear accessory cells to present
antigenic peptldes to helper T~lymphocytes (Rosenthal &
Shevach 1973a, 1973b). TheSe elegant studies indicated a
3:"ole:for the macrophage in events dontrollad by ·the t
region of the MI1c and demonstrated an essential intel;'action
between macl;'ophage and T-h.elper lymphocytes (T,1nanue1981).
Further studie$ by Zieglet' and Unanue (1981) using the
bacter:l.ultIListeriUlllmonocytogGnea showed that an
intracel.lula.:l:'mechanism or processing (T,1nanue& Cerottini
1970) of the antigon Liate:dultlmonoeytogenel.'lby
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macrophages was required for the (~:x:pressiollor presentation
of antigen on macrophage and subaequent; recognition by T
cells Ln the concexc of H-2k. stUdies using lyso-
somotropic amfnas I ammond.a and chloroquine demonstrated the
inhibition of the development of e·ffective antigen
presenta't.ion when ...he :Lysosomotr<)picl;"eagents we;t'e.given
immediately c:.:':'l:.et"C\'ntigenL.ndin~~ to accessory .:911sI but
not at later times (Ziegler lit Ul'lianUe1982). Chloroquine
and ammonia caUSe the collapse of the intl;"acellular pH
gradient by raisJ.ng the lysosomal pH (Ziegler & Unanue
J.9S:a). Th:i.s collapse causes a qecrease in proteolytic
cleavage in the aoidic lysosome and thereby inhibition of'
effective antigert presentation (Ziegler .& trnanue 198:3).
Studies also Showedthat 'l' cell~l recognise chem.i.cal'l.y
denatured forms of al"ltigen (ThomaSPP et al 1981, St$ltte ~
.s1 19S9a) as well as native globUlar proteins (Matis II
.s1 1982) although the latter has since been disputed by
other workers (Sette et "111987). I:n 1959, Gell and
Benacerraf illustrated by means of delayed hypersl<al1sitlvity
e:>rperiments i:n guirtea pigs that T ceUs I like B cells I
cannot; differentiate between native and denatured
ant:Lgens. Later stUdies indicated that small antigenj.c
pep'l:!ides can be as effecti VG. as intact protein ;in ind.ucing
T oell :r'esponsl;)s (Matis et al 198,2, Thomas OW ~1..1 asaa ,
Thomas JW~ 1981). It Was also repor'ted using the time
kine'dcs of! purif~.ed protein derivat.ive (FPO) (~1aldr0l1,
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et al 1974) and Listerium monoo".yt09'enes(zieg'ler til
trnanue 1981) as antigen that a time lapse of 60min fol1.owed
the initis1 bil'lding'of antigl~n to maczophaqe and effective
presentation of the antigen by the aCcessory cell
(macrophag'e) to l' cells. All the above accumulated findings
led to the postulation of antig'en processing' (shimonkevitz
et al 1983).
1.3.2.1.2 MECHANISMS OF ANTIGEN PROCESSING ANP
P:RESENTAt.J:1ION.
The first step in antigen processing :l.nvolVesthe
internalisation or endocytosis of native g'lobular antig'en
bY aocessory cells (such as macroPhag'es) (Koch et a1 1989)
as seen in Fig 1.3. Two mechanfems of antigen uptake by
aocessory cellS have been suggesteci. The first mechanism
involves the pinocytosis of soluble antigen and has been
demonstrated to be size dependent. The second meohanism,
Which appears to be more common, involves the }:,'\.().din'1of
the antigen ;tothe cell surfaoe of the accessory cell
(Chesnut & Grey 1985). This bindin'1, Which takes pla.Je
prior to the endooytio event, could be via specific
receptors suoh as leotin-like carbohydrates such as man nose
or via non-specific, non-covalent interaotions tIJ'ith
ttnde:einedstruotures on the ce l.l, surface of the acoasaoxy
cells (Chesnut & Grey 1985). After internalisation, two
distinct pathways are used to process antigens depend.ing on
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which T cell ~esponse needs to be elicited (Yewdell &
Bennink lSH'lO). cytotoxic II' lymphocytes (CTLs) generally
require antigen presenting cells that are biosynthesising
antigen in the cytoplasm (Yewdell & Bennink .J.990). Xn
contrast, T-helper cells require a different antigen
processing mechanism involving the endosomal pathway
(Yewdell & BenninK 1990) which will pe discussed in this
section.
,
The initial cytoplasmic compartment involved in the pathway
of soluble antigens by accessory cells is a Vesid.l,e termed
an endosome (Koch et al 1989). However, it is presently
unknown in which exact intracellul.ar compartment the
interna.lisq,tion of antigen occurs (K:och et al 1989).
Because of the proteolytic cleavage of the native proteins,
acidic endosomal compartments sUch as lysosomes have been
suggested to internc:tlise the soluble antigen and partially
degrade it to amdric acids (Koch et a.1 1989). Cathep$in-O,
a membrane-bound enzyme :found in endcaomea is suggested to
perform the degrc:tdation (Olment et aJ, 1988). The extent to
which proteolysis is required l!or the presentation of
antigen in ccrrcext;of MHC class :U );nC)l.e(.;:ulesstill needn t,.,}
be established (Yewdell & Bennink 1990). It is known,
hoWevel:', that MHC Class :r:Imolecules prese~t peptide$
mainly del:'ived f170m extracellulc:tl:'ant:tgens (ie exogenous
c:tntigens) to helpar II' lymphocytes (tlc:tpb:i.tte a]. 1ge5,
Y'ewdell & Bennink 1990). The precise mechanism of how the
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Antigen presenting c_e_II_-.
t
Processing compartment
(lysosyrne 7)
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Figure 1.3 :
M0del Of antigen processing and presentation
(Redrawn from BuuS' (19'81»
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denatured or cleaved antigens are re"expressed in
conjunction 'N".ithMHC Class II antigens on the cells suz'f ace
of the cocessory cell is not presently understood (Owen et
al. 1981, Yewdel1 & Bennink 1990) .
Antigen processing and presentction has been shown to be an
energy~requiring, dynamic process that requires cell
viability (Shimor""'" ".1- 1 1983 I trnanue 1981). However I
it was ShOW!'lby
cleavage or.'even dar ".. -:•.t:. 'i,e::: the intracellular
p.i;"ocessingevent taking pIa ':' n~ ~e5sory cell
(Shimonkewitz et a: 1983" .t~g,res1.11ting in
al1tigen presentation by accessory cells, is necessary for T
lymphocyte recognition of the antigen and the T cell's
consequent activation (Kooh et al 1989, Babbitt et al
1985). Babbitt et al (1986) demonstrated, in a murine
model, using a defined synthetiC: immunogenic peptide, hen
egg lysosome (EEL) as an antigen, that presentation of the
antigen and the T cell's subsequent activation Was
resh-icted by Ia molecules.
1.3.2.1.3 MHC CLASS II BIOSYNTHESIS, ASSEMBLY ANI)
PRoCESSING
1.3.2.1.3.;1.Biosynthesis of Mlic Class II Glycoprotein!;;.
Like most. proteins and glycoproteins destined for the
plasma membz-ars, the HLA-DR region antigens are synthesised
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on memb.l:'ane-assooiatadribcsOii\eson tho rough endoplasmic
l:'<aticulum(RSR) (Cresswell ~ ;l.~e;'1, Ow,en ~.9.l. 19IH).
t:o vitro translation studies havei shown that the alpha.
and bata chains are synthesised as pl;'eoursO!."t:!'Wit :' '\ signal
sequence, an N-terminal peptide of 20-30 amino acids in
langth, in common with many othElt'membrane and. seol:'et~'d.
glycop:r.oteins (Owen at al 1913;1.). The nascent protein
sUbsequent.ly binds to the RER membrane via an REP. protein
known as a 'dooldng protein' (''' mer & Cresswell, 1982).
As tram~lation oontinues I bo~ J the signal sequence and the
remainder of the protein are oo-translutionally
assymetrically inserted through the membrane by an un)<:now:o
machand sm (owen ~ 1981, Cresswell ~ 19137). In the
presence o:e a mixed microsomal system, the signal peptide
is cleav~~g and tha Icora I oligosaocharid.a units are added
to the nasoent alpha and beta. subunits (l?loegh @t..al
1979). ~.l"hisabove scheme is followed by Class :t heavy
chain (alpha:)) and Class rr a1.pha and. beta SUbUl1.its. (l'Jwe.n
SlUl :l.98:1.)!The glycoproteins are ultimately orientated.
with their N-termin.us in the e'Xt:racytoplasmio spaoe (Owen
~ 1981).
PUlse/ohase lClbelling and 2-d gel eleotrophoresis have
pr.oved to be powerful techniques for the analysis of the
biosynthesis and glyoosylatiun of the I'IllA-DR antigens
(Machamer & Cresswell 1982). :tnthese experime.nts C1Clss XI
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antigen-positive cells are briefly labelled (5...10 mins)
with a radioaotive amino aoid suoh as 37S-methiQnin!a and
then excess unlabelled or lIoold" amino acicl j.s added. Class
II moleoule$ are isolate:-' at di:eferant time intervals
during a ~ubsequent inoubAtion at 37°C and analysed
thereafter by :a-d gal. electrophoresis (Machamer & Cresswell
1982) •
1.3.2.1.3.2 ASSEMBLY OF MHC CLAsS It GL~COPROTE!NS.
1.:).2.1. 3 .2.1. Function of the Aesociatecl lnvarial').'t Chain I
Ii.
Soon afte:r. the completion of tha synthesis of tha alpha and
):Jeta eha.ine, tha t!\olacules compla)Cwi1:!ha thil:'d
polypeptidSi, the gammaor Ii or. invar:lant chain (Machall\er lit
cr.esswell l,982, Simonis iUJ.. 1989, S'tocldngl'ar ~.J.
1989). The invariant chain relnl!l.inmassooiated with the
al.pha·,pata dimer throughout intl:'aoellUlar transport (Long
1985). The oHgolnaric Class rr-r; oomplax (Kooh ~
:1,989) movaa from tha endoplasmic retioulum (lllR) to 'I:.he
~"1\1i, body w'hsre the indiv:l.du~l chains urlclEll:'~o
POFlt...tr.an$la;cional modifioation!!:\ (Simonis ~ 1999).
HowliverI I;:ha Xi ohain is raleased fl'.")mthe alpba ...bC/;\ta cUmfilr
after the threfil chains have been through 'I:he Gol~(i compleX
(Sel<:aly ~t..2.1 1986, Miller & Germain 198$).
Although no evidence for the funotion of U'le invariant
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chain exists at present (Macha.me]."~ Cresswell 1982),
several possibi1itie~; including the assembly, aSl':1ociation,
and cyto!Jlaliimic tra.ns:port of the alpha-beta oomplex to the
cell surface have been suggestad (Koch & Intmme;~:lin9'1ge2,
Charron & McDevitt. 19'79). The latter possi~'ility (of
cytoplasmic transport) was disco\1nted when it was Shown
that Ill. molecules oan be expressad at the cell surface
aft.er transfeotion of alpha and beta ohain genes into cell
lines that do not express end.ogenous Ii (Sek.aly @t al :t~aG,
Millet' & GEl:rmain1986). Moreover I tne possibility exists
that Ii functions to oontrol poat ...transJ.ational procassil1<;1
Of Class XI mnlecul.as without the oVerall level of IEl.
expressior bein\~ affeoted (Hiller & (;ermain 1986 I Sinlonis
~ 19a$». MUl er and. Germain (198S) hypothes h ed. that
't.he function 0:: the invariant chain is to determine the
atl$ociat.:l.on ot tha antiqsn w.ith the Class II molGlcull::lin
the low pH environmen't of the endosome'll or lysosomcas.
T.heir hypothesis is supported by l3abbitt ~ (1985) and
Cr(lH!lswellls P,9S5) findings that antigEmic peptides
physically bind. to la moleCUles in cer'\::.ain oonfigurations.
T.heSElwork.ars sU9qest that the endocytic pathway of
transferrj.n"'neuraminidase oonjug'a,tes intercept with t.he
exocyt.ic pathtofa,yof vesioles carryilig' Ia"'Xi oomplexes to
the c.all surfaoe respectively.
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1.3.2.1.3.3. PROCESSING O~ MHC cLASS II GL~COPROTEINS.
The assooiation of Ii with Ia moleoules has pee).')shown to
be transient (Xiong1985). As mentioned earlier, the three
clhains (alpha, pata I Ii) are assembl.ed in the end.oplasmio
reticulum (ER) (O\,len·~ 1981, Kvist ~. :1.982). !<vist
~ (1982) found that Ii was present in the ER in amounts
exoeeding 'I::h06eof alpha and beta chains. As the Ia....:ri
cC)lRple:X:moves through the ER to the Golsri Ilpparatuslit is
tet':minallyglycosyl.ated at the 'high mannosel
oligosaocharide units as well as at. sElrine and threonine
moieties to It\ol::'t:) complex forms (O~ilm ~ 1981, KviEr!;S1:t
~ 1982) •
1.3.2.1.4 TaE MHC CLASS II"',ANTIGEN COMPLEX.
1.3.2.1.4.1 stt'uc:turalCharaoteristios of the MHC claSS II-
Antigen complex
l.'hestruotural oharacteristios of peptides neoessary for
~hair interaction with MHC molecules has baen an area of
intsn$iva investigation (Gray ~ 1989, Sette .!iL.U
1985a, l(urata « aarzofsky :1.990,Bhayani & Paterson 1989).
Thill~bove workers used immunogenic paptides derived :from
chickllll1ovalbumin (OVA) 323-329 (Sette .!it.....U 1989a, 10a9b)
pigeon or moth cytochrome a 93"'104 (in pigGon) (Bhayani &
tJaterson 1989) and sperm Whale myoglobulin l?133...146 (Grey
~..J!l. 1989). 1\.9 dc.ltail.edabove (Section :1..3.2.:1..1)
lJ:' ... help~r calls only recognise antigen When it is phyedcally
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altered (denatured or partially dE\graded) (Sette et $\1
:1.9B7) and su,bset,tuentlyre-expressed. The association
between antigenio peptides and the MHC molecule has been.
controversial. '.J:Iheantigenio peptide and the MHC mOlecule
oould both birtd to a reoeptor on. the T cell, known as the T
cell receptor (TCR) independently of one another, ie, dual
reoognition by the 'l'CR. (:Ploegh ~t C\J, 1981, AshWell IX
Scht1artz 1986). r.vheother alternative is that th"l II! oell
c01.l1d~erve as a site :forthe antigen and MHC mOleoule to
dritically inte~.!'aotwith eadh otl').et'(Watts & MdConnall
:1.986 t Babbitt st!L.tl. 198(;).
Recertt:bioohamical evidence Supportsl the latter
alternative, namely the concept of a ~pecific receptor""
ligand association (Watts & Mcconnell 1986, Buus ~~
198G) to forxr,a novel bimolecular struoture which than
serves as a subst:t:"atefor recognition by 'J! cella (Ea.hJ:litt
mt ~l 19a5). MOVeover I :I.tv. I baan dentonstrat,ad
expe:dlllantally using equilibrium dial.yais that the
MH:c...peptide (receptor ...Ugand) interaction illthe only
absolute requir~ment for ~ cell reoognition (BUUS ~
1987). It. is still unknown how the MH:C molGoulas regulate
the immune response during antigen pl:;'9salltation
(~abbitt ~. 1985) but it is thOUght to result from t.h~
stab:l1ising effeot of their association with the antigenic
peptides.
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It is known that 'l'-hel.per cells only recognise antigen that
is presented in assQcJ.ation with MHCmo).ecules (:Rosenthal &
shavach 1973a).
1.3.2.2 FUNCTIONall' MHCCLASS:t
1.3.2.2.1 Endogenous Antigen Processing.
Initially from Rtud:i.es of target ce11 recognition by
viru$-speci:F.ic cyto,todo '.t' lymphooy·e.es or C'I'f.J Is (Braoiale
.sUL.al. 1987), it was hypothesised that the MHOClass
I-restricts<;l lymphooyt.es reoognise f01:'eign a.nt.igens that
a.1:'Elaxpresse<;l in their native form on cell surfaces
(Gathing ~ 197a). HoWeva1:',later reports illust1:'ated
that cleaved viral peptides were also capable of
stimulating MHCClass I"'restricted lymphocytes (Geurt::'" .&
Fan 19$0, Maryanski ~ :1.986, Townsend !it al 1985,
198a). The site on the human protein rc.acognised by F.Oll'le
Clas/l;l I-I'Clstricted 'l' calls b defined as a stret.ch of 16
~uilino acid$ (Bl;lVan:1.997). whl'~realllthe compl.ete native :fot'-ltl
E1,eamsirl7eleva:nt for 1:'est.:t:'icted rElC'':>9'nit~j.on(.Bevan 1ge~I).
'l,'hase f indinr;;rs have led to the h¥pdtllit~sis tha.t. proc::a$ein9'
of antigen for MHCClass I""rEHlJt:):'ictec.\p1:'Elsentation, like
tha.t of MHCcl.ass n, also apPt:.'ars to J.nvolve proteolysis
and presel'l.ta't.ion of antigenic peptidas boul1d to MHCClass I
molecules to C'rt.fs (ejorkman ~ 1S)S7a, ';t'ownsel1d&
MCMichael :1.9a7) •
-,
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Morrison et a1 (:1.986) found that isolated influenl1:a
haemagglutinin (HA) polypeptide antigens that were
x:acognised by Class :t:-restricted CTLIS were not sensitive
to lysosomotropic ami.nes such a.s chloroquine thus
suggesting that antigen presentation to 11HCClass
X....rest:dcted virus-specific T lymphocytes occurs by a
distinctly different pathway to MHCClass II-restrioted
antigen presentation. It beoame evident that MHCClass I
molecules present peptides derived from exogenous or
oytoplasmio proteins synthesised by the cell (J3erzofskY.§t;
U 1~9a), ,,:hereas MaCClass II moleoul.es genel.'"ally present
peptides dl.'arl.ved frOl\\ Elndogenous protein (cressWell 1990).
Townsend ~.lll. (1989) showed that modificatiotl of the
N-terminal ami,no aoid of the in:e1uenzl!l virus nuoleoprotein
enhanced the l".uolaoprotein Is rate of oytoplasmio
degl:adatioh. ~rhis il10reased th($l.lysis o-e ~mUs exp:l;'essing
the viral antigen by MHCClass :r"'r.'estr~.oted corL";! (ToWnsend
tit ~l. 198a) , ']'h1s suppo.:t.s the hypotht:lsis that peptides
pref;Hmted by l>n-tCclass! moleQU1ElsundElirgoproteo:Lys.:i.s in
th~ oytopl.a~m and not. in the lyst:lsoma.l granules (cl;'essWell
1~90) •
It is pl:oposed that once the v.i.ral peptides have been
generated by proteolysis, they associate wito. the l<tHCcla.ss
:x; moleoules in the endopll!l.smio l:'(i),ticulum (E:R) or an
associated oo'\\partment (Cresswell. 1990 I Xewdell & rH~nnink
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J.990). This supposition, is supported by the observation
that brefeldin A, which inhibits transport from the En to
the Golgi apparatus, blocks the prs$entation of
cytoplasmically processed antigen thereby il')hib;tting
Class-X restridt~d T cell recognition of the
virally-infected cell (YeWdell & Bennink 1989, NUchtern et
.9l 1989). The molecular events involved in peptide pinding
Py MHC Class J. molecules are, at this stage, far from cl~ar
(Cresswell ;1.990). Evidence sugg"sts though, thut the
antigen:i.cstructures recog'nised on targ'et cells by CP8+
CTL's are binary complexes formed by the association of
peptide fragments of protein antigens with MHC ClaSs I
antigens (Cresswell 1990). In the normal courSE! of events,
the associated peptide-MHC compIt;lx'leaves the ER and
travels through the Golg'i apparat"l.lISwher~ l,t is expressed
on the plasma melnbrane (Nuch'tern ~lil\....M 3.989).
1.~L2.2.2 BJ;OSYNTI1ESISOF MHO CLAS'S I e,,}LYCOPROTE!NS.
The biosynthetic mechanism of MIiC Class I heavy chain
(alpha 1) is detailed above in Seotion 1.3.2.1.3.1 and as
stated is ve:ry similar to that of MHc Class I1 protein
sUJounits (Crese;Well ~ 1987).
1.3.2.2. 3 TH~ MIiC CtJ\.SS:r"'ANTIG:E:NPE1?TIPE COMPLEX.
1.3.2.2.3.1 li'unotionof the Associated Invariant Ohain,f.,2111.
Insig'ht into the role of B2m in HtJ\.expression was ga:tnad
:from the analysis of the Daudi cell line (Area"Gomez !i\ta).
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1978). 'I'hiseel). line was established from a Burkitt's
lymphoma, and has consistently been typed as
HLA-A,B""nega:l:iVe(l?loegh.§.Itat 1981). This celL line does
not synthesise B;amand no mRNA encoding for B2m is produced
either (Ploegh et al 1981). 'I'helack of B2m led to the
hypothesis that this might cause the failure of HLA-A and
HLA-B antigen expression on 'thecell surface (l?loegh et a.l
1981). Ploegh et a1 (1979) delUonstrc>,tedby pulse/chase
labelling experiments that the Syn'l:hesisof the HLA-A and
-B chains does occur in near normal amounts in Daudi cells
in the absenCe of B2m. HOWever, there was a lack of
expression of the heavy chain (domain alpha 1) at the cell
surface indicating that 62m is essential :torexpression of
flU-A and ....B antigens at the cell su:tface in Daudi cells
(l?loegh~ 1979 r Seong ~t aJ.19(38). Allen at a+ (:l!~ae:)
have shown that a murine cell line lac :ing the !?12mgene,
and that t...as tral'lsfectedwith an H"'.20bgene expressed the
heavy chain on r.he oell surface. IJ:ihisimplies that 132m
association with the heavy chain is not required for :i.ts
expression on the cell surface (Allen ~t~ 1986). Later,
l?erarnu ~Jal (1990) reported that it is not the
association Of· 82m with the heavy chain therl:results in
cell surface eXpression, but rather the way in which the
chains fold is important for efflciant intracellular
transport of class ! moleoules and their subsequent
expressiQn on the Cell surface. The posttranslational
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asso~ation o;f the neavy cnain alpnal with B2m as follawed
by pulse-labelled experiments can be seen quite early in
the ER (Krangel et al 1979). Association of alphal and B2m
is complete W:!,tbi Ii: 5"'10 minutes after the completion af the.
heavy chain and is accompanied by sUb$tantial changes in
the conformation of heavy chain (seong $lt aJ,.1988, SegE! et
a1 1981). AS$ociation is required for the t'apid processing
of the high-mannose oligosaccharides on the heavy chi:\in
that occurs in the Golgi apparatu~ (Sege et a1 1981).
1. :3 • 2 .2.4 FtrR'1'HERFUNCTIONS OF MHC CLMS I
MHC Class I antigens play a crucia! :.t'Olein the cellular
immune response by functioning as the antigen-presenting
molecules that enable C'l',r.,sto discriminate between foreign
or nonself f~:om self antigens (Bodmer 1972). Thus both NRC
Class I and class T.Imolecules possess a common feature:
they are involved in the recogniti of self and the
subsequent; t;'ansmission of a specific message f~'om one cell
subpopulation to another (Gopas ~t a1 1989).
:MHC Class I molecules have also been described as part of
more general phenomena, involving aspects such a,ISMHC
aaaocd.abed cellular adhesion by T oell adhesion nlolecules
or CAM (staunton 1988), contact inhibition as suggested Joy
Meda'W"'rin 1978 and demonstrated iJ'J Curtis & Rooney (1979)
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in syng'eneic epi.thelial oeLl.sof mice, interaction with
hormones such as insulin in transg'eni(~mice (Allison et al
1988) and interaction with viruses where the Class I
molecule acts as a 't7C:. ~ptor for the virus (Inada and Mit ,;
1984). Due et,~ (1986) showed that MHC Class :r heavy
chain can associate with the insulin receptor by
displacement of the 132mby the insulin rece_t:ltorin moust.
hepatocytes. Recently t\ 11-]\.Dachemccaot Lo protein
thymotaxin was identified and s:..own to be identical to 132m
(Dargemont et al 19a9). (Chemotaxis is a migratory process
of th9 activation of leukocytes Or other cells by
chemoattractants (Barl:ett1988». Besides its association
with the MHC class I heavy chain, f:r-ef:132m could also be
involved in chemotactic activity in the cell (Dargemont rt
a11989).
THE NATURE OF THE MH..:!-A.NTIGEN CQMJ.'LEX.
Characterist.ics of the Reoognition structu:r-e
on B Cells.
B cells are the eLaas of lymphocytes responsible f()r
1.3.3.
1.3.3.1.
g'enerating an antibody rl~sponse, The mo~ eouLas on the B.
cells responsible for specific recognition of anti.r;rensare
the different classes of antibodies that can be expressed
either as call-surface molecules acting as receptors, or in
secreted forms serving' a variety of pu~poses (Raitt 1989).
These incluc1e the initiation of complement mec1iated ]\.i).ling
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and the inactivation of viral particles by d.irect binding
of the antibodies to the virally·...in:eec~ed cel.L (Roitt
1989) .
1.3.3.2 CliARACTERISAT!ON OF THE T CELL ANTIGEN RECEPTOR
The equivalent recognition of the B cell's antibody
structures on the T cell is the membr ane+bound T cell
antigen receptor or TCR (Davis & Bjorkman 1988). The TCR
is specific for a combination of foreign antigen with an
MRC mo Lecu.Le (Davis & Bjorlcman 1988). The basic
arch":"cectureof antibodies and their :modes of interaction
with antigen on .B cells ar",well understood. (Davis &
Bjorkman 1988). By ccntnraab, very lit .1e l1'lolecUlardata
about TCR' s or their ligands has been a"a~Uable until
recently (Davis & Bjorkman 1988).
1.3.3.3 CHARAcTERISTICS OF .THE TCR WITH THE llliC....
ANT!GEN COMPL:E.X
•The characterisation of the antigen recognizing str1lot.'l.1.re
on the various olasses of T cells has been a difficult
problem for i1n1nunologists(Kappler et al 19B1). Various
models have been proposed to explain how '.c: cells are a);)1e
to demonstrate an apparent dual specificity for antigens
and MHC products such that the T cell on;ty functions when
donfronted with both the app'roprLaticantigen and MHO
prOducts (Kappler et a1 1981, Ploegh et al 1981). Sorne
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workers proposed bro independent .TCRIs (Ashwell & Schwartz
19~!6, Koch & Hi:i1nmerling1982) while othe:cs have proposed a
single TCR~.,ith a physioal interaotion oocurring between
antigen and MHCprod.uots on the antigen-presenting oel1
(BabbH:t et .aL 1985, sh Imonkewf.t.a at al 198?, Benacerraf
1978, BuUSet al 1986) in other words, the TCRrecognises.
the antigenic peptide in association with the IffiCmolecule
at a single site as described in seotion 1.3.2.1. 4.1 (Davis
& Bjorkman 1988). Xt was demonstrated by the use of an
energy transfer of the TCRin an evanescent energy field
that th(:.\MHC....peptide interaotion is greatly stabilised by
'the TCR (Watts et. al 1986). Ho~.,ever, this hypothesis of a
ternary or trimoleoular oomplex (Sette et al 1989a, 1989b,
Bhayani & paterson 1989), between the peptide MHC-'TCRwas
not demonstrat;~d biochemioally (Kappler et a], 19S1) until
the elucidation Of the three-dimensional strt.lcture of
flLA-A2by x"'ray orystallography (Bjorkman §t al 1987a,
19870). (See Fig;:i..4 for a proposed. model of a ternary
complex between TCR,MHeand antigen). The orysta.l
structure illustrated that the MH.CmoLecu Ls interaots
intimately with the antigenio peptide and itlent:1.fied the
probable antigenic binding site to be a cleft on the outer
surface of the MHCmoleoules betw~en the tWo alpha-helilJes
(Bjorkman et al 1987a, 1987b). Similarly, a hypothetical
model Of the antigenio binding site in the stru,cturally
similar MHCClass II molecules suggests that this ola.ss of
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Figure 1.4 :The trlmolecular complex .tor antigen specific
'T-:cell receptor, recognition of antigen ana an
Ia molecule (redrawn from Ashwell and
Schwartz (1986) )
(
TOR
la
/
~
TOR
la
TOR -'- T-cell receptor
Ag = Antigen
la = MHO class II
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antigen ccntiaIus a similar peptide binding region (Brown et
al 1988). HoweVer, their hypothetical structure of the
foreign antigen recognition site produces only a frarne"Work
of generating testable models for peptide binding to MaC
Class n. Berzofcky et al (1987), proposes that a single
antigenic peptide associates with a MHC molecule in a
specific conformation. This generates TCR diversity by
overlapping epitopes (residues interacting with the TCR)
being present on that specific molecular species (Berzofsky
et al 1987), In order for the peptide to be immunogenic
(Buus et al 1987) the epitopes must be predominantly
amphipathic in nature (Berzofsky et al 1987), that is,
naving alpha .....helices that have hydrophilic and 'lyu.:r;ophoblc
residues on oppos i.: sides. Berzofsky I s hypothesis may
ultimatelY pr.ove important in vaccine devolopment for the
prevention of AIDS (Acquired :tmmunodeficiency Syndrome) ancl
Hepatitis B (Berzofsky et al 19B7). Lt.has recently been
shown that a single peptide can binc;lin lUore than one way
to a MHC molecule (Bhayani & Paterson 1989, Kurata &
Bor~ofskY 1990). Not only maya peptide employ different
agretopic residues (portion of the peptide interacting with
the MHc molecUle) (BerzofskY et al 1987) in binding to a
MHC mOlecule but each peptide may interact with a MHC
molecule in d,iffe~'entconformations (Bhayani & Paterson
1989, KUrata & Berzofsky 1990). Thus a single MHC molecule
appears to have different binding functions depending on
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the TCR that make up the ternary complex (Bhayani &
Paters'on 1989, KUrata & Berzofsky 1990). This could
perhaps explain the heretofore unknown phenomenon of how a
specific MHC can interact with so many different
antigens.
1.3.3.4 STRUCTURE OF THE T CELL RECEPTOR
There are four distinot TCR glycopeptides (alpha, beta,
gamma, delta) that form two distinct disulfide-linked
heterodimers (See Fig 1.2). Alpha: beta' and gamma: delta are
very similar to the immunoglobulins in pl."imaryamino acid
sequence, gene organi-satioh and tertiarj' structure (navf.s &
Bjorkman 19881 sim et al 1984). Transfection of human
cells with murine alpha:beta T-cell reoeptor ger.es
established that alpha and beta chains of the TCR (Ti) ar~
SUffioient to transfer both antigen and MHc speoifioit:t to
T cells (Sim etal 1984). In these experiments, cytotoxic
T cells tha·tbear T3 receptors were used (sim at al 1984).
It has also been established that antigenic peptides bound
to the MHc molecules at what appears to be a sinqle site is
the major class of 'objects' that alpha:beta Ti cells 'see'
(Bjorkman et al 1987b, Babbitt et al 1985, Davis $( Bjorkmah
HSS) • yet another complicating feature of.hOW a T dell
sees antigen involves the CD4 and CDB (UCluster of
Differentiation") gl.ycaproteins found on the surfaces of T
cells (Davis Ii< Bjorkmal:'.19138). CD4 or CD8 moLecu Las , knovn
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.1'.6 I "mce$sory 1 molecules are only expressed on mature '1'
cel1~ (Gay et al (1988) The majority of C04+ cells are
of the helper phenotype, while mO$t C08+ '1' cells are
cytotoxic or suppressor (Davis & Bjorkman l.988).
WheT:.discovered C04 was named '1'4or LeU"'3 in man, L3T4 in
ll\OUse(Marrack et al 1983) and COB Was named Leu-2
(Engleman et al 1981). Monoclonal antibodies against Leu"'3
and Leu,,:"Were found to block T cell proliferation in
response to Class II alloantigens inman and also block
cellular cytotoxicity mediated by recognition of Class :x:
moleCUles (Engl.emal;et al 1981, 3wain et al 1983, Biddison
at al 1982). Marrack ~t al (1983) demon$trated that the
L3T4 (C04) mo Lacu.l,ewas not required for the functionaJ,
activity of the TCR receptor with the antigen-MHC complex.
However I later studies using gene transfer have illuertrated
that the C04 and CD8 moLeou l.eamarKedl~y enhance T-ceU
responsiveness (Sleckman et.al 1987).
CD4 is an invariant 55-Koa s1.l.l~facereceptor (Littman
1987). I~s expression on T lymphoc~tes is tightly
associated with their restriction to MHC Class XI antigens
(M<:lueret al J..,984).Similiarly, the expression Of COS
correlates st:;ictly with MHc Class I !l1iolecules.Gay et al
suggested that both the TCR and COil,ll\c)leculesmay bind. to
the same MHO molecule on the antigen presenting cell.
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(APC). comodu.l.at.Lonby TCR~and CD4 suggests that CD4 may
lie in close proximity to TCR (Gay et al 1988) or may even
be associated with it (Chuck et al 1990). CD4-TCR
complexes have recently been det9cted on the surface of
human leukaemia T cells demonstratinq that these cOJ:nplexes
pre-exist on cell surfaces as stable moleoular assemblies
(Chuck et a1 1990).
1.4.1.
MHC EXPRESSION IN TISSUE
Tissue distribution of:HLA-AfB,C Class I
1. 4.
antigens
MHC Class J. ant.igens (HLA..-A, 8, C) are expressed on the
surfaces 0:: all nucleated somatic cells (paar et al 1984a,
Fleming et a1 1981, B\;lrahet a1 1970). studies by Da.ar ,gj;;"
a1 (1984a) ot the detailed distribution of HLA Class I
antigens thr01.lghout+"e body s1.lggestthat these antigens
are not as ubiquitous h their distribution as previously
suggeste'fl. Daar et al (1984a) sug-gests that t:he
exaggeration of HLA Class I antigen distribution could be
because techniques such as indireot immunofluorescence, do
not alloW' detailed examination of tissue morphology. The
use of monoclonal an'Ubodies (MOABs) together with a
sensitive immunoperoxidase staining technique as used :by
Daar et a1 (1984a) allowed for the exa.mination of the
detailer'\distribution of fILAClass I antigens.
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HLA Class I antigens are expressed on virtually all adult
tissues though at varying levels (Elliott et al 1989). The
organ with the highest HLA antigen expression is the spleen
followed by other lymphoid, organs (Elliott et al 1989).
The lowest amount of Class I exp:t'es~ionoccurs on muscle
and nervous tissue (Elliott et al 1989) ,lithneurones and
Skeletal muac Le I under normal conditions I demonstrating- no
or weak Class X expression respectively (Daar et al
l%,la). The prima.y distribution of "classical" HLA Class
I antigens in the gut, glands, lung and kidneys is on
epithelial derived cells (Elliott et al 1989). Vascular
endothelial cells also express MHC Class I antigens
(Elliott gt al.1989).
1.4.2. DIS'l'RIBUTIONOF HLA CLASS :t ANTIGENS IN LIVER
In studies of MIW ct.assI antigen distril::>utionin normal.
tissue, it wa<>:l;oundthat all blood lTessel endothelium,
biLe duct \~pithe1ium, Ubrol::>lasts,sinusoidal lining cell,s
(including Kupffer cells) and interstitial dendritic cells
expressed these antigens (Oaar et al 15:)84alDaar et al
1983" Barbatis et al 1981). However I the identification of
Class I ant:Lgen on hepatocytes varied according to specimen
used (Daar £~t al 1984a). Reports on the expression of
class I antigens by hepatocytes are confli ,ting. Several'
demonstrated nO MHC Class :r expression (Barbatis et al
1981, ta.utenschlager et al 1984, Fukusato et al 1986)
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whereas oth~rs reported distinct expression of HLA Class r
antigen by hepatocytes (Montano et al 1982). The
discrepancies of HLA Class I antigen expression on
hepatocytes may be due to differences in the tissues used,
specimen handling in processing, sensitivity of the method
and interpretation of the staining as well as the
inducement of HLA expression by anaes+het.Lc agents or other
orugs (Daar et al 1984a, Fukusato et al 1986).
However antigen display was noted on the cell surface of
hepatocytes in many liver diseases including chronic active
hepatitis (CAR), hepatitis B virus (HBV), hepatocellular
oarcinoma (HCO) among others as well as on certain hE:.j?atic
cell lines (Fukasato et ftl 1986). Montano et al (1982)
reported a relationship between the expression of HLA Class
! antigens on hepatocytes and the level of HBv replication
in chronic HBV infection: al.'.tigenxpression on the
hepatocyte plasma membrane is increased during the
hepatitis E antibody (HBe Ab) phase of chronio infeotion.
It is not presently known whether a common mechanism
.nderlies the induotion of HLA Class I antigens by such
disparate factors as toxio agents, immunologic stimuli,
viral infection and neoplastio transformation or whether
the appearance af HLA Class I antigens represents a
non$pecifio manifestation of hepatocellular injUry
(Fukasato et al 1986).
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1.4.3. TISSUE DISTRIBUTION OF Hk~ CLASS II ANTIGENS
In contrast to MHC Class I lnol~cu.leSi Class II antigens
exhibit a more restricted tissue distribution (Elliott et
al 1989). Initially, Class II antigens were described on B
lymphocytes, epidermal Langerhans cells (Klareskog et al
1977) and endothelial cells (HirschbQrg etal 1979). They
were later found to be expressed on activated T cells (Fu
et al 1978) as well as specialised,antigen-presenting cells
SUCh as macrophages (Unanue 1981), dendritic cells (Hart &
Fabre 1981) and Kupfier cells (Richman et al 1919) as well
as fibroblasts (BosS & Str.:>minger1986). The results ·0£ a
study by Daar et al (1984b) of the detailed tissue
distribution of Class II antigens using a MOAB and the
peroxidase-anti-peroxidase (PAP) staining technique on
f;-:eshlyfrozen normal tissues, incHcate t,hatHLA Class II
antigens have a far wider distribution than was previously
thought. In normal human tissuei the distribution of HLA
Class II antigens is found on the upper respir"l.torytrq,ct,
small intestine, kidney and breast (in addition to above
mentioned cells) (Daar et al 19Mb).
1.4.4. DISTRIBUTION OF MHC CLASS II ANTIGEN IN LIVER
studies on hepatocytes of normal liver and epithelial oe11S
of the bile duct have demonstrated that these cells do not
express Class tI antigens (Daar fot al 1984b). Other
stUdies, however, have demonstrated that these antigens are
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expressed by Kupffer cells (Walter & Israel 1987) and 'che~
interstitial dendritic cells around the bile ducts and
portal triad (Daar et.al .1983, Daar et al l£"Ab).
1.5 MEC EXPRESSIoN IN MALIGNANCY
1.5.1 Introduction
As first shown by Zinkernagel a110Doherty (1979) T-cell
mediated cytotoxicity of virally-infected and neoplastic
cells require the presence of MHC CJ,assI antigens.
Foreign antigens (antigenic peptides) on the surface of
accessory cells interact with the TCR .andare identified as
'nonself' or abnormaJ,only when presented in conjunction
with 'self' Class I antigens (Lassam & Jay 1989). It
appears that this ,tnteractionis essential for the removal
of independent cell variants that presumably arise
frequently in multicellular organisms (Freshney 1985).
Thus the development of malignant tumours represents not
only neoplasmic development but also the fa)_lure of host
resistance to eliminate aberrant cells (Tanaka et al
1985). Transformation of a cell Ls aLone insufficient to
ensUre the escape of tumour cells from immune survl:lillance
(Tanaka et al 1985). It has therefore been hypothesised
that suppression of MHC Class I antigens is a necessary
step in the development and clonal selection of malignant
cells (Katzav ,eta1 .1983, Hanunerling et al 1986) and is a
possible mechanism whereby neoplastio cells escape from
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immune surveillance (Tanaka et al 1985).
1.5.2. SUGGEST.ED MECHANISM OF MHC CLASS I SUPPRESSION
It has been suggested that suppression of the MHC Class I
mRNA levels in a variety of highly oncogenic cells results
from a substantial decrease in transcription initiation
(tassam & Jay 1989). This may e:xplain how cancer cells can
be made immunogenic by the derepression of endogenous Class
I genes with modulating pharmacolQgical or physiological
agents such as the interferons or IFNs (Tanaka et al 1988),
since class I mHNA accumulation is neaiLy always increased
in IFN-treated cells (Tilnaka et al 1988). It is currently
believed that cis-acting DNA sequences both 5' and 3' to
the transcription initiation site are required to achieve
full induction (Korber et al 1987). Analysis of the 5'
region of several HLA Class I genes has led to the
identification of a 30 pp interferon response sequence
(IRS) (Friedman & Stark 1985). Despite these advances in
the oharacterization of the IFN response, it is still
unclear whether IFN acts directly to induce Class I
transcription or whether other mediators are in'lfolved
(Tanaka et al 1988).
1.• 5.3. ROLE OF ONCOGENES IN i'iAtIGNAl{CY
The search for the genes associated with oncogenesis has
led to the identification of a group of highly ¢onserved
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genes whose products contribute directly to normal cell
proliferation and differentiation as well as to the
development of the organism (Bishop 1987). These cellular
genes, termed protD:-Qncogenes or cellular oncogenes
(c-ones) may be converted to transforming genes by
mutation andlc)r by molecular mechanisms (Carbone « Levine
1990). It has been found that certain oncogenes such as
IC'as,which has been identified as a gene capable of
inducing tUmorigehicity (Sob~U 1990, Barbacid 1987) as well
as mye, mos, r.af,sre, :fesand flUS can induce
metastatic potential in certain cancers upon transfec·tibn
(Bishop 1987 I Egan et al.1:,87). In addition it has been
demonstrat,ed that (!·-.i:os, a prc1to-bncogene that controls
the expression qt' MHC genes may suppress meta5tasi~ by
acting through a. mechanism by which immunogenicity of the
tumour cell is increased via expression of the H-2K alltigen
(Fel.dman & Eisenbach. 1985}.
L5.4 ROLE OF MHC IN NATURAL KILtER CELL RECOGNITION
Natural killer or NK cells are responsible for the
spontaneous lysis of a variety of neoplastic or
virus-infected target cells (Heberman Ii< ortaldo 1981).
Most of the evidence implicating NK cells as a defense
mechanism against tumOUr growth and met<:istaticspread is
base." em the cCll;relationbetween the susceptibility of
tumour cells to lysis by NK cells ~n vitro and the
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inhibition of the same tumour cells in vivo (Gopas et
al 1969). It has been widely accepted that unlike T cells,
natural killer cells recognise their targets in non-
MHC-restricted manner (Gopas et a1 1969). However, Karre
et a1 (1986) dispute this view and have proposed that NK
cells are effector cells in an organism's defence system
that are geared to detect the deleteq or reduced expression
of self~MHC, Karre et al (1966) hypothesise that there is
an inverse relationship between MHC Class 1 expression and
susceptibility to lysis by NK cells. Some workers (Tanaka
~t al 1988) however, suggest that MHC antigens can clearly
inflUence the susceptibility of certain tumours to NK
lysis. However Pena et al (1990) recently demonstrated
that HLA Class I antigens do not playa decisive role in NK
susceptibility of Cell lines derived from hUman solid
tumours and suggested that molecules Which are lFN-gamma
induci)::llemay confer NK sUsceptibility to these lines.
Finally, Gopas et al (1969) suggeated that there is no
quantitative, inverse correlation betw~en metastatic
potential, NK activity and MHC expression. studies on NK
aQtivity of lymphocytes isolated from patients sUffering
from Hce show a defective NK system (Son et al 1982,
Saibara et al 1989). Although the cause of this depression
is as yet unknown, it indicates a disturbed immune system
in aee and thus should be further investigated (Saibara et
M 1989).
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1.5.5 AN!MAL MODELS IN MAt!GNANCY
Several experimental animal tumour systems have bean used
to provide evidence for the hypothesis that down-regulation
of Class I antigens oan allow transformed cells to escape
immune deteotion (Lassam & Jay 1989). :tthas been shown b:y
various workers that rodent cells that were transformed :by
the highly oncogenic strain of human adenovirus 12 (Ad-12)
did not express MHC Class :r antit;:fl:!ns(Hammerling et.al
198b, Sohrier et al 1983, Be:t"nardset a.l 1983). HoWeve:):.",
in contrast, it was found that a non-onoogenio strain named
AdS expressed normal levels of MHC Class I surface antigens
(Schrier et al 1983, Bernards et al lS83). ',tIransfeotionof
a functional. MHC clas,:,;I gene into a highly tumorigenio
Ad-J.2 transformed murine cell line :r.estoredH-2K expression
and resulted in a complete loss of onoogenioity ('l'analcaet
al 1985, Hammerling et al 1986). This provided direct
evidence that the 6ncoge11ic potential of Ad-12 transformed
oells resulted from MHC Class I suppression (Tanaka et .al
1985). Similar transfection studies with Class I-deficiiEmt
cellR derived from ohemioally-induoed or spontaneous
neoplasms have alSO demonstrated inoreased ·tumour rejection
or reduced metast" tio potential (Flaksin et. al 1988,
Wallich et 0.1 1985, aui et al 1984). Reoently, differences
in the regulatory functions of H""2D and H"'2J.<gene products
eXpressed on tumour cells haVe been identified (Gopas et.al
1989). reldman and Eisenbaoh (1988) and their oo~workers
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(Wallich et al 1985, Plaskin et al 1988) have established a
relationship between metastatic potential and the ratio of
H-2I< to H....20 MHC mol ecu l.as expressed on the cell surface
(Eisenbach et al 1983). These workers have demonstrated,
using metastatic clones of murine fibros~rcoma (Wallich at
al 1985) or Ldwis lung carcinoma (Plaskin et al 19S8), that
H-2 gene transfection resulted in conversion of a meta-
stat.ic to a non- or lOiV'-metastatic phenotype. It appears
that H-2D is involved in immunological toler.:anc.e,which is
the failure of the immune system to r:aject the locally
growing mass (Feldman & Eisenbach 19S5). Thus H-2~ has an
j,mmunogenic acti vit.yWhile that of H....2P causaa suppression
(GOpaS et a1 1989). Genel."aJ,lyit appears that alterations
of ~lass I antigens that affect recognition of tumour cells
by CTLs can be because of:- a) qUantitative regulation or
loss of specific Class I antig'tms (Gopas at al 1989) b)
aberrant expression of class I molecules (Wortz.l et al
1983) and c) generation of novel class I antigens.
Aberrant Class I mOlecules haVe been detected on an
ultraviolet radiation-:l.nduced fibrosarcoma 1591, a
C3H ..derivec1.tumour cell line (Wortzel et al 1983).
1.5.6 MHC REGULAT'CON IN HtJMAN CANCERS
In agreement with the ",nima! moO,els studies mentioned in
sect~ion 1.s .5. Ilreduction in MHC Class I antigen
expression has also been observed in a variety of. human
.'~
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canoers. These oancers, particularly thc:';;eof epithelial
derivation, appear to express greatly reduced levels of
surface MHC Class :t antigens (Lassam $( Jay 1989/ Hui et.aJ.
1984). They include small"cell lung car'odnoma (Ooyl~ g,".:LJil.
1985), mammary caxo.inoma (Fleming et a1 1981, Nata 1 i .§.t. a1
1983, Moller et al 1989), and colorectal car-oinoma (MombUrg
et.Jll. 1986 f van den Ingh et al 1987, t6pez-Nevot et al 1989
and Norazmi et aJ, 1989) as \'1e11 as gastric and laryngeal
carcinomas (Lopez--Nevot et al 1989). Similarly, cell. lines
derived f:rom several of the above tumours also have :reduced,
levels of MHC Class I antigen expression (Tanaka. e'!:; al
1988). Natali eta]. (1989) hypothesise that the selective
loss of a HLA polymorphic epitope SUch as HLA-A2 may
explain the mecnani.sm by which tumour oells of oertain
solid ·tumours escape immune surveillance.
1.6 HEPATOCELLULAR CARCINOMA
Introduction
Hepatocellular carcinoma (HCC) , is one of the most oornmon
malignancies in the world (Wanebo etJal 1989, Kew 1990).
The prognosis of this tumour is so grave that, its
freCJ:ue.~cyrate and mortality :rate are almost equal (l<:et>l
1983). Reports have estimated it to be responsible for 250
000 to 1 250 000 deaths per yea.:r(ReW 1990, Cook & Moosa.
1985, Chlebow$ki ~ 1984). :ets fUlminant course, low
rate of :reseotability and, poor response to Oheltlo't:herapy
51
make the prevention of this tumour of utmost importance
(Rew 1983). Thus HCC presents one of the most urgent and
important challenges in the field ot liver disease (Rew
1990). MO'~eover( investigations of che many and diverse
manifestations of this tumour may lead to a petter
understanding of the basio biology of neoplasia (Rew 1990) •
1.6. 2 EJ?IDEMIOLOGY
Hce oocurs commonly ag'e"'adjustedinoidences g'reater than 20
per 100 000 per annum, (Rew 1990» throug-hout Africa south
of the Sahara and in many parts of the Far.East and Pacific
Basin (Higg-inson 1963, Geddes et al 1970). The malig-nanoy
has a moderately hig'hincidence (10-20 per 100 000 per
annum) in Japan and Southern Europe (Dunham and Ba.ilar
1968, Higg'inson 1963). Hec is unoommon or rare (2,9 per
100 000 men per annum) in NI:lrthAme:dca, Britain, south
America, Australia, India and in South Afrioan caucas t.ans
(Wanebo €Ita1 1989, RaW 1990). The hig-hest frequency of
the tumour has been reoordAd in MOQambican Shangaans, Who
have an ag'e-standardised inoidence rate of 106.9 per 100
000 per annum (Prates &. Torres 1965) although simila:r:
frequen01es may exist in chinese living in mainland China
and Taiwan (Rew 1990). ~eoent evidence sugg'ests that the
frequency rates of HCC may be increasing in certain lOW
incidence regions including North ~merica and parts of
Europe (Patton &. Horn 1964, saracci & Repetto 1980,
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Manderson et~ 1965). This increase may reflect a larg~r
number of patients with alcoholic cirrhosis, improved
treatment of this condition leading to a larger survival
rate or the emergence of new etiological agents (Rew
1990) •
The geographical distribution of the tumour is well defined
even in countries of high incidences ,such as M09ambique in
which the occurrence of the tumour is nine times more
common in the easte:t:nor "'oastal regions b1.an in the inland
areas (fIarington et a1 1975). Moreover, south African
negroes have a higher incidence (28 per 100 000 men per
annum, Rew 1990) than African-Americans (8 per. ;too 000 men
per annum, Wanebo et a1 1980:. indicating that individuals
of African or even Asian descent who migrate to countries
with low incidences of ace have lower .i.ncidencesof the
tumour compared with individuals ;t'emainingin their lands
Of origin (Higginson 1963). This phenomenon could be
lifestyle-related (KeW 1990) and suggests that
environmental factors rather than genetic or racial
predisposition may play a ~ole in the pathogenesis of HCC
(Rew 1990). HCC occurs predominantly in men in all parts
of the world (Kew 1990). Ir areas of high incidences the
male to female ratio :i.s5:1 (Wanebo .§...tal 1989) whereas in
popUlations of low incidences there is a less striking
preponderance of affected males (Kew 1990) •
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Worldwide the onset of che disease varies according to
geographical location (Kew 1990) but it predominantly
occurs in men over 30 years of age (Cook-Mozaffari and van
Rensburg 1984). In South African negroes it is frequently
encountered in their mid-twenties (Kew 1990) while in the
Far East HCC generally develops at an older age with a mean
age. occurring at 52~59 years (Okada 1976). Although HCC is
rare in children, hepatoblastoma is a distinctive tumour of
the liver in infants and children from 2-6 years with most
common age being three years (Shorter et al 1960).
1.6.3 ETIOLOGY
The pathogenesis of HCC is still unclear but available
evidence suggests that the malignancy is multifactorial in
etiology (Kew 1990, Wanebo et al 1989) and that the
tumo1.U::has different: causal factors in different parts of
the world. Kew (1990) suggested that Hce exists in two
forms. In areas of low incidence such as indust~ialised
Western countries ( the tumour occurs predominantly illolder
people being more common in males and is almost always a
result of a complication of chronic cirrhl';Jsis.This type
of tumour appears to have a better prognosis than that
occurring in developing countries which have high
incidences of HCC such as in sub-Saharan Africa and the Far
East (Kew 1990). In these areas, the tumour occurs in
younger men having little history of cirrhosis and has a
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high rate of mortality Kew (1990). Kew has also suggested
that different etiologic factors are operative in the two
foyms of the disease.
Even though racial and genetic factors appear to play Some
'tole in the pathogenesis of HCC certain risk factors such
as environmental changes, aflatoxin ingestion,
malnutrition, cirrhosis, chronic hepatitis B virus
infection and as hormonal factors have been identified as
the major etiolog:i.calagents of the disease (Ke'l{ 1990,
1'1aneboet al 1989, Shar & Kew 1982).
1.6.3.1 HEPATITIS B VIRUS (RBV) INFECTION
The first evidence of an association of HCC with viral
hepatitis ",asreported in West Africa by Paget in 1956
(Wanebo et al 1989). In 1970 Sherlock _gtal repc;)rtedan
association between chronic HBV infection and HCC. Studies
of the etiologic relationship between HBV and HCC were
advanced by the demonstration that a human tumour cell line
PLC/PRF/5 has HBV DNA integrated into the cellUlar g'enome,
which replicates hepatitis B sUrface antigen (HBsAg) (McNab
et al 1976). The most compelling evidence incriminating
chronic HBV infection in the pathogenesis of HCC worldwide
came from Beasley'S prospective study of 5500 HBV carriers
and 19250 controls in Taiwan (Beasley et al 1981, Beasley
19B8). HiS four year study established a relatiVe risk of
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234 with HCC occuZ':l::"ingin 40 carri-.':"sand 1. control subject
(Beasley et al 1981). Further investigation has ghown that
there is a close geographical parallel between the
existence of HCC and the prevalence of the RBV carrier
state (Kew'1.990). Kew ~t al (1986) have recently shown
that in south African negroes when the HBV carri:.'!rrate
decreases as a result of urbanisation the incidence of RCC
shows a corresponding decrease. Studies have also
indicated that development of HeC is not simply related to
HBV infection but that persistent viral infection is
required (Kew 1990). In areas of high incidence of the
tumoUr, there are no exceptions to the correlation with a
HBV carrier state, but in regions of low incidence such as
Greenland and Chile there is the exception of relatively
high HBV carrier rates and low incidences of HCC (KeW
1.990) •
The hepatitis DNA (hepadna) virus family currently
comprises four members: human (Tiollais et al 1981);
American woodchuok (Summers 1978); Beechey ground squirrel
(Summers 1.981, Marion et al 1980) and Pekin duck (Mason et
al1980). All the viruses are very similar and share
unique featUres which define the vitus family (Sununers
1981). A characteristic feature of almost all active
hepadna virus infections is the continuous presence in the
blood of both noninfectious and intectj,ous viral forms,
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sometimes causing a silent infection in early life, which
can lead to chronic infection (Robinson 1990).
'The genome of hepadnaviruses are amongst the smallest of
known viruses (Robsinson 1990). The HBV genome (See Fig
1.5) is a small circular, partially double-stranded DNA
molecule with a single-stranded region Of variable length
(Summers .!=!tal 1975, Landers et al 1977, Hruska et a1
1977) .
Recent advances in gene cloning techniques have led to the
detection of integrated HBV sequences in the cellular DNA
of almost all Hee's studied (Shafritz & Kew 1981, Brechot
et al 1980, Yaginuma et al 1985, Tur-Kaspa et al 1986,
Dejean et aI, 1986, EdnLanet al 1980). Two HBV sequences,
the open reading frame (orf) x and the pre S2/S (See Fig
1.5) region have been implicated to playa causal role in
liver carcinogen~sis by trans-activation of cel1ular genes
(KekUle et al 1990, Twu & Schloemer 1987). However not all
Hee's appear to contain a fUnctional crf x (Tur-kaspa et a~
1986, Dejean et al 1986). The Pre-S2/S is the only HBV
gene (Fig 1.5) found to be integrated into almost all
HBV-related Hee caSeS analysed so far (Brechot et al 1980,
Edman et al 1980, Dejean et al 1986). Recently Kekule et
al (1990) demonstrated that 3'-truncated pre-S2/S sequences
in integrated HaV DNA of Hee's encode for an as yet
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Map of the HBV genome
Figure 1.5: Redrawn from Robinson (1990)
58
unidentified transcriptional trans-activation activity.
1.6.3.2
There is no unequivocal evidence at present that any single
ch"'mical agent is responsible for causing HCC (Kew 3-990).
However, field studies have demonstrated a positive
correlation bebleen the incidence of Bce and the aflatoxin
content of food eaten in various parts of Africa (Peers et
al 1976, van Rensburg et al 1974), with the greatest intake
of aflatoxins occurring in MOyambique (Kew 1990).
Aflatoxin is a mycoccxi.nthat is a metabolite of the fungu.s
Aspergillus flavus (A.flavus) (KeW 1990).
Asper'1illus flavus is ubiquitous 1 nature and
contaminates many staple foed.scuffsincluding grains, soya,
cottonseed and ground nuts especially in tropical climates
where storage conditions iavour the growth of the fungi
(Linsell & Peers 1977). Aflatoxin B1 (s~e Fig 1.6) is
the most potent experimental hepatocarcinogen known with
dosages of a few parts per billion inducing liver cancers
in susceptible animals (Kew 1990). It is hypothesised that
aflatoxin B11 may play an etiologic role in the
development of Hee acting either independantly or in
combination with HBV (Kew 1990). Recentiy it has been
suggested that mutations in the tumour-suppressor gene p53
are caused by aflatoxin B1, or HBV, contributing to the
high incidence of Hce in areas where these carcinogens are
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major etiological agents (RsU et al 1991, Bressac et al
1991). Kew (:1.990)proposes that even if aflatoxin ilElshown
to be pathogenetical1y importa~1t in developing courrtzLes I
it is Unlikely that it plays a signi:eicant etiologic role
in develope<;l or western countries.
1.6.3.3 RELATIONSHIP TO CIrornOSIS
In :1.901,Eggel recoqnised an association petween Hac and
cirrhosis. Sinel:..then numerous pertinent reviews have been
published (Cameron 1976; Shikata 1976; Anthony 1979; Kew
1983; ZaJdm et al 1990) with cirrhosis itself being
regarded as a preneoplastic state that often pre<;lisposes to
hapabooaz-o'lrioqenasLs (Me1ato et ..a1 1989). BecaUse of these
studies, differences in the relationship of cil:"rhcsis and
HCC as well as in the nature of the underlying c~rrhosis
have emerge<;l. In 1983, Kew ~Ibserved that in areas Of low
inc:i.dence (USA, UK and Canada) the tumour develops as a
complicat.ton of a long"'sta.nding symptomatic cirrhosj,s
whereas in areas of high incidenoe (Sub-Saharan, South East
Asia) the two conditions frequently mani:t;est simultaneously
with death due to the tumour pefore the onset of symptoms
and signs of oirrhosis. In 1976, ShiJ{ata described the
type of un<;lerlying cirrhosis in countries with a low
incidence as being predominantl.Y microno<;lul.arwith a
macronodular form being more common in Africa. and the Fa.r
East. Becker and Chatgiadakis (1961) noted trat
o 0
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Aflatoxin 81 - chemical structure
Figure 1mB: Redrawn from Kew (1990)
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South African :Europeans manife$t micronodular cirrhosis
compared with the macronodular form observed in South
African negroes.
Generally, the micronodular form is associated with
ci'rrhosis Que to its most commonly recognised aetiologic
agent., alcohol, while that. of the macronodular va:r:iantis
associatec with vir,l,l,l01:' toxic factors (post-necrot:i.«;lor
post-hepatic) (Anthony 1979). Cirrhosis comprising nodules
of less tllan :3 mm in diameter are classi;E:i.edas
micro-nodular wllilst those larger are macronoQul.ar (Anthony
!'!tal 1978). The incidence of oirrhosis in cases of :aCC,
when intel;'nationa:J..lyreviewed, varies fron\ between 60 and
90 pe:r:centwhj.oh may be due to the diffel;'entforms of
cl,rrhosis .invarying geographical locations (Szmuness
1978) •
'J:'herole of alcohol itlhepato~'1aroil'logEmesisis still
uncertain (Anthony 1979) although it has bean reported that
the presence of cirrhosis rathe:z:than the direct effect of
al.oohol is more important in the carcinogenic proOesS
(MacSween 1982). Mechanisms other than the pr.oduction of
cirrhosis whereby alcohol could take part in the
caroinogens'c process havE'!also been reported (Liebet' .§_tal
1979; MacSWeen 1982). Although alcohol has not been shown
to act as a carcinogen in tlla experinlenta.l.situatioh, it
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may act as a co-carcinogen )Jy provoking (jell prolifel:'ation
or )Jy enzyme induction within the liver, resulting in the
metabolism of previously inert oarcinogenic factors (Alan
paterson-PhD thesis). The possibility that malnutrition
acocmpany Lriq alcoholism may }?la.ya role in carcinogenesis
has also been considered (Liel:lerat al 1979). .It has been
established that known carcinogens e.g. nitrosamines, can
contaminat ~ some alcoholic beV!.'ol'1":l.;reswhich may oontir Ibutie
to hepatoo!lrcinogenesis (Mi;.I.cSween1982). Furtherml::lre,
there is .10W evidence that nsv infection may overlap with
alcoholic liver damage and that this may be a fadtor in
liver ca.rdinogenesis (Brechot et al :1.982,Bredhot et al
1985). Mills et al (1979), invest:Lgatil1g the incidence of
the antibody tn HBsAg (anti-HBs) in chronic liver diseas~
(CliO) observed (! significantlY il'lcreasedfrec;[uel,\CYof the
antibody in alcoholic liver disease as comnaxed with otn."i:'
causes ot Ct.D and in controls. other studies haVe
supported this finding (chopra et al 1980, Goudeau eta;).
1981) while Bassendine ~ (1983) Were unable to
demonstrate a similar trend in their study1s COhort.
B:owever, Brachot et al (1982), in a study on alcoholic
livers using routine serology and recombinant DNA
techniques, demol1strated that patients sutfering from both
alcoholic dirrhosis and HCC all had Hev integrated into the
'tumour cell genome. Of the cases 0;E alcoholic liver
disease, 37 percent were serologioclly ~ositive ;Eel:' l1eV
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with 3 out of 51 displaying HBV-DNA integration into the
host genome (Brechot et al 1982). On the basis of theSe
data the authol's suggested that }lBV plays a par'c.in the
development of HCC in the pl'esence 0:1: alcoholic cirrhosis.
1.6.3.4 HORMONAL AND STEROIO"'REI.J\TEDFACTORS
Androger',ic steroids have become an acknowledged risk factor
in the development of HCC since an association was firs'\::.
described by Johnson et al (1972). The role of oral
contraceptives ari':],oestrogens is somevlhat more contra'"
Varslal. Initially the relationship appeared to be with
benign adenomas (:Klatslcin1977 i Ishak 1981) but in recent
years there haVe been nUmerOUS but contradicting reports of
nee dev€'loping in women taking contiraoeptif.vesteroids. (KeW
~ 1990).
1.7. l1I-iCEXPRESSION IN HE:PATocBLLULAR CARCINOMA
As detailed above (Section 1.4) I neither Class ! nor ClasS
II MHC antigens are detc~ctable on the surface of normal
hepatocytes however both classes of MHC antigens are
displayed in val:'ious·pathologies inclUding hepatitis.
These findings suggest that expression of MHC antigens can
be induced under certain circumstances.
In the stUdy of HLA expl"ession in HCC I Patel·son at a~
(198 a) reported a homogencus enhancement; or acquf.sition of
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MHC Class I antigens in the majority (94,3%) of tumour
specimens \.,ith a concomitant e:{presSion of the HLA Class
I--associated invariant chain, $2m, in all put 2 cases. MHc
Class II expression was observed in approximately half of
the specimens examined, (Paterson et al 1988) PAP staining
in corrjunct.Lon wi.th monoclonal antibod.ies (MOABs) resulted
in a sparse and heterogenous display. Whereas, the
invariant chain (Ii) also present in approximately half of
the cases, was frequently intensely stained and extensive
in distribution (Paterson et al 1988);
Several permanent hUman hepatocellular carcinoma (Ilce) cell
lines have recently become available. These cell lines are
useful tools for the study of MHC gene expression and
regulation in hepatocytes as well as for the investigation
of the asoociation of MHC antigens with transformation of
human hepa.tocytes (Sung et al 1989). ace cell lines a.lso
present useful models for investigating the association of
MHC antigens ,'lithhepatocyte diffe:t;"entiationand
transformation, and for explaining the role of these
antigens in host immunity to HCC (Sung et al 1989).
'I'hepresent study therefOl1e employed the use of HCC cell
lines as a mod,el,to further the understanding of MHe
antigen expl:ession in this cal:cinoma..The first aim Was to
elUcidate the expression of MHC antigens On the cell lines
under spontaneous ccnd itiona. '.[Iheseexperiments were
performed in order to establish a control or baseline level
of MHC an'tigen expression for USe in further experiments in
this study.
The second aim was the investiga.tioliand elucidation 0:1; the
effect of potential modulating agents on antigen
expression. An i.ncrease in MHC antigen expression in HCC
cell lines using certain agents has been reported by other
workers (Sung et al 1989, Krief et al 1988, F'ukUsato at al
1988, Yoshioka et al 1989). Such an increase in expression
may suggest a potential therapeutic Value of th,e.:;e
modUlating agents as well as further clarifying the
biologic significance of the aberrar,:-MHC expression
observed in HCC.
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CHAPTER2.
CELLCULTURE
2.1 Introduction
Tissue culture was devised at the beginning of this century
(Carrel 1912) as a method for studying the behaviour of
animal celJ,s free of system vClriations that might ari~e in
the animal both during normal homeostasis and under the
stress of an experiment (Freshney ~987). In ~907 Harrison
chose the frog as his tissue sourCe, presumably because it
was a cold-blooded animal, and therefore incubation ~:las not
required. .Later, the empryonated hen's egg I which provided
dlversi-t.y of cell types in primary culture was used
(F'reshney 1987). In 1943 Ear:Le et al produced tihe first
continuous mammalian cell line using rodent tissue. In
1952 Gey et al demonstrated, \.,.ith t.he establishment of the
HeLa line derived .from squamous carcinoma of the cervf.x,
that human tumours COUldalso give ri:ile to corrcf.nuous oe11
J,ines. Sinoe then most of the interest in tissue culture
has remained in avian and mammaLi.an tissue (Freshl"ley :1.9$7).
The term cell cultUre was coined to refer to cultUres
dez'Lved frc)m dispersed cells t.aken fronl the original tissue
by enzymatic, mechanical or chemical disaggrega't.ion and.
today the 'terms cell cultUre and -tissue aultur$ are
interchangeable (Freshney 1987). The development of cell
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culture as a modern, sophisticated technique has been
helped by technical iltlprovements such as the ccmmez-ci.a),
supply of reliable media and sera, greater control of
contamination with antibiotics and clean air equip,ment
making it accessible to a wide range of interests (Fres);tney
J.981). Cancer research ranging from understanding
neoplasia to the scudy at cell interactions and
intracellular control mechanisms in cell differentiation
(Freshney 1985), metastasis (Feldman & :Eisenbach 1988) and
tU'lnou:r:igenicity(Tanaka et al 1985); chr-omoaoma L analysis
of cellS derived from the womb by amniocentesis (Valenti
1973), monoclonal antibody prod1.lotd.onby hybridoma
techniques (K8hler & Milstein 1975), somatic cell
genetics stud,ies using somatic cell fusion techniques
(Barski et.al 1961, Littlefield 1964) and genetic analysis
of inherited traits (Buchwald 1984) at'e among acme 0'1: the
areas of research that depend heavily on tissue culture
techniques.
Besides the abovementioned advances, gro-vlingce l.Ls in
culture has at least three major advantages (Freshney 1987,
Buchwald. 1984). :Firstly, the Pt'ecise cOntrol of the
physiochemical environment (pH, temperature, osmotic
pressure I 02 and CO2 tensiun). Secondly, th(~ con:t.rol
of the physiological cond,itions where the cells can be
isolated frolXlthe biologi.cal milieu. of the donor' and ~ept
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under relatively controlled (but not always defined)
conditions (Freshney 1987, Buchwald 1984) is possible. The
third advantage is that cell cultures can make each dOno!."
imnlorta] since culture may produce a homogeneous cell 'type
which can be perpetuated over several generations or
indefinitely stored in liquid nitrogen in medium containing
a cryoprotective agent, for example glycerol 01:' D1180
(Freshney 1987, auchwald 1984), The major disadvantages of
cell culture are the strict aseptic conditions and
expertise of the operator required (suchwald 1984).
Besides contamination by bacteria, moulds and yeasts,
contamination with micro-organisms such as mycoplasma, :I:rom
the media used or from the operator result in the culture
being compromised (Freshney 1987, BUChwald 1984). huother
disadvantage io the expenditure Of effort and materials
required to maintain relatively little tissue with the cost
of producing cells in cUl'ture being about ten times that of
animal tissue (Freshney 1987). Furthermore, many
continuous CEllI lines exhibit variability frOm one pai:>Si',
to the next. (Freshney 1987, Buchwald 1984). ThUs the
validity of the cultured cell as a model of physiulogical
fUnction in vivo has b(!!enfrequently criticised
(Freshney 1987). The most obvious difference of cell,
culture to the in vivo situation is the alter,'ationof
the cellula:!:'elwironment, caused by the dissociation of
cells :from a three-dimensional s<eomet.ryto their
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propagation on a two-dimensional sUbstrate. In addition
there are changes in cellulA.rmetabolism such as energy
metabolism and production of hormonest , The culture
environment also lacks several systemic components (the
endocrine and nervOus systems) essential for homeostatic
regulation in vivo (Fref;hney1987) .
AH:hough, the existence of such diffe;t:encescannot be
denied, many specialjs~d functions are expressed in culture
such as alpha fetoproteirt (AFP) Fr.-oductionin th'~HCC cell
line Hep 3B as reported by Knowles (et al 1980) (Freshney
1987). Thus, appreciating the limits of the mode.L, cell
cultUre can still be a very valuable tool (Freshney 1987)
for analysing in vivo situations.
The process of cells undergoing malignant or neoplastic
transformation in vitro is termed the evolution of cell
lines and the point of transformation a 'crisis' (Freshney
1981). After evolving the cell line becomes continuo1.ls,
immortalized (Freshny 1987). Since malignancy cannot be
easil~' demonstrated, in vitro, properties pertaining to
miiligno.ntcells illVivo are applied to the in vitro
situation (Freshney 1987). The models testing neoplastic
properties such as tumourigenesis, ir1Vasiveness and
metastat:i.sin vitro have mostly beer.demonstrated by
the Use of a similar expel"imental approach. TumOUr Cells
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that are grown in vitro are injected into laboratory
animals and the resulting neoplastic process, if any,
observed (Tana:kaet al 1985, Feldman & Eisenbach 1988).
2.2 CULTURE OF HEPATOCYTES
Establishment of normal adult cells in culture is
exceedingly difficUlt but advanGes in cell culture
technology have only resulted in the maintenance of.some
normal or months in culture (Reid &. Jefferson 1984).
Chang established the first normal hepatocyte cell line in
1954 (Chang 1954) and since then many attempts have been
made to isolate and culture human hepatocytes (Maekubo et
",11982, Hsu et al 1935, Reid & Anderson 1984, Demoise et
al 1971, Re,~se & Byard 1981). various methods have been
attempted v.tithviable hepatocytes being successfully
isolated by perfusion of the liver ·tissue specimen with
collegenase (Hau et al 1985, B.::Hletet al 1984) using
conditions based on those optimised in the pig (Ballet et
al 1984). Digestion with the protease collegenase coupled
with other enzymes that digest structural protein SUCh, as
dispase (lisuet al 1985) or hyaluronidase (Bellemann et al
1977) either after perfusion (Ballet et al 1984) oL'as a
nonperfusion technique (Bellemann et al l;i'7)al~o proved
to be a successful method for obtaining viable
hepatocytes. Co-culturir,g of hepatocytes with fibroblasts
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as feeder layers vIas demonstrated to improve hepatocyte
function and life:::panin cult,tire(Reid & Anderson 1984).
Ultrastructural and biochemical examination of the hepa=
tocyt~s in culture showed resemblance to many characte-
ristics (.'f the liVer (Bellemann et al 1977; Ballet et a1
1984). Hot"ever t in general, after nepaccoyties Were Plated
onto cell culture plastic into a serum-supplemented medium,
they changed Lnbo a squamous-like Shape, exhibited rapid
bi~chemical and morphological deterioration and within two
weeks had lost their viabilitJ (Reid & Jefferson J.984).
2 • 3 HUMAN HCC CELL LINES
The establishment in vi/ero of cell lines derived from
HCC is a logical approach to the laboratory investigations
of the tumour. Permanl""1tcell lines derived from these
blmours allo\1 for a range of studies that oannot be oarried
out on biopsy or postmortem material (Alexander et a1,
1976). The majority of hepatoma 01311 lines were initiallY
derived from rodent hepatooytes (Darlingtan 1987). One of
the first human HCC cell lines described was designated by
Chen in 1964 as (Chen 1964). In 1975, FogO. « Trempe
established the line SK Hep 1 from an asciteS effusion of
an adenocarcinoma of the liver (Alexander at al 1976),
altho'ugh this Li.ne is subaaquerrt.Ly oonsidered to be
fibroblastic in nature (Alexander-personal comr,lunication).
In 1976 Doi established two cell lines from a
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hepatoblastoma that were morphologically distinct but both
exhibited AFP production (Doi 1976). Also in 1976,
Alexander et al established a HCC cell line from a primary
hepatoma of an African male. and designated it PLC!PRF/5
(Alexander ~976). This cell line. exhibits a variety of
hepatospecific funotions as well as AFP and albumin
production (Darlington 1987). I.thas been studied with
respect to the integration of the HBV genome in the
cellular DNA and its expr'esei.cn of the HBV surface antiqen
(HBsAg) (de Koning ~ 1984, Knowles et al 1980, McNab et
al 1976).
Aden and co~workers established two lines Hep 3B and Hep Gz
from primary hepatocellular carcinoma and hepato~1a$toma
respeotively (Knowles et al 1980, Aden at @J. 1979). Their
method utilised mouse feeder layers (Aden ~ 1979). Rep
3B, a well differentiated oell line, has been oharaoterized
with respect to the produotion of albumin, AFP, HBsAg as
well as other liver-speoific phenotypes (Darlington 1987).
The expression of dHferentiated functions of Hep G2 has
also been extensively s'tt,lo.ied(Aden ~ 1979, Bouma et. al
1989, Dat'lington et al 1987). Although IiBsAg or
integratj,on of viral DNA are absent in 'ch:i,scell line,
HepG2 has retainec;1a large number.'of hepatospeoific
phenotypes (Darlington 1987). Chang ~ (1983)
establj,shed the poorly differentiated HA22T/VGH oell line
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from a chinese male with HCC. This cell line does not..
express HBsAg (Chang et al 1983). unlike all of the above
cell lines which only grow in monolayers, HA22T/VGH oan be
cultivated not only in a monolayer, where it expresses some
hepatospec1fic gene products (suclt as C3 and C4 complement)
bUt also as suspended cell aggregates where its production
of liver~specific products as Well as plasminogen and
albumin increases (Chang at al 1983).
Mahlavu was successfully establiShed from a needle aspirate
from the edge of a suspected tumout' nodule (prozesky §.t al
1973). This cell line expreSses HBsAg and appears as
polygonal epitheloid ceUs which tend to grow in sheets
(Prozesky at al 1973).
Tong pac was established from an Italian male with primelxy
HCC (Lin et~ 1984). This cell line secretes both HBsAg
and AFP into the cu~ture supernatant and several REV-DNA
ilitegratiol'lsites have been demonstrated (tin Sl~ 1984).
All of the above cell lines can be maj.ntained in defined
media such as DMEM or RPMI ...1640 SUpplemented with 10%
heat~inactiv~ted FCS (personal communication Dr E Bey,
Highveld Biologicals, Jhb. SA).
Variou$ studies testing- the comparative. morphology and
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tumourigenicHy of HCCcell lines have been performed
(Snouval et aJ. 1988). These studies have attempted to
produce tUlnours in athymic rats and mice as a method of
establishing whether the cultured cells are indeed
mo.lignant a nd. not from non-malignant components of the
original tumUU1l'specimen (Fogh et al 1977).
shouve.l ,nt._ql (1~88) I invest.i,gating the ce Ll, line
PLC/PR'F/, Hep G2 and Mahlavu, found that When the cell
lirlas ware inClf,lulated subcutaneously (s , c.) into athymio
Balb/c nude 'ilir.c attd N/NIH outhred nude rats,
Well"'ehoa~~::lU1Cft.odtumtlurS were produced. In nude rats,
PLC/PRF/5 c~lls were the most tumourigenic followed py
:r.!ahlC'.vu. EXPElriments using Hep <:'::2 Were not performed in
nude rats $j.'t':['la these cells were extremely difficult to
grow in athymic mioe (ShC)l,.lval~ 1988). In athymic
mice, PLC/PRF/5 was the most tumourigenic followed bY
MahlavU and thEln Hep G2 (Shouval~· 1988). Metasl'tase$
were infrequently observed fol.lowin9 s.o. hepatoma cell
inj ection, J;'egardless of HCCce:Ll type used. r'l\Q
irJ;'espective of al1imal strain (Shcmval ~ 1~88). t.t'his
oorrell!\tes with the in vivo situation, in Which
,pulmonary ll1et~stases are generally confined to terminal
CaS.9S (Raw & Patersol1 1.985). The abOVe types of expElriment
oonfirm the mal.igllal1t phel10type of the HCOcell li11e6 as
well as! providing- a model for assessil19 the responsEl of
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novel 1\1odesof treatment for hU1\1anHCC.
Because the study of the characteristics of human hepato1\1a
cells is limited-by the availability of tissue, HCC cell
l:tnes provide a model for st.udying the differentiati.on Of
human hepatocytes (Chang et al 1983). Since HCC cell lines
exhibit various hepatospeoific phenotypes (Darlington 1987)
they can be studied for theit exptession and regulation of
hepatocyte markers as well as the induction of.hepatocyte
markers in v-it:ro. tt was therefore of il"lterestto
examine the expression of the :major histocompatibility gene
products on the surface of suoh cell lines in the present
study.
2.4.1.
MATER:tAtS AND METHODS
cell lines
.....-
Cell lines used are listed in Table 2.1 and were obtained
fro1\1Highveld Biologicals, Jonalln'i'lsburg/SA and as kind
gifts fx;om Dr S Aspinall (!1eduhsa, GSRanltuwa) to Professor
A Patersen. On examination t11ey were found to bEl f.ree of 9.
:mycoplasllialcontamination. The abs~ .O~ HI: mycoplasillawas
confirmed by Roschst DAFt f.luorl.h'lCH;:m..stain (tiighveld
Biologicals) •
DEFINED MEDIA USED
Dulbecco's modification of :Eag'les11EM (DHEM) (DulbcacC"oand
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Frl:!eman1959, Morton 1970) and RPMI-1640 (Moore et al 1967)
were obtained commerciallY (Highveld Biologic~l$,
Johannesburg, SA). HCC cell lines were grown in OMEM ~nd
cells in suspension in RPMI-1640 medium. Foetal calf Serum
(PCS) was used at a concentration of ten and five percent
for HCC cell lines anr: oells grown in suspension
respectively. Appendix 3 describes in detail the
constituents of both RPMI"1640 and OMEM.
MAINTENANCE OF CELL LINES
cultures were grown in disposable 25 and 75 am3 cell
cUlture flasks (Cel-cult, sterilin, Hounslow, UK) in a
humidified 5%C02-95%air inCUbator at 37°C. The growth
of the culture WaS monitored daily and cultures fed
approxima'cely three times per week with fresh medium.
Cells from conflUent oultures were trypsinized from their
substrate (approximate time to reach conUuency being one
\"eek) using a freshly made trypsin (O,25%)/EDTA (0,0:1.%)
mixture (both from Highveld Biologicals, Johannesburg, SA)
at a ratio of 1:1 at 37°C and disaggregated into a single
cell suspension. Trypsinization was terminated by the
addition of fresh medium containing 10% Fes at 37°C. The
cells were harVested by centrifugation for 5 min at 200 g.
Cells were resuspended in sml fresh m~ldium at 37°C and
aliquots withdrawn for oounting on a hemacytomete:t: anCl
viability assessmsnt by the trypan blUe Clye exclusion t.est
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using' stal:lda.rdprocedures. cells grow):).i):).monolayers that
were used for experim"ant.s had a viability of 85·-90% while
cells grown d.n suspension that were used for experiments
had a viability of greater than 95%. Thereafter, cells
Were diluted further in fresh medium and subcultured by
plating' them out in cell curture. flasks. Cells grown in
suspens;i.oh were harvested hy oentrifugation for 7 min at
200g, counted and their viability assessed. cells we.re
then further diluted in fre.sh medium supplemented with 5%
Fes (Appendix 3) and incubated in a. humidified 95% ail:"-5%
cO2 incubatol:" at 37°C.
2.4.4 ~R~SERVATION OF c~tts
Cells were pl:"eserved at a cell conoentration ai 10 X 106
cells/mi usin,g glycet'al as a cryapl:"otective agent (Appendix
3) and ~tOl:"edin liquid nitrogeh for up to six months
witllout adVerse effects on their viability (Rijntjies et.al
198'S). When needed, cells were thawed (Appendix 3) I
counten, theil:"viability assessed and l:"eseede.d.
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TABLE 2.1 LIST OF CELL LINES USED IN THIS STUDY
HCC Cell lines
PLC\PRF\5
Appearance
Epithelial-like
Hep G2
Hep 3B
Tong PHC
HA22T/VGH
HA59T/VGH
II
"
u
Fibroblast-like
II
MahlaITU u
Reference
Alexander et a1
(1976)
Aden et a1 (1979)
Aden et aJ.,.(1979)
Lin et a.1 (1984)
Chang' at al (19$3)
Kind gift of
C chang
Prozesky etal
(1973)
Control Cell Lines
Rajia Spherical cells
in suspension
K562b
Pulvel:.·taft(1965)
1.oz2:io& Lozzio
(1975)
a. Raji was established in 1%5 f;t'omthe tumour tissue Or a
Burkitt's lymphoma (Pulve;t'tatt1965). It ~'as been typed
u
to express m-rC Class I and II antig'ens as well as thei::c
respective invariant chains (Nilsson et a1 1974)
b. 1<562 was originally established :erom a pleural effusion
of a patient with chronic myelogenous Leukem i.a in terutinal
blast crisis.
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2.5 RESULTS AND DISCUSSION
Cell lines Were successfully grown according to suppliers'
recommendations. The appearance of the various dell lines
is summarised in Table 2.1. The cell lines PLc/PRF/5, Mep
313,Hep G2 and 'rONGPRC appeared similar on morphological
examination under a microscope. All were epithelial~like
and grew in monolayers. The Alexander cell line PLC/PRF/5,
appeared under mi.czosoopal, exami.na'cLon , to be squamous-like
with canaliculi and sinusoid-like :f;ormationssometimes
visible. In the cell line Hep G2 after reseedil1g, the
cells appeared to grow £r01\\ islands with the islands
eventually forming a monolayer (Aden at.aI, 1979). Hep 3:8
appeared undex the micJ:oscope as squamous-like cells \'lith
monolayer growth evident. HA22T/VGH, HA59'r/VGH and Mahlavu
appeared as m01;'efibroblast-like with a monolayer cell
growth. Mahlavu tended to grow in sheet-like fashion,
K562, an eryth.romyeloid cell line (Nilsson et ilJ, 1974) was
spherical in shape \dth project.i(:msthat of MHC antigens
(Lozzio & Lozzio 1975) were refractile under phase
microscopy. I't tended to form clumps of cells in suspension
during growth periods, Which were easily disaggregat~d on
gentle shaking. Raji, a B-lymphoid derived cell line, grew
as smooth spherical Ct;llisin suspension.
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The abovementioned HCe and control (Raji and K562) cell
lines were used for all experimental work performed during
this present study.
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CHAPTER 3
INDIRECT IMMUNOFLUORESI.'ENCEASSAY
3.1 Introduction
Ilmnunofluorescence is widely used for the study of cell
surface antigens (Boucheix et al 1985). Compared with the
radioimmunoassay (RIA) or the enzyme linked immunosorbent
assay (ELISA) i.tallows for study at the single cell level
(Boucheix et al 198.5). Irheuse of indirect
immunofluorescence assay is hamper-ed by the fact that it is
difficult to perform quantitative studies, however it
ensure.s rapid qualitative results (Boucheix et al 1985).
The USe of a specific conjugated antibody such as
fluorescein isothiocyanate (l<'ITC)depends on the fact that
dye molecules can be chemically linked to antibody
moLeou Las without impairing the capacity of the antibody to
rea.ct specifically with the antigen (Marrack 1934).
Considering these favourable aspects and because of its
simplicity and ease of experimentation, the expression of
MHC antigens on hepatoma cells grown in culture was
assessed.
3.2
3.2.1
MATERIALS
primary Antibodies
W6/32. (Dakopatts, Denmark) A mousei)
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anti-human monoclonal antibody directed
against the monomorphic determinants of
HLA"A,B,C (parham et al 1979)
ii) TAL IB5 (A kind gift of J. Bodmer, ICRF, UK)
A mouse anti-human monoclonal antibody
directeQ against the heavy, ncnpo Iymozphd,o
chain of HLA-DR ~DR-alpha) (Adams et al
1983) •
iii) Anti-Beta-2-1....
(Dakopatrt.s , Denm.
monoclonal antibody 0" .~
".....62r.i)
~9 th.eHLA
class I-associated Lnvaz-Lam ';111::.. 132m
(BjerrUln& Birgens 1986).
iv) VIC Y1 (An-De~'-GruhBibre::;earch,~aumberg i
Austria). A mouse anti-human monoclonal
antibody directed against the HLA-D regicm ...
6.ssociateQ invariant chain, Ii (Antibody
isotope IgG1) (Qua""A.ntaet al 1984).
Table 3.L summarises the various primary antibodies
anQ their specificities used in the
current study.
3.2.2 SECONDARY ANTIBODY
Fl.ouresceln IsothiOGyanate (FITC) conjugated
F (ab1)2 f:t'agmentof rabbit anti-mouse
TABLE 3.1.
clone
W6/'32
TAL IB5
anti-B2m
VIC Yl
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LIST OlfANTIGENS AND PRlMAR,Y ANTI130DIES AND
THEIR SPECIFICITIES.
S:gecificity
HLA ....A/BIC
RLA-DR
B2m
Ii
source
Dakopatts,
Denmark
Gift of
J Bodm$r
(ICRF ,UI<)
Pakopatts,
Denmark
An ...der-Grup
Biore.search
l<aumberg,
Austria
Reference
parham
et al
()..979 )
AdamI?
et al
(1983)
Bjerrum &
Birgens
(1986)
Quaranta
~t iil,l (1934)
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immunoglobulins. ~hs ~ntibody reacts with all
mouse l:gG sUbclasses, and mouse :tgMand :tgA
(pakopatts, Penmarl(.).
3.2.3 CONTnOL AN~lBOPY
A F!~C-conjugated goat \~nt:~"'serumto human
immunoglobulins (!gG, ItjM, IgA) (Hyland, USA)
was UJsd as a non-specific antibody.
3.3. ME~HODS
~he j,ndirect illtmUl1ofl'uorescence assay (:t:Cf) ',",asperf(';)rmed
on viable hepatioma cells grown in monola)i'ers using' a
modification of the protocols descril:>ed by l?ernis and ~se
(1985). :en order to examine the effect (;Lf any) of fbling
on HHCexpression and to assess which method was optimal
experimentally, modified teChniques for assessir~g
immunofluorescsnce on both viabls and fj,xed calle were
adopted for the control cell. lines 1<:562 and Raj i.
INPIREC~ IMMUNOFLUORESCENCE ASSAY
The techniques of Pernis and Tse (1985), modified for
indire : immu11oUuorescence (Ill") staining' of hepatiome,
cells, were lJerformed as described below. Confluent
monolayer HOCcells were trypsinized, counted on a
hemacytometer and their viability assessed by a trypan blUe
dye exolusion test as described in section 2.4.3. The
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s.ingle oell suspension was diluted to approximately 2:x:104.._
oells/ml in complete DMEM (s~ction 2.4.2). Cells were
cUltured on 22:x:22mmglass coverslips (Mentzel-Glaser,
Germany) in plastic petri....dishes (l?romex,south Africa) in
an humidified incubator containing 95% air-5% CO2 at
37°C. After 24 hours the viable cells had adhered only
to the surfaoe of the glass coverslips, and not to the
sUl:'faceof the petri-dish and had reached a 20-40%
confluency. The coverslips were then removed and their
bottom surfaCe glued using a cyanoaorylate adhesive to a
standard microscope slide. In order to ensure that the
cells remained viable, cells on the top su:t::eacew re kept
moist with PBS (Appendix 1) throughout the assay. The
cells were then incubated with 50ul of one of the mouse
anti-human antibodies listed in Table 3.1 at a
predetermined optimal dilution in PBS (Appendix 1) at 4°C
for 45 minutes. As a mecU.umcontrol, two coverslips were
inoubated with pBS (50ul) alone. After inCUbatiOn, the
slides were washed in a Coplin jar for two minutes with
stirring in ice-cold PBS (Appendix 1) to wash Off excess
antibody that had not bound to the cells. The Washing
procedure did not affect cell counts on coversHps as
75-80% of the cells remained adherent. Cell viability was
also maintained with this treatment. Thereafter cells were
Lncubatied wit.h the secondary antibody, an anti....human
FITc-conjugated antibody (SOul) at an optinlised dilution in
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PBS. Of the two ooverslips that were incub~ted with PBS
only, one coverslip was incubated with a non~specific
antibody (50ul) while the other was incubated with the
anti-human FITC-conjugated antibody (50Ult see section
3.2.3). cells were incubated at 40C in the dark. After
45 minutes, the oClverslipsII/erewashed in a coplin jar for
2 minutes in inoe-oo).dPBS (Appendix 1) to minimise the
amount of non~speoifio baokground fluoresoence. The
oove:t'slipoontaining adherent cells were covexed with
another glass coverslip (22x22mm) and the coverslips sealed
with ~lear nail varnish (Cutex, RSA). After these staining
perparations, the s~ides Were examined without delay under
fluorescence using a fluorescence microsoope (Leitz,
Germany) •
DOSE OP'rIM:tSATIONOF PRlMAR~ AND SECONDARY
AN"'!BODY CONCENTRATION roa USE WITH CELL
r.i.. JS IN Ill"ASSAYS
To determine the optimal dosage of both the primary and
seoondary antil?odiesrequired for the most speoific
fluorescence, a dose dependant IIF was performed using the
oell line TONG PHC. Five hundred miorolitres of a oell
suspension of 1:x:106ce11s/m1 in RPI-1I-1640supplemented
with 10% FCS (oomplete RPMI) (Section 2.4.2) was added to
eaoh well of a tissue CUlture slide (Labtek, Miles
soientific, USA). Cells were CUltured under standard cell
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culture conditions. After 18 hours of incubation at 370C
in an humified 95% air-5% CO2 chamber the medium was
gently removed from each well, and the dose dependent assay
performed as illUstrated in Table 3.2 using the method as
described in section 3.3.1. As washing with PBS or
Rl?MI-1640 did not alter the appearance of flUorescence
(Results not shown) all washing was performed with PBS for
eoonomy. After staining the cells, the plastic
demarcations were remoV(;;dfrom the tissue culture slide and
the slide sealed with another clear glass Alide using olear
nail varnish (cutex, R~A). The slides were vieWed under a
Leitz flUorescent microscope (Leitz, Germany). The optimal
dosage for each monoclonal antibody as well as for the
i!'ITC....conjuc;;,"'·.eas determined in the Close response
experiments was adopbad for all the IIF experiments:
performed on H( dS well. as oontrol cell lines, :Raji anCl
l<562. The optittl...J. dosage for each antibody is tabulated in
'rable 3.5.
3.3.3
3.3.3.1
IIF ASSAY PERF.ORMED ON RAJI AND KS62
A Modified IIF Assay Using Viable cells
Raji and X562 oells were harvested, enumerated and their
viability assessed using the trypan blue eXclusion test
(Section 2.4,3) and the cells brought to a final
concentration of 1 x 106 cells/ml. After oentrifugation
at 200 9 for 7 minutes at room tempreture, as muoh fluid as
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T.ABLE 3.2 CHEC~ERBOARD TITRATIONS FOR OPTIMISATION QF
PRlMAR~ MONOCLONAL ?\NTISODIES (MOASs) AND
FITe-CONJUGATED SECONDARY ANTIBODY USED IN THE
Xl;]' ASSA~
Dil'Ll'cionsof:
MOABs a 1:5 1:10
.
1:50 1:100
FITC"
conjugate ,1::3 W6/3:3 W6/'32 WG/32 W6/3:3
1:5 anti-B2m anti-82m anti-82m anti~82m
----------~-~~--~--------~-.,-----------------------
1:10 TAL ISS TAL IB5 TAL IB5 TAL I135
1:50 W6/32 W6/32 W6/32 W6/32
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possible was carefully aspirated. The cell pellet was
resuspended manually in the remaining supe:r:natant (500
ul). Thereaftex', 75ul of the primary antibody at the
optimal dose of 1:50 was added 'co the cell suspension and
the suspension gently mixed. After incubation for 45
minutes at 4°C, the tub!;;;was filled to apprOXinlately 10ml
with cold RPMI-1640 (Highveld Biologicals, Jhb. RSA). The
cells were recentrifuged at 200 g for 7 min at 4°C and
the supernata.nt removed. ~he cell pellet was resuspended
manually i11the remaining supernatant (SOOul) and
thereafter the caUs 'Washed twice at 4°0 ~lith cold
(4°C) sterile PBS. After the second wash the cell pellet
was resuspended manually in the remaining supernatant and
the cells incubated in the dark at 4°0 with 75ul of the
secondary antibody (See Section 3.2.2). After 45 minut(',s,
the cell suspersion was diluted to 10ml with cold PBS and
re~centrifu9'ed at 4°0 at 200g for 7 minutes. After the
removal of the supernatant, the cells were gently
reSUspended manually and the final volume adjusted to SOoul
with PBS. One drop of the cell suspension was pl~ced on a
standard glass microscope slide, and the suspension sealed
by a g'lass coverslip (2.2x22:mm)using clear nail varni$h
(Cutex, RSA). The Cells ~ler(=examined under fluorescence
(:t..eit~,Germany) without delay,
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3.3.3.2 A MODIFIED !IE' ASSAY USING FIXED CELLS
In previous experiments a number of fixatives were
investigated in order to examine 'the effect of different
fixatives on NRC antigen expression. These included
ice-cold ethanol, ice-cold acetone and 2% paraformaldehyde
at room temperature. Ethanol and paraformaldehyde both
caused the disappearance of fluorescence as observed unc'l.er
the fluorescent microscope, however the use of acetone did
not interfere with IIF staining. When ice-cold abetone was
used as a fixative the following procedure was adopted:
200'1..1.1of a lx 106 cells/ml suspension was placed onto a
standard microscope slide. After air drying, the slide was
.immersed in ice-cold acetone for 60 seconds. After furt;h.er
air drying, the cells were exposed to the primary and
secondary antibodies as described in section 3.3.3.1.
3.4 RESULTS
The results obt.ained by incubating cellS from the various
liCC lines with the panel of monoclonal antibodies are
summar f.aed in Table 3.3. Expression of NRC antigens was
scored as "ne. .ltivell When 20% or less of the hepatoma cells
in the field of vision examined spontaneously displayed a
specific stain and "positive" when an homogenous stain of
the plasma membrane of 80% Or more cells in the field of
vd.s i.on could be <:letectedunder spontaneous conditions. As
sh9wn in Table 3.3 all HCC cell lines inVestigated
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TABLE 3.3 EXPRESSION OF l:ILAON flCC LINES a INCUBATED
WITH MOABS AS DETECTED BY Tl:IEIIF ASSAY
MOABb PLC/ HA22T/ HA59T/ TONG REP G2 REP 3B }~HLAVU
PRF/5 VGH VGl:IPHC
WEi/32 + + + + + +
anti ..
132m + + + + + 1- +
TAL IBS _d + +
VIC Y1 + +
a. Refer to Table 2.1 for description of Hce lines.
b. For specificities of MOABs refer to Table 3.1.
c. "+" denotes spontaneous expression.
(ie ~80% of the ceJ.ls in the field of vision examined
spontaneouslY fluoresced) •
d. II_II denotes negligible spontaneous expression.
(ie ~20% of the cells in the field of vision examined
spontaneously fluoresced).
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spontaneously express MHC class I antigens and its
associated invariant chain, B2-microglobulin. The
intensity of staining varied between cell lines and from
cell to cell, althol.),ghin all cell lines used, virtually
all cells (a.pproximatelY 100%) were bound by the anti-HLA
Class I and anti-B2m monoclonal antibodies. As shown in
Table 3.3 tn.e Alexander cell line, PLC/PRF /5 and the. c;e.ll
lines Hep G2, Hep 3B, TONG PHC and Mahlavu did not
sponbanaous Ly exhibit surface MaC Class II, a.ntigens using
the !I~ technique. The cell lines HAZ2T/VGli and Hl\591Jf/YGH
exhibi ted strong staining for both ~C class II arltigens
and its associated Lnvar-Lant;cha Ln , (See '~able 3.3).
Representaitive patterns of !IF staining arIa shown in Fig
3.1 to Fig 3.5. MHC antigens appeared under fluorescence as
fine granulAs on the cell surface.
Table 3.4 summarises the results obtained using both ViabLe
and fixed cells for the IIF assay on the control cell lines
Raj i and 1<562. 'llhereappeared to be no differenCes in the
MIiC sur f ace antigen expression b\~tween viable and
acetone-fixed Raj i and I<562 cellS: as detected by indirect
immunofluorescence staining. Using botih via.ble and fixed
cells Raji spontaneously expressed both classes of MItc as
well as their respective invaria.nt ehains. 1<562 dL' not
spont.aneously express MHC antigens (See Table 3.4). This
assay therefore confirmed the validity of using the eell
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Figure 3.1
Immunofluorescent staining of tn,~ human HCc cell line
ItA22T/VGH demonstrating spont?.oeous Hl:.A-A,B,C expression as
detected with tne monoclonal antibody W6/32. The figure
demonsbr at.es fluorescence as fine green granules on the
plasma membrane. (Magnification 40x)
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F.igure 3.2
Immunofluorescent staining of the humah ace cell line
Pl~C/PRF /5 demonstrating spontianacus HLA"'A,B,e expressiOh <is
detected by the monccl.onaI ant.Lbody W6/32. '!'he figure
demonstrates fluorescence as fine grl.lnules on tl\e cell.
surface. (Magnification 4vX)
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FIGURE 3.3
J:mmunofluores.cence staining to demonatir-atiethe spontaneous
presence of beta-;;:-microglobu).in (B2m) on the human lIce
oell line HA22T/VGH. The figure demonstrates flUorescence
as fine. gl;'eengranules on the plasma membrane.
(Magnifioation 40X)
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FIGURE 3.4
Immunofluorescence staining to qemonst~ate spontaneous
exp~ession on theJ human HCCcell line HA22T/VGH. The
sur-face structures we~e detected. by indi~ect
immunofltlor.escence using the. monoclonal antibody TAt IBS
(anti-I{LA-OR). (Magnification 40x)
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FIGURE 3.5
Indirect immunofluorescence staining to demonstrate
spontaneous HLA-D region-associated invariant chain, Ii,
expression on the human Hee cell line HA22T/VGH. The figure
demonstra.tes tluo;l:escence as fine green granules on the
plasma membrane as detected by the monoclonal antibody
VIC Y1. (Magnification 40x).
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lines Raji and K562 as positive and negative control cell
lines respectively. The HCC oells did not react with
normal mouse gamma-globulin or PBS.
The results of the dose response experiments performed on
the monOClonal and FITC conjugated antibodies used in this
study (Table 3.1) are summarised in rable 3.·1';.The amcunt;
of fluorescence observfld for each dilution of MOAB and
FITC-conjugated antibody may be summarised as follows: when
no MOAB was used for the assay/ irrespectiVe of the dosage
of FITe-conjugated antibody I no resulting IlF st.aining was
observed. This lack of :flUoreSCence was designated as "(lit
as seen in Table 3.5. A dilution of the MOABs W6j32
(anti-HLA Class Il and anti-132m of 1:5 with a corresponding
dilution of 1:2 of the FITC-conjugated antibody resulted in
maxd.maf,non-specific binding of the MOAB as well as :rnaximill
nonMspecific backqz ound flUorescence being observed. The
fluorescence observed when these dilutions were used for
III" staining was designated as "3+" as seen in Table 3.5.
Similar degrees of fluorescence Were also observed for
dilutions of MOAB and FITe-conjugated antibody at 1:10 and
1:2, 1:50 and 1:2 and 1:5 and 1:5 respectively. When a
specific display of MHC antigens was coupled with a minimal
non-specific ba,ckground.fluorescence, the d.esignation of
"2+" was assigned.. The symbol "+,,was aSSigned to the
al1lountof fluorescence observed when the dilutions of MOAB
TABLE 3.4
W6!32
anti-132m
TAr~ '",)35
VIC Y1
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SPONTANEOUS EXPRESSION OF HLA CLASS I AND II
AND INVARIANT CHAINS ON 1\562 AND RAJI CELL
LINES AS DETERMINEP BY THE IIF ASSAY
Live Fixed FixedLive
+
+
+
+
c
a. The speoificities of ea..::hMOABs is described in Table
3.1.
b. "+" implies spontaneous expression (ie. .2. 90% of the
cells in the field of vision examined sporrcaneous Ly
fluoresced) .
c. "_" implies negligible spontaneous expression (1e .$.10%
of the cells in the field of vision examined did not
spontaneously fluoresce).
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TABLE 3.5 OPTIMALDILUTIONSOF MOABsBINDINGTO
HL-ll.-A,B,C, D ANDTHEIR RESPECTIVE INVARIANT
CHAINS, B2m ANDIi, t]SING THE CELL LINE TONG
PHC
MOAB o 1:5 1:10 1:50 1:100
FITC-
conjugate 1:2 3+ 3+ 3+ 2+
1:5 3+ 3+ + +
1:10 no binding with HLl\,-D regicll'l antigens was
was observed
1:50 2+ + + +/-
Each MOABdirected i:\gainst a certain HtA specificity as
outlined in Table 1.2 was Used at dilutions indicated (0,
1:5, 1:10, 1:50, l:J~O).The dilution of the
FITC-,oonjuga.ted antibody used is shown on the vertical
axis (1:2, 1:5, 1:10, 1:50). Each FITC-conjugated dilution
was used against a ditferent MOABdilution and
FITC-conjugated antibody result~d in maximal spec:l.fic
display of MHCantigens and negligible amounts of
non-Specifio background bjnding'. At these dilutio):ls, the
dosage of MOABand FI'l.'C-cClnj1.1gated antibody was oons Ldexed
optil"ised. For the monoo.LcnaL antibody W6(32
100
(ant:i-HLA-A,B,C), a dilution of 1:50 and FITc-conjugated
antibody dilution of 1:50 optimal. These dLl.utif.onc
demonstrated the most defined and clear fluorescent
pattern. (Fig 3.1 and 3.2). Binding of TAL IE5, an
anti-HLA-DR antibody, to any cells of the cell line TONG
PHC was not observed at any of the doses used
(1:5-1:100). For practical uurp)ses therefore, the dOGage
of 1:50 fqr TAL lE5 was employed for fUrther !IF
experiments. As seen in Figure 3.5, T.IFstaining of
HA22T/VGH cells using this dilution of T,A;t, lB5 aLao
resulted in a o..ear and defined fluorescent pattern. The
monoclonal antibody, anti-B2m, was optimised at a dilution
of 1:10 using a FITc-conjugated antibody dilution of
1:50. An example of the resulting crisp fluorescent
pattern is ahowr; in Figure 3.3. The dilution Of 1:1000
was employ~d for VIC 11 (anti-Ii) according to personal
information from W, Knapp. The clear rIF staining
resulting from this dilution of the MOAB and a dilution of
the F!TC-conjugated antibody of 1:50 is shown in Figure
3.5. The assignment of "+/_u was given when the
monoclonal antibody was too dilute to maintain its
specificity (Table 3.5'.
3.5 DISCUSSION
Table 3.3 summarises the spontaneous e.x:pressionof MHC
Class I and II surface antigens as well as their
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respective invariant chains, B2m and Ii. The results of
this present study indicated spontaneous expression of MHC
class I and B2m on all the HCC cell lines investigated.
These are consistent with those previously reported (Sung
et al 1989 I FU)msato et al 1986, Krief et al 198 I Franco
at a1 1988). All the abovementioned studies employed an
indirect immunofluorescence assay as a method of assessing
MHC surface expression on the following HCC cell lines:
PLC/PRF/5 ( Sung et al 1989, Krief et al 1988, Franco et
al 1988, Fukusato et al 1986), Hep 3B, Hep G2 (Krief et al
1988, Sung et e\l 1989, Fukusato et al 1986), Tong PHC
(Sung et a1 1989)J HA22T/VGH (Krief et al 1988, sung et al
1989) and Mahlavu (Fukusato et al 1986, Sung et al 1989)
investigated in this study. The cell lines Hep G2, Hep 3B
and TONG PRe did not exhibit spontaneous MHC Class II
antigen expression a~ shown in Table 3.3. Sung et a1
(1989), Fukusa,to et al (1986) and Krief et al (1988),
using the rIF technique, reported similar results on these
three cell J.ines. The rusults of the present study
demonstrated that the HCC cell line PLC/PRF/5 does not
spontaneously express MHC Class II antigens. This finding
is in agreement with that of Sung et al (1989), FU]{Usato
et al (1986) and Krief et a1 (1988) who showed that the
Alexander cell line does not express HLA-D region antigens
undl?r spontaneous oondd'tLons , However I Franco et al
(1988) zeporrted that Alexander cells spontaneously express
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MHC Class II antigens at low levels as detected by the IIF
techni.que. Thi~ discordance in results could be explained
by the variations in MHC antigenic profiles of the
different generaticns Of th~ uell line which is expected
from cell Gulture Work (Freshney 1987) as Well as
differences in sensitivity in the methods of detection
used.
Krief et al (1988) and Sung et al (1989) reported the
constitu·tive E?"'{pressionf MHC Class II antigens in the
less differentiated hepatoma cell line, HA22TjVGH.
Similarly, the present study also reports s~ontaneo~s
expression of MHC Class II in the HA22T/VGH cell line.
MHC Class I! and its associated invariant chain, Ii were
both spontaneously expressed in the cell l.tneHA59T /VGH as
assessed by the r!F technique in this study. The status
of MHC antigen expression in this Hee cell line was not
available from the literature.
Cells that Were. labelled with a non~specific antibody
d:i,rectedagainst the heavy chains of all the classes of
the immunoglobulins in order to assess the specificity of
the IIF technique did not exhibit any fluorescence. This
indicates that the fluorescence obaez-ved on liCC cells was
indeed because of the immunolabelling cf specific MHC
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antigens on the plasma membrane of these, cells. In order
te assess the sensitivity of the assay, cells used for
this assessment were labelled with the secondary but not
primary antibody. That ne fluorescence waS observed on
these cells implied firstly I the monoclonal ant.~;~;odies
were conjugating with specific MHC antigens on the cell
surface and not to random cell surface receptors such as
glycoproteins and secondly, the FITc-conjugated
immunoglobulin F(ab1)2 fragment was labelling the
monoclonal antibodies and not undefined antigens on the
cell surface.
In Table 3.4 the results of MaC surface expression for the
cell lines Raji and K562 are summarised. The cell line
Raji was employed as a positive control cell line because
it spcntaneously expresses HL\-A,B,C,D antigens as Well as
the invariant chains, 132mand Ii. Raji has been
consistently reported to express MHC Class I and II
antigens spontaneously (Nilsson et al 1974). K562, an
erythromyeloid·~derived cell line, did not spontaneously
express MaC antigens as seen in Table 3.4. This cell line
has been typed as expressing no significant amounts of MHC
surface antigens unrierresting or unstimulated condi·tions
(Lozzio & Lozzio 1975). For the above reason, K562 was
used as a negative control in this study. Thus the IIF
assay confir:rnedthe validity of the assignment. of these
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two cell lines as controls for the present study. The
results of the optimisation of the monoclonal antibodies
and F:tTC-conjugated antibody are summarised .j,rt Table 3.5.
optimal fluorescence was considered when maximal specific
binding to an HLA specificity was coupleetwith negligible
non-specific background fluorescence. The optimisation of
antibodies used in indirect immunofluorescent staining is
necessary because the sped.fic activities of each
monoclonal antibody is different, resulting in maximal
binding of the antibody occu~ring at different dilutions.
The monoclonal antibody W6/32 (anti-HLA-AIB,C) exhibited
maximal alltigen-antibody binding at a dilution of 1:50. A
dilution of 1:100 was too high to be of any experimental
use. Similar results were observed for the monoclonal
antibody I anti-132mbut for this MOAB, a lO'Vlerdilution was
used experimentally (1:10) as fluorescence at a higher
dilution seemed to fade more qui.ckly.
The results of the present abudy correlated wit,h t;hose of
Boucheix et al (1985) in that approximately 10% of the
cells used in experiments were lost after 2 washings and 2
incubations. Viability decreases by lest:'than 10% in the
course of the experiment (results not shown).
staining of cell surface antigens with corresponding
labelled antibody frequently fails when CI,nLnappr'oe \a'!:e
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fixative is used. ,Jessen 19(3). This is because of
changes i.nthe distribution and shape of the antigen as
well as cross linking of membrane proteins (Jessen 1983).
Since MHC antigens are surface antigens and can therefore
be stained directly with labelled antibody (Jessen 1983),
this study compared MHC antigen surface expression on
viable and fixed c~lls. The effect of fixation was
investigated by the use of different fixa'J,ivesnamely
ethanol, panaf o.rma.Idehydeand acetone and the optimal
fixative assessed. The results of MHC s~rface expression
on viable and fixed cells are summarised in Table 3.4
using ice-cold acetone as the fixative. As seen in Table
3.4 there vias no difH.rences in the expres:::;ionof HLA
Class I and II.as well as their respective i~variant
chains using both viable and fixed cells when acetone was
used as a fixative. No fluorescence WlS observed using
indirect inuuunofluorescence staining when para£ormaldehyde
and ethanol were used as fixatives.
It is worth discussing why the fixatives etharl01 and
paraformaldeh.yde were not suitable for the fixation of
control cells in the immunofluorescence assay.
paraformaldehyde is a cross-linking fixative which reacts
in a oomp Lex manner '\.fithcell proteins (JeSsen 1983).
'1'hisresults in the formation of links between adjacent
protein chains, thus effectively permeabilising cell
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membrane to antibody molecules (Jessen 1983). Th~ degree
of permeability depend.s on the concentration of fixatiVe
used with a higher ccncentiz-a'tLon }:Ieing less successful in
aohi.evd.nq permeability than a lowe);, one (Jessen 1983).
The permeabilisation of the oell membrane before addition
of antigens is not or,ltiuJ.al when det~loting cell surface
antigens since it mOistly leads to weaker immunostaining
and can cause higher backgrot.md flu.cr:ascence through non-
specific antibody interactions with ~\xtrar..:ellular
components (,J'essen 1983). '.rhus when a 2%paraformaldehyde
aqueous solution Wlasused as fixative for control cells
1<562 and Raj i, it could have been at i:oo high a
ooncentration and thus <lestl:oyed the clell structures
responsib].e for ant.Lbody reactions. .1\lnother possible
cause of an absence of fluoresoence be:ing observed "Then 2%
paraformaldehyde wc\s used I could be that the high
background fluorescence (for reasons oescribl1JQ.above.) made
obsez-vat.Lon of Mue antigen staining diffioult. ~Iimil.ar
reasons could have been responsible fc,r 96% EtOH not being
an affective fixative in the system uaad ~,n this study.
:tee-cold acetone is a classic fixativEl fOr Lmnunc-
cytochemical procedures and il.1 this study, proved to ';JJ.V'e
the best results as a fixative in the indirect
immunofluorescence asuay of Raj i and :t<562 cells.
DUring the immunofluorescence assay, cells Were incubated
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at 4°C fot'several important reasons. FirstlYI Fernis
and Tse (1.985) have detailed evidence that the recycling
of MHC Class I in activ~ted T lymphocytes occurs at
37°C. Pernie and Tee (1985) have demonstrated that MHO
moleCUles are continuouslY internalised or endooytosed and
that cells that are carrying MOAB, or are FITC-labelled
have these labels recycled with them. They have alSO
demonstrated that the time necessary for the
internalisation of 50% of the surface MHC class I antigens
is approximately 60 minutes, While the resurfa,cing of the
recycled antigens takes approximately 20 minutes (Pernis &
Tse 1985). HoweVer, this recycling process is Slowed down
considerably at 4°0 (Pernis & Tse 1985). Incubation at
4°0 also slows down cell metabolism, preventing SUch
phenomenon as ca);_lpingWh~.ch is the redistribution of cell
surface moleCUles (such M aLA) when cross ....linked or
exposed to antibodies (Klein 1986). The mechanism of
capping has yet to be elucidated but it is an energy
requiring process (Klein 1.986). Capping is blocked by
.i.nhibitorsof metabolism SUch as sodium azide, thUS most,
inoluding the Moabs Used in this study, are co"d,~.luted
with sodium azide. Antibody~induced redistribution of MHO
moleCUles can result in the effec~ivQ disappearancll;!of
these antigems (due to internaliso.tion of antig'en"'antibody
oomplexes) from the cell surface thus giving rise to falSe
negative r(:lsults. The USe of sodium a.zide together with
performing the IIF assay at 4°0 ensured that this
phenomenon did not OCCUt'.
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CHAPTER 4
ENZlfME ....t.INKE:P IMMt.JNOSORBENT ASSAY' (ELISA)
4.1. lntroduction
The enzyme immunoassay (EtA) or enzyme-linked immunosorbent.
assay (Et!SA) is a sensit~ive assay which is increasingly
being used to deteot. speoific antigens (such as malaria)
ooourring in lot'l' ~~oncent;rat.ion$ (Voller at al 1976). EIA.
and Ft.ISA t S are probably the mO:;3twidely used. of all
immunological asseys fo): dE~tect.ing antibodies to various
infect.ious agents since lal:'ge numbers of tests can be
performed in a relatiVely short time with t.heee t.ests
(:R.oitt et_s1 1989) •
The rationale behil'ld the enzy~la immunoassay is that an
antigen or. antibody can be linkac;:l to an enzyme whil,st.
retaining both immunolo't!ioal and enzymatic activity in the
resul ting conjugate (:Ro,itt ~ 1.9$9). In 1964/ Nakane
and 1?.:i.ercedemonstrated chemical linkage between enzyme and
antlbod,y, indicating th.ll effective use of an indirect
Lmmuncenayme assay. :tn 1970, Sternberger et al :r:'eporte.cl
that the j,nununoJ,.ogictl linkage of a peroxidase-bound enzyme
with al1ti:body Was bi(lohemically possi:ble. Sternberger ~t
al (:L970) developad a quantit.ative assay of the antibody
against. the spirochete mreponema pallidum. Later
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worker~ in this field Ot.)ncent::ated0):1. 1~hl'.!visual detection
and localisation rathe" than the irrJ"'.l.l'lologicalaspects of
antigens (Engvall & perlman 1972, Engvall at al 1971, van
Weeman & Schuurs 1971). Engvall and workers (Etlgvalt &
Perlman 1972, Engvall et al 1971) and.van Weeman & Sol'.uurs
(1971) developed techniquel.'l:eorquantitating specif.ic
antibodies using an alkaline-phosphatase labelled and
horseradish peroxidase-label~ed enzyme respectively. In
these assays, the Soluble antibodies 'V/erelinked to an
in.soluble solid phase containing al1'cigenin such a wP,y that
the reactivity of the immunological component of the
antigen ...antibody interaction Was retail1ed. The reagents
Used in these assays are highly stable, have a long.shelf
life and present no health hazards (Watt ~ 1988) •
~hree general types of E~ISA have been developed: a) the
direct method, in which antibody is detected and measu~ed,
b) ~he double antibody sandwich and c) the competitive
method. For the latter two assays antigen is imlnobilised
on a solid phase, and bound to an enzyme-labelled antibody
which is then detected colorimetrically. ~he sandwich.
method of performing the ELISA was ad(~pted in this study I
since the l:;Jr'otocolSof this technique were already
established in the laboratory.
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Th¢ existance of a substance that conferred resistance to
vir.al infections was demonstrated as early as 1957 by
J:saaos «r..indenrnann. Since then, the fsmily of inter;f~rons
have:been shown to be potent biomodulators involved in
antiviral activities, cellular differentiation and
proliferation CBranca 1988, Revel & chebath 1986, Rosa &
Fellous 1$)$4). Interferons are highly heterogenous in
their moleoUlar structure (nuc-co.tran~t al 1986) I with
three major classes of interferons having been desoribed.
These are: leukooyte ot'alpha interferon, :Cibroblast Or
beta inter:eeron and immun~~or gamma interferon (Pestka :!rt
.M. 1987) with all clMses l:>eihgpresent in all mammalian
species (Pestka r~tal 1987).
Human IFN"'alphaI ...a and -gamma have been shown bo have th~.
ability to indUoe a common set of proteins and activatioi'l.
of genes including MHC Class I genes (Madey et al 198~9,
Anderson & Berkowitz 1985, ottesen ~ 1990, Drig~ers ~
li 1990) and 13!a....microglobulin (Marley stLAl. 1989, Andersolt
& :Berkowitz ;1.985,~...ttesen et al 1990, Driggers ~ ;1.990)
as well as those encoding for 2',5'-oligoadenalyte
synthetase (Eades ~ 1990). HOWeVer lPN-gamma.,
synthesised by activated lymphocytes acts through a
distinot.ly different reoept.or (Weil ~..sl 19a3, Revel &
Chebath 1980) and differs in cell origin, induoing agents,
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physical and biological properties, and amino acid sequence
(Gray et al 1982) to rPN alpha and -B.
Interferon-gamma has been shown to be capable of increasing
the production of antibodies by B lymphocytes both in
v:i."oand in vitro (Nakamura et al 1984). In
addition. it has been demonstrated 'chat.IFN-gamma is
involved in activating genes encoding f.or MRC Class II
proteins and their associated invariant chain (Ii) (Pessara
gt al 1988, Ucer et al 1985, Sugimoto et al 1989, Basham
& Merigan 1983, Koch et al 1D84), suggesting specialised
role fer IFN ....gamma in immune regulation (Basham 6( Merigan
1983). It has been previously reported (Krief et al 1988,
Yoshioka at al 1988) that inoubation of hepatoma cells with
lPN-gamma enhanced the expression of HLA Class I and II
expression on these cells. This present study, therefore,
undertook to determine Whether recombinant-lPN-gamma and
"'alpha exerted an effect on l1f[Cexpression on the HCC cell
lines investigated in this study.
4.1. 3 SODlt)'M BtJ'l'YMTE
Sodium butyr~te is a physiologically occurring fatty acid
that has been shown to have a wide variety of effects on
mammalian cells Ln cultUre (Prasad & Sinha 1976/ Cand.i.cloet
£1 1978). Initially, it was shown by Leder & Leder (1975)
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that butyric acid was capable of inducing globin gene
expression in Friend erythrolf'Jukaemiccells. Evidence
accumu Iatied over the past few years suggests that butyrate
may also b(3an importA.nt pharmacologic agent for studying
the mechanisms of gene expreasLon (de Haari et al 19$6,
Prasad & sinah 1976). It has been shown that butyrate
causes increased ace,tylation of histones R3 and H4 as well
as alterations in chromatin structu.re and activity (Kitzis
e.tal 1980). eteHaan et al (1986) and Riggs et al (1977)
reported that sodiUm butyrate inhibits ONA synthesis, and
induces hypermethylation of DNA in normal and transformed
embryonic lun<;rfibroblast cell lines thus affecting gene
expression. Since butyrate effect· different genes and
different cell types in a tissue ....specific manner, sodium
butyrate may be capable in both inducing and/or repreSsing
expression of genes (de Haan et al 1986).
As a differentiation modifier (Marks & Rifkind 1984),
Sodium butyrate has the most consistent effect of inducing
the differentiation of transformed cells in culture into
more mature or "normal" cells (Engelmann .!'aLaI19$7).
Because butyrate is a nontoxic and a:ntiproliferative
compound, it has been suggested that it may be valuable in
the chemotherapeutic treatment of solid tumours as well
(Engelmann et al 1987, :Kaneko et.al 1990). :Kaneko and
cO-~lorkers also demonstrated that Chang but not PLCIPRF{5
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and llu-7 human hapat.ome,cell lines Wfare transformed into
fibroblast-J.ike ceii's\.,itha luarked1y elongated cytoplasm
when treated with novobiocin, a topoisomerase inhibitor,
and butyrate (Kaneko et al 1988,1990) • Nakagawa et a1
(1985) demonstrated that butyrate. Lnducec' a significant,
dose-related inhibition of PLC/PRF/S cell growth.
Morphological changes were revealed using Giemsa-staining
of cC:!llstreated with lmM sodium butyrate (Nakagawa" et al
1985). These workers also demonstrated that butyrate
caused a significant decrease in the total accumu Latied
extracellular alpha-fetoprotein (.AFP) level in PLC1'PRFI5
(Nakagawa et al 1985). Cook et al (1985) similial:"ly
reported that sodium butyrate dec:t"easesAFp mImi\. lWels in
rat hepatoma cells in vitro.
Tb~ mechanisms of action of sodium butyrate on various cell
lines are currelltly unknown (praSad & Sinha 1976).
However, Sutherland et 0.1 (1985) While invel'Stigatingthe
pattern of differentiation in the K562 cell line initiated
by sodium butyrate, observed that after incubat.ion with
sodiUm butyrate, HLA Class I antigens were detectable on
the cell :membrane. It appears that the mechanism by which
sodium butyrate and gamma interrel;'oninduce HU expl;'ession
is under genetic cqntro,l, sutherland at aJ,.(1985) cl.etected
an increment in th~~ level of HIJ\.""'.h,B,C :mB.NAin K562 cells
that had been pretJ~eated with sodium butyrate for :3 days
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and thereafter incubated \vith IFN-gammafor 48 hours.
MoreoVer it appeared that sodium J:;-'tyrate and gamma
interferon synergistically induced HLA. Class I expression
(Sutherland et al 1985).
since human leukaemic oell lines (such as K562) can be seen
as mcdeLs of certain stages at ncrmaf differentiation
(13akhski et al 1983) I it is possible that the expression of
11LA antigens lnight be related to some proce~s of
differentiation (Sutherland et. a1 1985). Fot" this ::easOh
the present study undertook to investigate the effect of
sodium butyrate on the status of HM expression on human
hepatoma Cell lines.
4.1.4 CLOFAZIMINE
J
_d
CICJfazimine, also known as Lampnena or B663 (See Fig 4.1)
is an effective anti-leprosy agent (Barry et a1 1957,
\Tischer 1969, Yawalker & Vischer 1979). Apart from its
direct anti-microbial properties, clofa~ildne has been
shown to stixllulate phagocytic and microbicidal activities
(Bl:andt & svensson 1973) of human and murine neutrophils
and naoz'ophaqe s by potentiating the activity of lysO$oxnal
enzymes (Cline 1970, Sarracent & Finlay 1982), Cl,ofazimine
also possesses anti ...inflammatory and immunosuppressive
properties (Gatner et. al 1982, Andel;"son1985, Anderson et
al 1976).
Clofazimine : Chemical structure
Figure 4.1: Redrawn from Vischer (1969)
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It has been found that in mycobacterial diseases such a.s
myco):lacterium t'Qberculosis r the capacity of phagocytes
for intracellular killing is inhihited (Wadee et al 1987)
It has been reported that clofazimine can reverSe the
3.nhibitory effects of mycobacterium tuberculosis on
phagocytic intracellular killing mechanisms (Wadee et al
1988). Similar results were reported by Cline (1970) who
demonstrated potentiation of the killing of listeria
monocytogenes by macrophages. In phagocytes this
potierrt.Lat.Loncauses lysosome pr'oduc+Lon, release of oxygen
metabolites such as hydrogen pezox i.de as well as increased
activity of thehexose-monophosphate shunt (HMPS) (wadee et
a11988). Clorazimine has been demonstrated to prime
macrophages for expressing H.LA-DR antigens (Wadee AA
personal communication). BecaUse of such priming by
cLof az Lmd.ne, the present stUdy undertook to examd.ne the
effeot of cl.ofa;:;imineon the HLA expression of various Hce
cell lines.
4.2. HATF:RIALS
4.2.1. primary antihodies
Monoclonal antibiodies used in this study are J·isted in
Table 3.1 (page 82).
4.2.2 Secondary antibodies
The peroxidase-labelled antibodies used in this stUdy were
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a) horseradish peroxidase-linked sheep anti-mouse J.g whole
"antibody (Amersham International, Amersham UK)
b) peroxidase-conjugated goat anti-mouSe (capps-L Labs,
Cochranville, USA.)
4.2.3 LYMPHOKINES AND CHEMICALS
All lymphokines and chemicals were mad? up as a stock
solu,-ionmaintained in RPMI-1640 (Highveld Biologicals,
Johannesburg; SA), filter sterilised through a 0,22 um
filter (Millipore, Bedford, MA, USA) and the resulting
solution stored at 40C until used.
a) Chemicals:-
Clofazimine fA gift frolUR Anderson, University of
pretoria) provided as a stock solution of 200ug/ml In 1%
DMSO
Sodium Butyrate (Merck Chemicals, N' ich, Germany)
stock solution of 50 roM in H20
b) Lymphokines:-
Alpha Interferon, IFN-alpha (RoChe, Basel, switzerland)
having a specific activity 3 :x: 106 Ulml A stock solution
of 3000 1U/m] tn RPMI-1640 was USed.
Gamma interferLn, IFN-gamma (Amersham International,
Amersham, UK) a human recombinant secretory form, having a
specific activity of 1-5 x 107 U/mg. A stock solution of
10000 IUlml in RPMI-1640 was used.
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4 .3 MEr.rHODS
Determination of MHC antigen expression on HCC
cell lines by the ELISA
Confluent rnonolayer HCC cells were trypsinized, counted ox~
a hemacytometer and their viability assessed by the trypall
4,3.1
blue exclusion test (Chap 2.5). only cells havirlg a 75%
confluency and viability ~1ere used for this assay. The
ELISA "9,5 performed in flat-bottomed 96....well culture plates
(Cel-cult Sterilin, Hounslow, UK). All procedures were
performed at room temperature unlesS otherwise stated. The
incubation times used in these experiments were previously
optimiSed in this laboratory (A. A. Wadee-personal
communication). The plates were Washed four times with
PBS-O,S% Tween (Appendix 1) between each step. Ten
thousand ceUs of the various HCC oell lines (Table 2.1) in
complete OMEM (Section 2.4) were added ho each. Well and the
plates were incubated in 95% air-5% CO2 in a 370C
incubator. After 24 hours the cells were seen to have
adhered to the bottom of the ~ell and they had reached 85%
confluency. Thereafter the cells were fixed for 30 minutes
at room temperature with. 100 ul 0,5% paraformaldehyde such
that the final concentration of paraformaldehyc\e was
0,25;%. After three \'lashingswith }?BS-'l'WI;ll:.;;nI unbou d 6ites
on the surface at each well was blocked. with 0 I ~\% BClvine
Serum Alb~min (SSA) in carbonate buffer at a pH of 9.6
(APpendix 1) and the plates were Lnoubatied at rot:>m
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tempel::'ature for 60 minut,od. The plates Wfi:lrewashed four
times in PBS··Tweenand 100ul of an approl'i.l:iately diluted
primary antil)ody in PBS-TWeenthen added to each well. The
antibodies, W6/32 (anti-HLA -AlB,C), TALIB5 (anti-HLA-PR),
anti-£2m and VIC Yl (anti-Ii) were employed as the primary
antibody in the ELISA. After incubation at room
temperature 1:or a .further 2 hours followed by four washings
with J?)3S"TweE~n,the cells were incubated with 100 ul of the
enzyme-labelled antibody (Section 4.2.2) appropriately
diluted in PaS-Tween. Since TWeen is an anionic detergent,
it bloc){s elf.lctrostatic interactions thus avoiding
non-specific bindings between antibody and cell membrane
proteins. All dilutions of primary and secondary
antibodies t-le.re therefore made :i.n PBS-TWeen. Thereafter I
cells '\>lereincubated in the dark with 100u1 of a peroxidase
substrate, O~phenylenediamine (OPD), in the presence of a
0,03% H20;;!solution. substrate bUffer (Appendix 2). 'l'ha
. colorimetric t:eaction, measuring the extent of antibody
binding, was :stopped after 15 minutes with soui 2,5M
H2S04, The ol?tical density (00) of each well was read
at a waveleng1;h of 492 nm on an ELISAMu:ltiskan Titertek
spectrophotom~lter (Flow Labora tor ies I ::t:rvineI Ayrshire I
Scotland)
DETE~:r.NATIONOFNON"'SP:SC:CFICBACl(GRO'ONDDl!:NSJ:T~
The control bLanks Used in the assay were as follows: to
the ,\>1Ii:l11sof the first column in every plate, only Clells
120
and the peroxidase substrate (OPO) were added. To the
wells of the second G)olumn in every plate, cells,
enzyme ..labelle.d antibody and ('PD were added. In order to
obtain a value. for nOi'l~sp~dif;Ld bin.ding the mean of the
values of the fir.-st co Lunm We.l:e subtraoted from the mean of
the second column. 'l'his vaaue wag, now used, as a cell
blank. The blqnk was :zubtraci~ed from all 00 mean values
before these results WE-Iresubjleoted to statistical
analyses. It was observed tha:t the amount of non-specific
background density appe~\red to' inoraa~e as the shelf life.
of the pe.roxidase-labell~d cOhjugate lengthened. For this
reason, two different pe:t::oxidase-labelled (';1onjugates were
used in this study.
D]!)T]!)RMINATIONF Ol?~~IMALANTIBODYCONCENTRATI.ONS
ItEQt1IREDTO DETECTlSURlfACl!):Mac AN'IJ:'!GENS
In order ,to standardise a.nd dei~ermine the optimal
conditions :eor the J::~r..ISA,part:tcular reference Was given to
two essential vC\dables I namel)' the conoentration of the
p:"imary (mo110clonal antibody) amp the secondary antibody
(enzyme-labelled oonjugate). <:heolcerboard Er..tSAIs were
pel;'formed on t.he following Hce cell lines: 'Pr..C/PRf'/$,
HepG2, 1Ie);>3B./HA22T/VGH, HA59T/VGH, 'l'ONGPHC a.nd :MahlaVti in
ordel;' to establish th~ optimal dilutioh of pl;'imary and
Sacol"lpary ~lhtibodias. In these ex~eriments t.he mon~~clonal
antibodies ~~6/32, anti-B2m and TAr..:ca5 \"-=re diluted '1:0
1:10, 1:50, 1:100 and 1:200 .Hlutio~ts in l?BS....TWeen
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(Appendix 1). The monoclonal antibody VIC ~l was diluted
to 1:500, 1:1000, 1:1500 and 1:2000 dilutions'1n PBS-Tvteen
(Appendix 1). Plates were coated with 10 000 cells in
100ul of oomplete OMEMand incubated for 24 hours at 37°C
Ln a humidified incubator (95% air"'5% C02)' Cells were
fixed with a final concentration of 0,25% paraform-
~ldehyde and unbound sites block.ed with 0,5% eSA (Appendix
1). Following four washes with PBS-Tween (.l\ppendix 1), the
various dilut.ions of the monocf.cna), antibodies (Table 3.1)
we:t:e added b;l quadrupf.s well~. Aftet plates had been
incubated at: rOal" temperature for 2 hours t.hey were washe(1
four times with PBS"Twe9n. E:11zyme"'labelled conjuqate at
val:'ious dilutions was added to the WellS, such that each of
the dilutions of. the MOABwas incubated wit:.h each di;J,ution
of the secondary antibody. The plates were then
incubated for. (jl~ minutes at z'oom t.emperature. After a
final fOUr washes, 100 ul of the pel:'oxl'dase substrate
puffe:!: (Appendix 2) were added alia t;:b<;!rea..::'Cion termina'l;., d
after 15 minutes with SOul of 2,5M li2S04 (Appendix l).
Opt.ical densities were read at 492nm on an EL;tsAmultiskan
Titertek spectrophotometer (Flow Laboratories, J:rvine,
Ayrshil:'e I ScotlarIl1).
DETECT!ONOF SURFACEANTIGENSONFIXEDCELLSOF
THECELt L!NESK562 ANDRAJl a~ ELISA
Raji and K562 \olere used as positive and negative oontz'ols
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respectively in this study. Raji spontaneously expresses
MHC Class ! and II antigens and X<562 eXpresses only
negligible all\ountsof t.heseantigens. After viability
assessment (only cells in suspension with a 85% or higher
cell viability were used) and enumeration, oells were
plated at a final concentration of 1 ~ 104 cells/well in
100 u1 of oomp1ute RPM! in 96-well flat-bottomed cell
culture plates (Cel-cult, sterilin r~td,Hounslow, tJI<).
After plating, the plates were immediately oentrifuged at
200g in a modified plate centrifuge for 5 minutes. The
supernatant was gently aspirated and the oells fixed by the
addition of 100 ul of 5% formalin at room temperature for
60 minutes.
FiVe percent formalin was used as a :fixative of Raji and
K562 cells since glutal:'aldehydeand paraformaldehyde (even
at :final conoentrations of 5%) t'v'erenot as effective
fixatives. The cells did not I.'emainadherent to the bot~~om
of the Wells when these fixatives were used. Thereafter,
plates were centrifuged again SIt200 g for 5 mirlutes•.
Af'l:ergentle washing of the plC!LtesI unbound sites were
blocked with 0,5% BSA in a carbonate buffer (Appendix 1) at
room temperature for 60 minutes. Subsequent steps in
performing the ELISA were as described in section 4.3.1.
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THE EFFECTS OF r-IFN-Atl?HA, r-IFN-GAMMA,
CLOFAZIMINE AND SODIUM BUTYRATE ON HCC CE!,L L!NE
EXl?RESSION OF MHC ANTIGENS
Confl~ent HCC monolayer cells Were trypsinized, counted on
4.3.3
a hemacytometer and their viability assessd by the tryp~n
blue exclusion tests as outlined in section 2.5. Of a
singl~ cell suspension, lOO~l of a stock solution of
4xl05 oe11s/ml made up in DUlbacoo's MEM supplemented
with 10% FCS (Both. from Highveld Biologicals, qohannesburg,
SAl section 2.4) was added to each Well. The cell density
of 40000 cells/well resulted in a plating oonfluency of 50
percent. When cell densities higher thatl.this Were used,
the maj ori t.y of ceUs lift.ed fJ;'omthe si~J;'faceof the v.J'ells
after 72 hours. The plates were Lncubabed in a humidified
incubator of 95% r:.ir-5%CO2 at 3700. A-eter 24 hours,
vaz Lous dilutions of the Lymphckd naa r-IFN-g'amma and ...alpha.
and the chemicals clofazimine and sodi~n butyrate (seotion
4.2.3) were addeo to the wells using a oheckerboard
experimental design and the plates incubated at 370C in
an humid:lfied (95% air-5% CO2) chamber. In order to
determine! the optima.J.time J;'eg:uiredfor maximal stimuLation
Of cells to be achieved plates were relnoved from the
inoubator at 4, 18, 24, 48, 72, 96 hQur~ and the cells
fixed wlth a final concentration of 0,25% pal:'afoJ;'maldehyde.
The plates were inCUbated at room tempeJ;'ature for 30
minutes anti thereafter at 40C until l:'equired (maxima.l
time being 96 hours). The ELISA was performed on all
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plates simultaneously. After fixing, the plates were
incubated with 0,5% BSA in a carbonate based buffer ab room
temperature for 60 minutes. Four washings with PBS-Tll1een
were folloWed by incubation with the panel of monoclonal
antibodies directed against MHC class I and II antigens and
their assoc:Lated invariant chains using predetermined
optimal dosctges (Section 4.3.1. 2). Thereafter the plates
were washed four times with PBS-Tween and the cells
incubated with the peroxidase-labelled antibody at room
temperature for 60 minutes. Subsequent steps in performing
the ELISA were described in section 4.3.1. The optical
densities of each well was measured at 492 nm on an ELISA
Titertek Multiskan spectt.:Jphotometer (:Flow Laboratories) .
Values obtained for wells containing cells that had not
been stimulated were subb:acted from ,\,',"'1.1s containing the
lymphokine or chemical stimulated cells. This reading was
used to indicate any change of MRC expression that th,(;!:Se.
agents had caused on the cells.
ASSESSMEN'l'OF THE OPTIMAL LYMPHOKINE AND
CHEMICAL CONCENTRATIONS REQUIRED TO STIMULA'l1E
MHC ANTIGEN EXPRESSION
TO determine the optimal conoentrations required for thle
4.3.3.1
expression of NRC antigens, various concentrations of
r-IFN-gamma, sodium butyrate and clofazimine were added to
w'ells containing 1 X 104 cells. Reoombina.nt-IFN-gamma.
was used at a concentration of 50, 100 and 200 IU/ml,
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sodium butyrate at dilutions of 1, 2 and 5 roM and
clofazimine at 0 I 5 I 1 and 2 ug/ml. Recombinant-IFN-alpha ~
was used at a concentration of 200 IU/ml. Experiments were
performed on the acc cell lines HA22T/VGH, HA59T/VGH and
Tong PHC. 'rihemonoc.Lcna.I antibodies W6/ 32
(anti-HLA-A,BtC) I TAL IBS (anti-HIlA-DR) anti-B2m, VIC Yl
(anti-Ii) were used for the detection of MHC antigens (All
monoclonal antibodies were diluted in PBS-Tween). All
results reported represented a mean of at least three
different experiments.
RESULTS
Determination of optimal Antibody concentration
for use in ELISA
The optimal dose response of the monoclonal antibodies
W6/32 and the enzyme-labelled or secondary antibody
4.4
4.4.1
observed for the HCC cell lines PLC/PRF/5, TONG PHC,
HA59T/VGH, HA22T/VGa and Hep 3B are shown in Figure 4.2.
on each of these cell Lf.nea a definite sporrcaneous
expression of MaC Class ! antigens as detected by the MOAB
W6/32 was observed. (Results of Mahlavu and Hep G2 not
shown). As shown in Fig. 4.4, the dilution of the primary
an.d secondary antibody at which maximal detection of MHC
Class I antigens occurred on the cell lines PLC/PRF/5,
HA59T/VGH and HA22T/VGH was at dilutions of 1:50 and 1:500
respectively. The optimal dilutions of the primary and
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secondary antibody on the cell line, Hep 3B, occurred at
dilutions of 1:200 and 1:750 respectively, ,,,hileon the
cell line TONG PRC, optimisation of primary and secondary
antibodies occurred at dilutions of 1:50 and 1:750
respectively (Fig 4.2).
!n order to determine the optimal concentrations of both
the primary and secondary antibody that. would bA required
fOr maximal resolut:i.onof MHC Class 1: antigens by the
ELISA, dOSe responsE!.experiments were performed using
varying dilutions of the monoclonal and enzyme-labell.ed
antibodY. Figures 4.3 to 4.7 demonstrate the dose response
curVes obtained for the RCC cell lines Hep 3B, TONG ~HC,
HA59T/VGH, HA22T/VGH and PLC/PRF/5 respectively. These
graphs show the differing optical densj.ty values obta.ined
:eor every dilution of th.eprimary and ~iecondary antibody
used in this study. Each cell line exhibited a different
dose response curVe.
on the cell line, Hep 3B, the optimal dilution of the
primary antibody was observed to be 1 ii 200 while
optilnisation of the secondary antibody dilution occurred at
l.:750 (Figure 4.3). A dilut:i.onwas regarded as optimal
when 1:he optical density measured for that particular dose
Ct·;: the primary or secondary antibody was rail\::edwith a
standard deviation of le:$$t;han 0,15 when c01l11~ared';olith
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Figure 4.3
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Figure 4.4
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Figure 4.5
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Figur:e 4.6
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Figure 4.7
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former 0);' latter doses of the antibody. In figure 4.3, a.
dilution of 1:100 of the HOABW6/32 and a 1:500 dilutio\l of
the enzyme-labelled antib()dy resulted in a non....specific
response to the printary antibody being obse:l:'ved. Using the
same dilution of the MOAB,the same type of response was
observ~~d a'l: a lO~'lerdilution ct the 13econdary antibody
(1: 100()). Howeve.:I'Tht:-;nthe dilution of the MOABwas 1: 200,
a ~O$edependant rE:ispon$ewas observed as either higher or
lowel: dilutiC'.lS of the secol'dary al'ltipody resulted in
lowered op'dcaJ. dens.i.ty valu$$ (see Fig 4.3). A simiJ.ar
type o:E doae .~pend~.nt response of the HOASW6/:;:2was
observed on the celt line TONGPRC, as shown in Fig. 4.4.
Ths optimal dilutio'ls for ~q6/3:2 and the peroxidasla-labelled
conjugate on this call J.in~~were 1::30 and 1:750
respr;.cti vely. Higher and lower dilutions of the pril'nary
and secotidary ant.ibodies resul tad in an inconsis'tent
response being observed as lUeasured at an 00 of 492 nm. On
the cell line PLC/PRF/5 (Fig 4.'7), the optimisation of the
primary and secondary antibl::>d~~occurred at dUutions of
1: 50 and 1; 500 respectively. As shown in T!'igure 4.7 I the
Alexander cell line, PLC/PRF/5, appeared to eXpress ~
decreasil"lg amount of HLAClass I antigen with higher
dilutio.'ls of the 110ABCl.Sl measured at an ODof 492 nm, On
the liCCoontinuol1s cell lines liA22T/VGHa.nd liA59T/VGH,a
v"riable dose response of the primary a.nd secondary
antibody was Observed (Figs 4.5 and 4. E) respectd.vely). As
shown in Figure 4.5, the cell line liA22T/VGliappea:l:'edto
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exhibit a constant response despite varying antibody
dilutions. 'rhis cell line also e~hibited the highest
amount of spontaneous MHCClaSH!>I antigen expression as
measured at an ODof 492 nm (:Fig 4.5). The consistency
that was obser'Ved in antibody dose response could Perhaps
be because this cell line exbibited a minimal number of
Class I antigenic sites that were easily saturated
irrespective of antibo;3.y dilution used. In Figure 4.4
the variable dose response observed for the cell line
fIA2?T/VGHis mimicked at all dilutions Of Primary antibody
used. DO$e response curves were obtained as a 'mean of
three expe:dments performed at different times.
The optimal di;Lutions of the )?:1:imaryantibody I '~ALIe6
(anti"'HLA-DR) and the pe.r:oxidase-labelled conj\.1l;ratet3
antibody for the HCCoell. lines PLC!'PRF/5, TONGJ?IW,
HA59T/VGHand HA22T/VGHare shown in Figure 4.8 (results o:C
the Hep 3BI Hep G2, Mahlavu cell lines not sncvnj , AI:>can
be seen in Figure 4. a I 1I!HClass XI antigens Well:'e
spontaneously expressed by P'f.;C/PRFI5,HA59T/VGHand
HA22T/VGHos].l lines whilst TONGl?HC(as well al~ Hep 3B,
:aep G2 and Ma\hlavu res\llts not shown) only ~xh:l.l:>:Lted
negligible amounts of MHCClass I:t an~ it;fl~r.~ s)_:)o)'ltaneC)us).y.
The figul;'es 4.9-4.12 demonstrate tb(' dO$es of the MOAEITAt.
!ES required for the cell lines l?LC/P.RF/5 r HA59~P/VGHI
HA22T/VGHand, TONGl?HC. Fig'ure 4.9, i1.lusttt"atel$l that
P.LC/1?RF/5 spontaneously exprflsses HLA"'ORantigelrls~ at all
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dOSBS of the MOAB and enzyme-labelled antibody
investigated. DoseS of 1:50 and 1:500 of the primary and
secondary antibodies respectively were optimal as at these
dilutions maxama), detectior. of the r-m:c antigens occurred.
High standard, deviations were observed in Figure 4.10 in
the determination of the optimal dose on the HA59!r/VGH cell
line. !rhis could suggest that a ctilution ,of 1: 10 of of the
MO}'!..BTAL :[65 was too low experimel:l:t.al1yresulting in
maximal hon~specific interactions of the MOAB wit~
antigenio sites. On the oell line HA22T/VGH, (Fig:. 4.1l),
the optimal dilution of the primary and secondary
antibodies required. vIas 1:50 and l:500 respectively. This
dilution of 1:50 of the prinlary ant:ibody was seen as
optimal in contrast to a 1;10 dilution :because of the
unsatisfaotory standard deviation as well. as of \'he cost Of
using the 1110)\13 at this l.ow dilution. Higher dilutions of
the MOli.B ~AL :ta$ resulted in unsatisfaotorily large
stand~.rd deviations.
In the cpll line TONG PHC (Fig. 4.12)J a dilution of the
peroxiaase~labelled, conjugated antl.loodyOf ;1.:500resulted
in non'"'speoific interactions losing observed for all
d,ilut.ions Of the primary antibodY !rAL 1B5 used. ThIs
dilution of secondary antiloody resulted, j,n a fals·e :positive
~ 0.4
.~
8
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Figure 4.9
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Figure 4.10
1:SO() 1:750 1:1000 1:200(1
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DilutIons ot monoclonal t\ntlbody TAL. ISS:
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Dose klnetloe of the monoclonal antibody TAL 185
for use in ELISA using the cell llne HA59TNGH
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FigUre 4.11
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Figure 4.12
1:500 1:1000
Dilutions of paroxidaSE~';c:lballad conjugate
1:20001:750
Dilutions of monoclonal antibody TAlIB5:
1:10_ 1:50~ij 1:100~I 1:200•
Dose ktnetlcs of the monoclonal antibody TAL 185
for use in ELISA using the ceil line TONG flHC
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(rig. 4.12), sLnca the 00 value obtained was higher than
the 00 value at 0.04 o,eained for the nn.gative control cell
line K$62 (Fig';4.15). At higher dilutions of the
peroxidase-l~1;;elled. conjugate, the spontaneous expression
of RI.A.-DR antigens as detected by the ELISAdecreased
dramatically. A dilution of ~:2000 of the secondary
antibcdy detected i!ilmost zero amounts of BLA-DR antigens
(Fig 4.12).
In order to optimil;;e the d'
directed aqa Lnat; 13:2 microg J.
dose response experiments (mea.
experiments) was perfonued using thr ...
of the MOAB
Ql1.€! set of
1f'i'.' ·'\.t
", ..: }T/VGH.
As Seen in FigUre 4.13 I the use of this i'.... J.1. ..),.t:edin
satisfactory 00 values only at a dilution of 1::1.0. HOWeVer
thes$ 00 measurements were coupled with high standard
c1eviations values. Therefore this monoclonal antibody,
although pr'odnct; specifications Lno Iudad use for the Et,:tSA,
was unsatisfactory for this stUdy. HoweVerunavailcibility
and cost of other anti··52 microglobulin monoclonal
antibodies precluded the use of other cotnmercially
available products.
kccordJng to the supplier's sj?ecificatidns (results not
shown) the optitnal dilution Ol: the MOABdirecbad tI :)ainst
the BLA-DR region associated invariant ohad.n, VIC'll., was
1~1000. This dilution was confi:l:med by' the expe.rimerrc
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performed 01.1 the HA22T/VGH cell lin,e usi:ng 1:5001 1:750,
1::1.000, 1:1500 and 1:2000 dilutions of the prima:cy
antiJ.)ody. 'l'he peroxidGlSe-labelled conjugate was used at.
dilutions Of 1:1000, 1:1500, 1:2000 and 1:2500 (Fig.
4.14). When the prima:):y and secondary a.ntibodies were bot,h
used at a dilution of 1:1000 f the higho~;,t optical density
meaSUreltlents were obtained. Higher dilutiotts of the
priltlary ani;;Lbodies and secondary antibl,')diE:'s (e9' 1:2000 and
1:2500 resl:>ectively) re~>ulted in a no:n",specific response
since at. these dilui:ic>tlf! negligible amoullts of the antigen
was d,etected. At l()wE~rdilutions (eg 1:750 of the pri!nar:~t
and 1: 1000 of the secondary antibodie:;l): high values for the
standard deviations werElIobtained impJ.ying non-specificity.
DETECTION OF MHC ANTIGE:NS (~L RAJ! AND THE K562
CELL LINES.
'.rhe validity of the elssignments of K!%:2 and Raj:l oeJ..ls
lines as the negat.i.vH and positive dontr(.)ls respectively
4.4.2
were borne out by 'tM, optical den:llit3.es obts,inea tor the
detection of MHcsurface expression on these cell lines
(fi~/1.rt'es 4.15 and 4.16 respectively). When optimal
dilutions; of the prima:r.y ant:.iboclie::l d:b:eoted against Ml!C
Class I (W($/32) and Class IX (T.I\L :mS) as well as their
respecti.ve Lnvazi.ant; chaLns 32m (anti-132m) and Ii (V:tc Yl)
were used in the (~sSlessment of antigen expression on the
e 0.4e
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Figure 4.13
1:500 1:1000 1:1500 .,:2000
Dilutions of peroxidase-labelled conjugate
Dilutions of monoclonal antibody antl-B2m:
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Dose kinetics of anti..B2m for use in ELISA
using cell line HA22TNGH
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Dose kinetics of VICY1 for use in ELISA
using cell line HA22TNGH~
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erythromyel.oid cell line 1\562 (Fig. 4.15), negligible
amounts of M:HC antigens were detected at an 00 of 492 nIll.
'JJheoptical density val1.leof 0,03$ was obtained when
detecting Et,A-A,B,C, using the MOAB W6/32, and 0,032 OD
units wb,en detectil1g'JrtLA-DRantigens using TAL IB5.
Measurel1\ent of MHC Class I and ):I antigens resulted in
optical dens1.ty values of not greater than 0/04 (incJ.udinsi
standard dc.viations). For this reason, any c~pt,ical
densi ty value below t:his value of 0,04 indicated. that the
particular class of MHC antigen Was not spontaneously
expressed. Any 00 vialues obtained above the value of 0,04
Were interpreted as that the cells spontaneouslY expressed
a particular class of MEC antig'ens. In the cell line 'JJONG
PHC (Figure 4.12) a negl.ig'ibleal1\ountof spontaneous Mac
Class II expression as detected by th~ MOAB TAL lB5 was
observed. The 00 value measured at dilutions of 1:2.00 and
1:750 for the primary and seoondary antibodies respect.ively
was 0,04 unit, This finding indicated that TONG PHC did
not expreSi5 Mh~ Class I:t antigens spontaneously. FigUl,'e
4.16 shoWS the results obtained for MHC Class I and II as
well as their associated invariant chains, B2m and Ii
respectively, on the cell line Raji. As obserVed in figure
4.16, MHC antigens were deteoted by their respective
primary antibodies used at optimised dilutions and wer~
spontaneoU$ly expressed in high amounts.
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4.4.3 ltSSULTS OF MHC ANT1GEN EXPR:E:SSION AFTER
LYM:PHOKINE AND CHEMICA!.. STIMUU"TION.
Figures 4.17"'4.19 show the responses obtained· for the
different doaas at the Lymphok.i.nea and chemic,ils on the HCC
oell lines T4>NGPHC, HA22T/VGHand HA5SlT/VGH.These
figures show nesponses as measured in <>0units at an
optimised Lncubab.icn time of 24 hours. '.rhe aD values for
stimulate¢i cells (xxxx) are compared with thelse measured
:for uns'timulated or oontrol ce l.l.s Ui In as ~leen in
figures 4.17"'4.19. The effect of each dose of the
Lymphokd.nas or chemicals used was detEllrmlnedusing MaABs
directed ag~~inst IvIHClass I, Class IJ: I .G2mand in some
caSes I Xi. The results of the effectiil of the chemicals,
sodIum buty:rate and clofazimine an.r.lthe lym};,lhokines,
interferon-'alpha and ~gammacl,re given undez separate
headings.
4.4.3.1 EFFEcTS OF CLOFAZ!MINE ON MHC EXPRESS!ON
Clofaz ililin(~was used at the dosages of 0, 1, 1, 2ug'lml as
well as 0,1, 1, :5 ug/ml. On.t.he oell line !A59T/VGll (fig
4.:1.7) cLof azimine did not Lnczease the expJ:'ession Of Class
r antigens at any of the do~~aS(esinvestiga'tted. For this
class of MHCantig9tl, the 01:> values of clolEazi:mille
ati:mulatecl colla were less 'chan those obtained for the
unsti,mulai!ed Or control oe1.1s as cletected by the MOAl3WC5/32
(antj_...aLA·~A,a,C). This res'ult implied an inhibition of Mllc
14:9
Class I expression when oaLLs of this cell line were
incubated with clofazitninE~. The exprEllssion of 132m was
negligibly enhanced after incubation with 011 ug/m1 but at
higher doae s of cLcf'azLmi.rie, this ef£E~ct fell away (fig
4.17). The optimal dose or clo;Eazimil1e for obtaini:ng
maximal differentiation between stimulated and unstimulated
cells was l/O ug/ml wO,tenmeasuring HDA-DRexpression. The
effect of clofazimin~ on Ii expression was variable with no
significant enhancement ()f this inva:dant cha ; n observed
(fig 4.17).
In the cell line ToNG PRt (Fig 4 .:L8), :atA expressiOll
increased wit:h higher doses of clofazimine. Similarly, as
in the cell line :aA59T/VG:H,at lower doses of clofa~imine
(0,1 ug/ml) no enhancement of HLA-A,BtC was observed in
TONG P:HC. .l\.t higher doaas of olofazimine (1 and 2 ug/ml)
the differen·tiation between t;;timulated and unstimulated
cells increased with a 2 uglml dose causing a sUbst:antial
enhancement; in MHCClass I expression. The optimal doae of
. olofazimine rot' enhanced B2mexpression was lug/ml. At
this dose. maximal differentiation of stimulated and
unstimtlll.<ted cells was observed when detecting 132m.
Irrespective of the dose of clo:f:azimine used , HLA-DR
e:>!:pression was enhanced in a constant nannez- (1.5 fold
increase in ODunits). However, this enhancement was not
very marked when comp~red to that caUsed by sodluln butyrate
or gamma-interferon (Fig 4.:1.$).
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Figure 4.17
Expression o'fMHC class I ~nd " antigens following chemical and
Iymphokine stimulation using the cell line TONG PHC
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Figure 4.18
Expression of MHC class I and" antigens, following chemical and
lyrnphoklne stimulation using the cell line HA22TNGH
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Figut:e 4.19
E)cpression of MHC class I and n antigens foUowirlQ chemical and
lymphokine stimulation using the (}elliine HA59TNGH
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In the cell line Hl\.22T/VGH (Fig 4.1~) the effect of
clofazir.linQ. on MHCexpression was not as enhanced (at any
dose invest.igated) when compared t() that on the two cell
lines discussed, aboVe. HLAClass r antigen expression was
increased with the highest dose ,Of 5 ug/ml causing a
greater enha.icement; th~n a o, 1. ug/ml dose. Even at. this
higher dose, Class I expression Was not markedly enhanced.
Tr.le respcnse of B2mto this chemd.caf was variable with nc
consistent enhancement noted. H:tA-DR,expression was,
slightl.y enhanced in HA22'l'/VGH after incubation wi·th
cl~)fazimine with the largest effect of this chemical .'
occurring at a dose of 1Ug/ml (fig 4.1c' •
4.4,,3.2 EFFECTS OF SOO;-'''M Bt.1'L'YR,A'l'E oN MHc EXPR~. 'SIaN
Sodium butyrate was used at dO~\lages0''; 1,2,5 mMola:t.· No
significant effect of sodium bu,tYrilte a·t any dose was
obSel~ved on the HCe cell line HA59T/VGH after an optimised
incubation time of 24 hours (fi~f4.:L7). HLA-A,B,C
expression 011 stimulated cells appear ed to decree.s9 with
high{ar dosages of this chemical 'whencompared to
unsti.mulated cells. The expression of B2mwas not increased
at the lower doses investigated however I a dose of 5 lli!~
resul'.:ed in an enhancement of B:2mexpression. The responsEa
of both HLi\-DRand Ii to this chemical was variable. A
slight enhancement; was ohser=ed at Cel::tnin dosages , I ile a.
inhibition in these antigens' expression Was not~ed at other
dosages (fig 4.~7).
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The effect of sodium butyrate on IvT.J1Cexpression was most
markeu. in the cell line TONG PHC (Fig 4.18). NRC Class I,
Class II and B2m antigens exhibited large increases in
expression. MHC Class ! expression was enhanced after
incu,batibn with sodium butyrate at all the dosages
investigated. The largest enhancement; of this antigen IS
expression occurred at a dose of 2 roM sodium butyrate (fig
4.18). Thia dose was therefore regarded as optimal. A
similiar e:ffect was observed in B2m expression after
inCUbation with sodium butyrate with the optimal dose
occurring in the range of 2 mMolar. HLA-DR expressj.on was
markedly enhanced (a fold increase in 00 units) in the 'rONG
PHC cell line after Lncubatid.cn with this chemical. t~\.,.~
dose of sodiUm butyrm.te that ca.used the maximal
differentiation between stimulat~d and 'lnstirnu,la.tedcells
'VIasin the .k',').ngeI.)f 2mM. This dpse WC'.stherefore regarded
as optimal in enhancing HLA-DR expJ:'ession (Fig 4.1.8).
In.the cell line HA22TjVGH (:c'ig4.19) inCUbation of these
dE:!lls'i'lithsod.\Unlbutyrate l;-es'ultedin enhanced MItO
expression, although this Ii!ffectwas not as marked when
compared with that observed in figure 4.18. As in 1110NG
PRC, MHC Class :r and B2m antigen expression was enhanced
with the optimal dose occuring in the range of 2roM sodium
butyrate (fig 4.19). HLA-DR expz-eas.Lon was markedly
enhanced in the HA22TjVGH cell line after inCUbation with
sodium butyrate. The optimal dO$e of Sodium butyrate that
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resulted in the most marked enhancement; of MHCClass II
arttigen expneas Lon was Ln the range of 2lllMolar (fig 4.19) •
This is well within the phY!:1iologica). concentratiotl of
sodium butyrate.
EFFECTS OF INTERFERON· GAMMA AND -ALPHAONMliC
EXPRESS!ON
The effect of gamma interferon on MHCexpression was
investig<:ited at dosages of 50, 100; 200 HilmI after an
optimised time of 24 hours. Recombinant-!FN' ....alpha was
used at a constant dOse of' 200 It1/ml at an optimised
incubation time of 24 hours. Th;l..s lymphokine was used as a
control to assess the specificity of the effects of
r-IFN-gamma. That is, whether or not the resulting
enhancement; of MHCexpressioll WaS because of r-IFN"'galllltia.
;:cn the cell line HA5T/VGH(Fig 4.1'1) no effect on MHCClass
I expression wa.s noted after these calls ware incubated
with both interferons used in this study. There was no
difference in the lack of HLA-Ale,C expression at all the
dosages of r""XFN-ga,mmainvestigated. A lo~"er expression of
these atltigens was obaez'vad When cells of HA59T/VGHwere
incubated vdth r-IFN"alpha. A n~gligi.ble enhancement of
132mexpression was observed at all dosages Of r--:CFN'-ga:ntma
used. fILA-DR expression was enhanced, but onl,y slightl.y
When ccmpaxad to that observed hi TONGPHC (Flg 4.:t.a) after
incubation with l::'-IFN"'gamma. The optimal dose of
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r-IFN-gamma for this effect to be most marked was lOa
IUjml. No enhancem~nt of MHC Class II antigen expression
in HA59T/VGH was observed after Lncuba+Lon with 200 !t1jml.
r-IFN-alpha at a time of 24 hours (fig 4.17).
The most noticeable feature obs~rv€:d in the TONG pl{C cell
line (Fig 4.18) after incubation with r-IFN-gamma was tho
sUbstantial increase in aLA-DR expression (a 12-fold
increase in OD Values). This ennancement of aLA-DR
expression were raised when any of the doses of r....Ifo''t-l'-galfu''Tla
used. A slightly less marked enhancement (8 fold increase
in 00 units) of MHC Class II expression was observiid after
incubation with r-IFN-alpna. MHC Class I expre~sion was
enhanced after Lncubat.Lcn \vith r-IFN"'garnma at all dOSageS
investi.';:lated.The most marked increase in HLA-A,B,C
expression occurred at 200 IU/ml Of r-IFN-gamma. This
dosage WaS therefore regarded as optimal. The effect of
r-!FN-alpha onMHC Class I expression was almost mir:r.ored
by that observed at a dosage of 50 IU/mi of r-IFN-gam'lna.
That is, there was nQ difference in the enhancement of MHC
Class I expression after incubation with r-!:PN-aJ.)?haor
IFN-gamma. A similar effect was observed for B2m
expression. The enhancement of this <3,11tigen1sExpression
was larger after incubation with r-IFN'-alpha than at any
dosage of lPN-gamma investigated.
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Incu}:)ationwith 200 IU/ml of r-IFN-alpha resulted in
enhanced MHC Class I expression (2.6 fold increase in 00
units) in the HA22T/VGH cell line (Fig 4.19). However, no
enhancement of,B2m expression after incubation with this
lymphokine for 24 hours was observed in this cell line.
HLA-DR expression was enhanced after a 24 hour inoubation
with 200 IU/ml of this lymphokine when 'mpared to
unstimulated celJ '.
THE EFFECTS OF .GYMPHOKINE AND CHEMIC:AL
INCUBATION TIMES ON HLA EXPRESSION.
Time kinetics were performed at 4, 18, 24, 48, 72 and 96
hours using lymphokines r-IFN-alpha and -gamma and
ohem.i.caLs clofazimine and sodium }:)u1:.yrate.Figure 4.20
4.4.3.4
depicts the time response curve obtained for sodium
butyrate using dosages of 0, 1, 2,5 mM on the
representative cell line TONG PHe. At four and 96 hours a
nonspecific response was observed. Inoubation times of 48
and 72 hours resulted in a non-specific increase 0'1: HLA-DR
antigen expression on cells that had not been incubated
vlith scd i.umbutyrate (ie control cells). Based on the
results obtained for HHC antigen expression in the control
cell line, K562 (Fig 4.15), TONG PHC expressed negligible
amounts of MHC Class II spontaneously (Fig 4.11). The
incubation time of 24 hours resulted in the most. specific
re~ponse of control (unstimulated) cellS, that is
negligible amounts of HLA-DR expression were observed on
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control oellS. This time period waS therefore chosen as
the optimal incubation time for the maximal stimulation of
the cells. Similar types of time response experiments were
performed using clofazimine and r-IFN..,.alphaand -gamma.
The same incupation time of 24 hours was observed •
4.5 DISCUSSION
Shimonkevitz et al (1983) demonstrated, that fixation of
antigen"'presenting cells with formaldehyde did not impair
their ability to present antigen. Similarly, Fukasato et
al (1988) del1h?nstrated that fixation had no significant
effect on the reactivity of cell surface antJ..yoenson
PLC/PRF /5 cells to monoc Icna), and poLyc Lona k antibodies in
the ELISA. For the above reasons and because the ELISA
protoool had been previously standa:;:dised in our
laboratt;)ry, the ELISA was perf.ormed on fixed cells usin9'
paraforrt(aldehyde as the fixatiVe.
All assays Were performed at least three times a\nd it was
observed that intra-assay va:dation of tt'iplicat~~
determination was low t-/hilethe intra-assay or dal-to-day
variation was considerable. This may account for tha large
values obtained for the standard daviationfl in Figures 4.10
and 4.13. orhe monoclonal antibodies proved 1:...) be specific
and sensitive in the detection of the non-polymorphiC'l
regions of MHC Class I and II antigens and their resp~19tive
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associated invariant chains. The monoclonal antibody
directed against B2m, however, proved to be sensitive only
at lower dilutions ie. 1:10 which is unsatisfactory in
terms of 00st.
Notwithstanding, the modified ELISA was able to quantitate
cell surface MHC moLer ' les m a sim~le; specific and
sensitive. manner (Fukasato et a1 1968). Fukasato et al
(1988) stated th~~.t their result~ obtained using ELISA as a
ml:thod of detecting MHc surface antigens in the cell line
PLC/PRF/5 ...:lorrelatedwell with those obtained in flow
cytomet:l:'icanalysis. These authors found that the Alexander
cell line did not spontaneously express MHC Class II
antigens.
Results obtained using the ELISA as a method of detecting
surface MHC antigens correlate with those obtained from the
inununofluorescence assay. MHC Class I antigens were
sp(mti:l:rtaouslyexpressed in the HCC cell lines: PLC/PRF /5;
HA22T/VGHi HA59T/VGHi Hep 3B; He~ G2i Mahlavu and TONG PHC
using both the ELISA (Fig 4.2 and Fig 4.13) and the IIF'
assay. MHC Clas~ II antigens were not expressed
spontaneously on the following HCc cell lines: TONG PHC,
Hep 3B, Hep G2, Mahlavu (Fig 4.8) using both the ELISA and
IIF teChnique as methods of dete0tion. spontaneous
expression of MHC Class II antigert~ was observed on the
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HA22T/VGH, HA59T/VGH and Alexander cell line as detected by
the ELISA (Fig 4.8). No spontaneous expression of HU-DR
was noted on PLC/PRF/5 using the IIF assay and flow
cytometric analysis. Franco et al (1988) detected low
amount of MHC Class an'tigens on Alexander C J.lsbut Sung et
al (1989) and Krief et a1 (1988) found negligible amounts
of spontaneous MHC expression Cn P"LC/PRF/5 using an IIF
assay. In this study, comparatively high levels of
spontaneous Class. II antigens Wl:. •.cedetected using the
ELISA. This difference in results could possibly be d'ue to
the increased sensitivity of the EL:tSA compared with IIF
staining or different generations of the cell line being
used.
The conditions for optimising the qetection of MHC
expression on the HCC cell lines wel:;'eaChieved by a series
of dose response experiments. In.F'igures 4.3-4.7 and
4.9-4.12, the optical density valUeS o:Otained for the
variOU$ dilutions c..!' primary and secondary antibodies are
shown. h dilution was chosen as optimal when 1) it showed
the highest 01) Value, 2) this high OD value obtained was
specific ie a standard deviation of hot more than 0,15
uhits was obtained 3) the background non-specific staining
was not more than 0,01 00 units and 4) the cost of using
the antibody .at this dilution was not too high. From these
experiments the optimal (.losesof the primary antibody W6/3'2
(anti-HLA-A,B,C) as shown .:1,nFigures 4.3-4.7, and the
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monoclonal antibody TAL IB5 (anti-H!.A."';DR)as shown in
E'igures 4.9-4.12 '!leredetermined. The optimal dilution of..,
the primary antibodies dir~?cted against the associnted
inva.riant chains, VIC Y1 (.mti-li) and anti-132m was
determined as shown in Fig 4.13 anq 4.14 respectively.
These two figures show the dose response experiments
performed on the representative HCC cell line, HA22T!VGH.
'rhe optimal dilutions of the secondary enzyme-labelled
conjugated antibody Wel'ealso determined from these
experiments. These dilutions were USed for all further
experiments.
'rhe validity of the assignment of J;io$itiveand negat.i.ve
control given to the Raji and 1<562 cell lines respectively
was confirm~c1 by the ELISA (Fig 4.16 and 4.17)" HHC
antigens were detect.ed on these cell lines using previously
optimised dilutions of the primary and secondary
qntibodies. Raji expressed MHC antigens spontaneously WhJ.19
1<562 did not express these ~ntigens.
'I'hereSponses to the chemical, clo"fazimine, were different
among the cell lines uaed in these experiments. Resul ts
obtained when clofazilliinewas used to assess its effects on
MHC Class I expression in the cell lines HA22'r/VGH,
HA59T/VGH and TONG PRC (Fig 4.17-4.:1.9).indicated that.,
clofazimine enhances at higher (>5 ug/ml) than lower (0,1
ug/ml) concentration.
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When detecting MHC Class II antigens .afterincubation with
clofazimine, the cell lines investigated exhibited
different responses (Fig 4.17-4.19). In the cell line
HA59T/VGH (Fig 4.17), enhancement of MHe Class II
expression was dependant on the da:~eof clofazimine
invesL~gated. The dose of 1 ug/ml resulted in maximal
differentiation .between stimulated and unstimulated cells.
A similar result was observed in HA22T/VGH (Fig 4.18). In
the cell line TONG PHC, the enhancement of MHC Class II
expression did not depend on the dose of this chemical
investigated. Clofazimlne has been shown to enhance HLA"'DR
expression on the surface of macrophages after their
priming with PPD (A Wadee~personal communication). The
method of detecting these surface antigens was the ELISA..
No ilccounts of MHC enhancement on cells in culture after
incubation with clofazimine has been reported.
The physiOlogical concentration of sc;ldiumbutyrate is 2 :mI1
(Miller gt al 1987). Although reports have indicated that
results with this cell differentiation inducer have been
observed at concentrations of up to 10 mM (Leder « Leder
1975, de Haan et al 1986). The results of this stUdy
indicate that sodium butyrate achieves m~ximal enhancement
of HLA expression at its physiological concentration. In
Figure 4.18, Lncubat.Lon of sodium butyrate with cells of
TONG PHe resulted in enhancement of MIlCClass II Class II
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and 132m expression which was dependant on the dose used.
The same effect, although less marked, was observed in the
cell line HA22T/VGH (Fig 4.19). No result indicating
enhancement was obtained after incubating HA59T/VGH cells
with any dose of sodium butyrate (Fig 4.17). Kaneko et al
(1990) and Nakagawa et al (1985) investigated alterations
in gene expression and differentiation states in the Chang
and P'LctPRF/5 cell lines respectively. Both these groups of
ivorkers used :1, mM sodium butyrate in their experiments.
However, there was no literatUre account of the effects of
this chemical 0:1 MRC expression on HCC cell lines.
sutherland et •.al (1985) reported the st.imulation of MEC
Class I expression in the K562 e:tythromyelaid cell line
after incubation with sodium butyrate. In their
experiments, sodium butyrate aChieVed maximal. enhancement
of HLA expression at a dose of 1,5 mM.
Fukusato et al (:1,988)and Yoshioka et al (2989)
demonstrated enhanced expression of HLA Class I antigens on
PLC/PRF/5, Char.g and S1(-Hep cells after reaction with 100
:tU/rulof IFN-gamma for 24 hours. These workers used the
ELISA as a method of detecting' MHC antigrens. However,
Fukusato et al (1988) and Krief et al (1988) were not able
to induce HLA Class II antigens with r-IFW-ganuna on the
more differented PLC/PRF/5 as well as Hep G2 and Hep 3B
(Krief et al 1988) cell lines in spite of the Ul'"" of
optimised experimental conditions. These studie5 employed
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an ELISA (Fukasato et al 1988) and flow cytometry (Kriet et
al 1988) as methods of detecting MHC antigens. Franco et
,i3.1(1988) observed that r-IFN-gamma was capable of
augmenting the expression of MHC Class II antigens on
Alexander cells using an indirect imtnunofluorescence
assay. Krie;f et al (1988) observed that the level of
HLA-DR"-'expression was inversely relate<;ito the degree of
cellular. differentiation of the cell line. ticer et at
(1985) reported that sensitivity to r-IFN-gamma depended on
the number of receptors with respect to enhancement ofMHC
Class II expression.
In the poorly di;fferentiated nee cell line HA22T/VGR Kriet'
et al (1988) observed uhat; 1.0IUjtnl of glyc..osylated
r-IFN-gamma was suffic.J.;mtto induce 100% HLA-DR expression
in this line as measured by flow cytometry. The present
study did not investigate the effect of r-IFN-gamtna on the
cell line HA22TjVGH, however the results obtained after
r"IFN-alpha stimulation showed a minimal enhancement o'i'UHC
expression (Fig 4.19). There have been no previous reports
on the enhancement of HLA. expression by r-1FN-gamma on the
RCC cell lines TONG PRC and HA59T/VGH. In the cell line
TONG PHC, which is defined as a moderately differentiated
cell line (Lin et al 1984), HLA-DRexpression Was
sube+arrt.La Ll.y enhanced after incubation with both
r-IFN-gat,ma and +aLpha (Fig 4 .1S). This result implied
that this effect was because of the general action of these
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Lympholci.nee (Fig 4. 18). The results of the present study
indicated 'that HA59T/VGH exhibited a slightly enhanced
expression of NRC Class II antigens when exposed to 100
IU/mI of r-IFN-gamma for 24 hours.
No assessment of the effect of the chem~cals and
Iymphokines investigated on the K562 cell line was
determined in the present study. Incubation with sodium
butyrate together with r-IFN-gamma resulted in the
stimulation Of MHC Class :r expression in the K562 cell line
(Sutherland et al 1985). such types of experiments, using
th~ K562 cell line would confirm the specificity of these
agents on the enhancement of MHC expression.
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CHAPTER 5
GENERA!, DISCUSSION
Each tumour systetn is unique. The level of specifi,? MHC
products on tumour cells is one of Several characteristics
that determine the t,umourigenic and metastatic potential of
cell::;(Gopas etal 1989). The different MHC ClasS I ano. II
products al:'eregarded as independent entities since each
locus or even sUblocus plays a different role in the
t'egulation of the immune system a.nd cell-cell recognition
(:Elliott at al 1989). For these reasons, it is difticult
to qet-ermine the role of MHC class I s}{pression in
malignancy. Many of the hypotheses relating Class I
eXpression, onbOgenicity and metastatic potential have
arisen from well-desoribed murine models (Gopas et al,
1989). AlthoUgh the etiology of eXperimental animal
tumours is important in determining whether MHC expression
influences tunlOul:'igenicityor ncti, the relationship between
liLA class I expression and ma1ic;mal'lcyis still not firmly
established in human (Gopas at a~ 1989).
A vast literature exists describing the expression of
HLA.-ArB,C antigens in hUman ma1ignandY. However, there are
several problems interpreting the clinioal data. Fil:'stly,
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because of the qualitative, subjective nature of the
techniques used (e9'!IF, PAP staining) absolute comparisons
among the different reports are difficult. Secondly, there
have been tew studies in which the monoclonal antibodies
empLoyed distinguished among f1J:J1I.-A, S, c subregion products.
This does not allow examinat.ion or detection of
noncoordinate expression of HLA Class :c genes in any
haplotype CEll.tot·1:et al 1989). Moreover I ad.nee the
i::echnique~1used are notl-quantitative with undefined
sensitivH:y J,e.'l/elS,expre~sion of trace levels of MHO
antigens that could be functionally relevant may be below
the thresho1.d of detectabiUty (Elliott et al 1989).
Masking of the membrane-bound HtA antigens by sia.lic acid
glycoconjugates could result in quantitative differences of
MHC Gxpress:!.onbeing observed (Go);laS§Ltal 1989). FinaUy,
very few of these ~4inical data have been analysed in a
statistica:lly t"190rO\lSmanner nHUott et~ 1989).
The s't::atusof. HLA-A (B, C antigen expression in
hepatocellular cEll:oinoma(Bee) is controversial (See
section 1.6). To date there is limited information
available on MHC expression in HOC as Iil. solid tumour or on
oell lines {Natali ~J. 1981., Fukasato at al, 1986, Franco
et a~ 1988). 'l'h~results of Paterson et ~l (:1.988)
describing liLA expressi011 on solid. tumours suggest that
malignant t.ransformation of hepatocytes is oharacterised
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by expression of C'.ass ! ant;ij?ns. These antigens may be
enhanGed or acquired de no'l1o~FukasatQ etA 1986,
Paterson at al 1988). The clinical releVance of this is
still uncertain and requires further investi0ation.
paterson and colleagues suggest that MHG Cl('\':;;'$I expression
in solid HCC tumours may be a contributing factor to the
limited metastatic potential of HCC with class I expression
restric1;.in<;1extensive intrahepatic tumour spread.
In colorectal carcinomas, a loss of liLA CJ.ass I expression
is observed when compared 'l'lithnon-necp Laatid.cepithelium
(Momburg et al 1986, Dear et.al 1982, van den Ingh at.al
1987). In a study of colorectal carcinoma, Momburg at al
(1986) observed a dgni:Eicant correlation between loss of
MHC Class I and decreasing degree of differentiation.
Metastatic tumours were found to be different in t.hAir MHC
phenotype when compared with the primary tumour (Momburg ~
II 1986) .
LOCUs-sp,Elcific ClaSs II (HLA-OR,.Dl',PQ) molecules can be
n'.adi:l.ydistinguished by HOABs agai~",;.stnonpolymoJ;"l1hic
determin.:mts. D.iUerential expzess Lcn of DR, DP, DQ
molecuS.es have been observed on gastric carcinoma as well
as mammary carcinoma (MeL.ler ~ 1989) •
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van Vreeswijl ..et al (1988) observed a relationship betTIleen
the metastatic potential of melanomas and the differe~tial
expression of HLA-"DP,DQ,DR antigens. Van Duinen examined
the differential expr'essLcn of MIlC Class x:r: antigens em
metastatic compared with primary melanomas. These WQr}\.ers
observed a higher percentage of ex!?ression of HLA-'DR,DP but
not DQ antigens in metastatic than in primary melanomaS
(van Duinen et al 1988). In additiol"lj van Duinen 'faunct
that a relationship existed between MHC Class I and MHC
Class It levels on melanomas and patient su.rvival.
Patel;"son et a1 (1988) observed Class II antigen expression
in nearly half of the cases of their series of solid HCC
tumou:rrs. In these tissues I staining displayed a
heterogenous pattern of MHC Class II antigens. These
antigens were always associated with Ii display, Which was
far more intensely staining (Patel:'sonet a1 1988).
'However, there have been few, if atly other investigations
to date on HLA Class II exp;t.-essionon solid HCC tumOUl:'s.
:tt has been suggestad that the ability to display Class :c:t
antigens in reS,@onse to appropriate stimuli may be
constitu't:ive to all cells and that it is the failUl:'e to
expl:'ess antigen Py a pel:'centage of tumours which l:'epresents
the abetl:ant state (Hoore and Ghosh 198·'). Most
investigation.s l;leing)?er:fol:'ll1ed0)1 'HCC oell lines must still
bE'.oonfil:'med established in humans (copas at...Jll.1989) •
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Despite its peor sensitivity and laok of subjectivity/ the
XFF assay is still a valuable tool in the gualitativsl
assessment of Mf{c expression (E:]'liottet al 1989). ;(n this
stUdy, !IF was pl:frformed in f'lrderto determine whether or
not the cell line expressed surface MHO. xt was not
employed as a quanti-cative assay.
Evaluation of MHc surface expression by IIF by the present
study indicated that all HOC oeU lines investigated
exhibited spontaneous MHC Class I ;;..ntigene:ll:pression.
Only two poorly differe"tia.ted cell lines, HA22'1'/VGH and
HA59T/VGH, spontaneously expressed MHO Class II products,
The lXF assay als~ validated the USe of the Raji and K562
as posi tive and neg-ative control cell :Lines respect.ively.
The I!F assay is rapid, safe and sensitive (Bouoh Lex e.t a1
1985). :rtF requires relatively little and tU1Sophist,\cated
equipment and is inexpensive. By contrast, the
radioimmunoassay initiated by Berson et a1 (1956) requires
harmful and exp.ansive nuclides. xt is therefore sub'"
optimal as compared to Ill" staining. Peroxidase
anti-peroxidase staining is similar in its benefits to the
Ill" assay and :ls more sensitive, although it is not as
rapid, but could also have peen .amployed in this study for
quantitative assessment of MHO expression.
172
Once the qual~tativ~ study of surface MHC p,ntigen
expression on the HCC cell lines w~s performed, the
quantitative assessment of antigens was performed using the
ELISA. This assay also detectl~ surface antigens but at a
hig;her level of sensitivity tbUi rtF (to date, there is no
literature that records the level of sensitivity for this
type of ELISA ). Through a series of dose response
experiments, the dilutions of the monoclonal and enzyfue-
labelled antibodies that resulted in maximal detection of
the surface antigens \'1ereobtained. These optimal dosages
were used for all further ELISAs, The ELrSA detected MHc
spontaneous expression of Class I sur-race antigens on all
the :aCC cell lines investigated. MHe Class !I antigen
display Was opserved under spontaneous condition on three
.trCCcell lines, PLC!PRF/5, HA22T/VGR and HA59T/VGl1. The
ELISA also confirmed the study's assignment of a negative
control to the K562 cell line and.pOSitive to Raji. This
assay is again, rapid and relatively cheap (Watt et al
1988) .
The optimal quantitative assessment of MHe surface
expression is floW' cytometry. This assay is highly
sensitive but requires a specially trained operator and
expensivtJ equipment. Krief et al (1988) determined HLA
expression on several Hce cell lines (HA22T!VGR, PLC!PRF/5,
Li7A, l1ee36, Hep 35 and HEP G2) using ;flow cytometric
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analysis. The finding by Krief et al (1988) that PLC/Pf].F/5
does not spontaneously exp:tessMHC Class II antigens is in
contrast to that of the present study. A possible
explanation for this anomaLouc result is that.different
generations of the cell line 'ti.' J.S used in the present study
and that of Krief et al (1988). :Ct is not unreasonable to
suggest.that the expression of these surface antigens vary
from one generation to the next (Freshney 1.987). Thus sOme
workers may have avaLl.abLe a generation of PLC/PRF /5.'that
does express; low amounts of I'1HClass II antigens (franco
et al 1988,) Vrhile others do not (Krief g:' al 1988).
The present Study investigated the effect of the mo~1.ulating
ac;rentsr-IFN ....alpha and -gamma on MHC expression on the
HA2~T/VGH, TONG PHC and HA59T/VGH cell lines. MHC class I
expression was enhanced on TONG PHC by 200 IU/ml
r-IFN-alpha after a 24 hour incubation period. This
finding of MHC class I enhancement by r-IFN-alpha is in
agreement with that observed by Kriet' et al (1988).
These workers also observed that in HCC cell lines an
inverse relationship existed between the possible
enhancement of class II antigens by r~IFN-'gamma and the
degree of cell.uLer differentiation. They found that
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10 IU/ml of glycosylated IFN-gamma is sufficient to
dramatically enhance MRC ~lass II expression on
HA22T/VGH. HOVlever Franco et al (1988), investigating the
effect of IFU..;gammhon the well-differentiated cell Li.ne
PLC/PRF/5, found that this modulating agent caused the
enhancement 0.£ I1HC class II antigen expression. In this
present studYI the moderately differentiated cell line,
TONG PHC (Lin et.al 1984), displayed a marked enhancement
of MHC class II expression after :5.ncubationwith 200 ru/ml
of r-IFN-gamma for 24 hours. The poorly u.ifferentiated.
cell line, HA59T/V':;H,displayed enhanced MHC class II
expression put this wan not as marked as that observed in
TONG PHC. This stUdy, therefore, did not confirm the
inverse relationship observet:1by K:cief et al (1988).
The chemical sodium butyrate enhanced the expression of MHC
(;'nall cell lineS inVestigated: TONG PHC, HA22T/VGH and
HA59T/VGE. This effect VIas:mostmarked. on TONG PEC,
moderate on HA22T/VGH and in the cell line HA59'lI/VGHthe
effect of sOdium butyrate on MHC expression VIasmini:mal.
In TONG :PHC anelHA22T/VGH, the effect of sOdium butyrate on
MHC expression was dose dependant with the optimal dOse
occurring in the range of 2 mMolar. The effect of this
175
chemical was most marked on MHC class II expression.
optimal incubation time for sodium butyrate to obtain
maximal differentiation between stimulated and resting
cell::;Was 24 hours.
Clofazamine had a variable effect on MHC Class I
expression. Incubation of cells with this chemical,
however , resulted in an enhancement of MHC class II
expression on liA.22T/VGH,HA59T/VGH and TONG PRC. Effect of
clofazimine em MIlCclass II expression Was most ntarxed on
TONe:PHC andHA59TjVGH and least marked on HA22T/VGH.
It is difficUlt to infe~:MHC gene expression from studies
using protein analysis techniques (e'1western blotting), as
it is possible that nt'l'lliAbecomes degraded by cellular
ribonucleases before tranSlation OCCUrS (Sambrook et al
1989). The most definitive method :eorestablishing whether
or not NRC gene products axe being expressed, is therefore
to examine the genes themselves. This may be achieved by
dot-blot or Northern Blotting (mRNA) analysis Which
establishes the pre-or post-translational status of the
genes. oi Bisceglie et al (1986) employed roRNANorthern
blotting to determine AFP status in Hee in vivo and the
PLC/PRF/5 cell line. There are no accounts of this
techniqUe being adopted by other workers in examining the
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status of MHC antigens all HCC cell lines. All studies have
concentraten mainly on surface or cytoPlasmic expression
(Krief et al 1988). Thus the examination of MHC expression
at a gene level should be further i,nvestigated.
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CHAPTER 6 POSSIBLE F.)TURE INVESTIG.Jl.TIONS
6.1 INTRODUCTION
Analysis of the DNA coding for the major histocoitlpatibility
gene products elucidated the complexity as well as the
complete amino acid sequence of the glycoproteins (Lee et
al1982). The general approach to obtaining complementary
DNA (cDNA) clones is to firstly obtain RNA en:r.ichedwith
the mRNA encoding for a particular gene from 2 homozygous
cell line ego Raji (Claesson et al 1983). Double stranded
CDNA is synthesised from the resulting enriched mRNA using
reverse transcriptase and ther, inserted into the
appropriate restriction site of a suitable plasmid.
Subsequent clones are derived from transformatio1.1
experiments with the plasmid and the DNA sequence of the
clones then analysed and the recombinant products
characterised. Such as cDNA clones coding or the heavy
chain of HIoA-DR antigens Since antisera against the Ii
chain were not available at the time, the apparent
molecular 'Weight was used as the characteristic of ·.!he
gamma chain in the screening of the clones (Claesson et al
1983). In their analysis of sequencing of the isolated
cDN~ clones, Claesson and colleagues determined that the
Lnve.r i.ant;chain was inverted when compar-ed with the HLA-DR
antigen, ie. the NH ...terminus of the Ii chain resided on._
the cytoplasmic side of the membrane (Claesson .et al 1983)"
The reasons for this are not yet known precisely but it has
been suggested that the complexity of HLX Class I antigens
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serves an important function (Floegh et a1 1981).
Establishment of cDNA clones not only allows for the
protein sequence and characterisation of the antigen for
whioh the clone encodes (T~owsdale et al 1984) but also
permits the study Gf the expression of mRNA HLA products
using Northern blot.hybridization (Kawata et a1 1984).
This. d.ld.sertationhas investigated the expression of MHC
antigens on certain hepatoma d~rived cell lines. MethOds
Of detection used in this study have quantita'tively as Well
as qualitatively examined surface expression of these
antigens. In addition, MHC expression on three cell lines
has been studied after the addition of certain lymphokines
and chemicals, HOiV.eVerlit is apparent thai;'further
inVestigations examining the MHO gene expression as Well as
the pre- or post- translational status Of these gene
products are required, Some of these studies have already
been initiated. These investigations are'
a) The LseLat.Lonof total cytoplasmic RNA from the
various cell lines and
b) The pUrification, isolation and characterisation
of cDNA probes directed against the MHC
(messenger RNA) •
The findings presented in Chapter 6 have demonstrated that
isolation of intact cytoplasmic RNA from various HCC and
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control cell lines using a guanidium thiocyanate method is
possible. The isolation and subsequent purification of
cDNA probes has also been demonstrated.
Further studies that need to be undertaken to investigate
the pre- or post~translational status of the MHC gene
products are: ...
a) The study of the expression of HLA mRNA using
Northern blot hybridization.
b) The effect that the addition of lymphokirtes a!td
chemicals has on the amount of MHC mRNA produced
as detected by Northern blotting. That is, can
the addition of a particular lymphokine cause an
increase or decrease of MHC mRNA iSolated frotr a
cell line.
The above studies would allow the comparison of the
:eindil'lgsobtained using the 'ELISA and the !IF technique and
those obtained from moleCUlar biological techniqUes.
6.2. MATERIALS AND METHODS
6.2.1. preparation of competent a.coli JM10l cells
A culture of B.ooli JM10l cells (kind gift of V
Mizrahi, SAIMR, Jhb, SA) was grown Up OVernight at 37°0
with shaking in 5.mlminimal medium (Appendix 5).
Thereafter, 50 ml LE medium was innoculated tV'ithO,5m). of
the overnight cultUre and the culture grown at 37°0 wi't~h
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vigorous aeration (Appendix 4) Cells were grown until an
00 at G50nm of 0.3-0.4, stored on ice for 15 minutes and
then harvested by centrifugation fer 10 minu'ces at 4000g at
4°C in a pre-cooled JA20 rotor (Beckman Instruments, palo
Alto CA, USA). After resuspension in lOml (1/~ original
volume) ice~cold O,lM MgC121 the cells were immediately
centrifuged fer 15 minutes at 2000g at 4°C in the JA20
rotor. cells pelleted as a ring at the bottom of t.hetube
and were gently resuspended in 10ml (1/ S origillal volume)
ice-cold a,lM Oa012• After cells had been stored on ice
for 60 minutes, they were centrifuged for 15 min at 400
at 2000g in the JA20 rotor. Once aga.in,cells pf!ll:Le'l:ladael
a d,istinct ring' at the bottom of the tube and were
resuspended in 2ml (1/25 original volume) of ice cold O,l~:
oa012' competent cells were either usectimmecliatelY or
stored on ice for up to 24 houire , after which Jeheyhad lost
viability and were unsuitable.
6.2.2 TRA.NSl"OR.~TIONOF E.COt! JM1D1 CELLS
For each transformation, 0,2ml competent )!l.cal! JM101
cells were used. Depending or.the concentration of DNA
(Appendix i), approximately 75 ul (eq1livalentto :angDNA)
of the DNA" Qontaining solution suspended in Tr.iIs-EDTA(TE)
(Appendix 4) WqS used for each transformation. The
followin~ eDNA p~obe~ were USeo in this stuoy: $-ABO-5
(anti-HLA-A,B,C), MCFI~lB (anti-HLA-ORB) anclp~gamma~2
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TABLE 6.1 DESCRIPTION OF cDNA PROBES USED IN THIS
STUD~
cDNA
probe
Directed Plasmid Insert Restriotion Reference
against (bp) Site
8-ABC-5 ELA-A,B,C pAT 153 669 Pst I Trowsdal.e
et al
(1984 )
MCFI-1J3 l-t1:',A"'DRJ3pBR322 510 pst I Kind gift of
J Trowsdale
(ICRF,London,
U .1<. )
p-gamma-2 pBR322 1287 Pst I
Claesson
e:Ltl
(1983)
The 8-ABC-5 and p-gamtna~2 recombinant plasmid were conferred
with tetracycline resistance while MCFI-1J3 was ampicillin
resistant.
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(anti ...ri). A full description of these probes is giveh
Table ($.2. A:t;terfl,dditionof the DNA-containing solution,
and gentle pipetting to ensure mixing, the Cells were
stored on ice for 60 min. in 1,5 mJ..Eppendorf tubes
(Eppendorf, Germany). A positive control of 2ul Gal KRTT
(lng/ul) having ampicillin-resistance (ampr) was used in
this study. After heat-shocking at 42QC for 2,5 minutes,
7 ml LB medium (Appendix 5) was added with gentle mbd.ng
and t.he cells inCUbated for 60 min at 37°C. Oiffer$nt
volumes (25, $0, 300, 700 ul) of the transformed 1:1.0011
JM10l cells were 'I:henspread on pre-Warmed sterile agar
plates (Appendix 5) innoculated with appropriat.e antibiotic
resistance. PJ.ates having ampr were inCUbated at nOc
for not longer than 18 hours while those have tetr Were
incubated in the dark a.t 370C for up to 36 hours. If
colonies were obaezved on the ampr plates on Which Ga.l
KRTE had been spread, 1'.. was assumed that the trans-
formation was successful.
lSOtATION AND Pt]RIFICA'J;'IONOF clDNA PROBES
Initial 1sc.)lationof CDNA prol:lesusing a rapid
pla.smid PNA minipreparation
The protocol, as outlined by S"mbrook et al (1989) I was
followed for th$ rapid plasmid miniprepal:'ation of the
iSolation of eDNA probl;:s. Briefly, A. cultul:'eof the
tl.~anSforlTleda.doli JMl01 cells was incubated overnight
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at 37°C with shaking in 15 ml polypropylene round
~ttomed. tubes (Falcon, Becton Dickinson, NJ, USA) in 1,5
ml LB med.ium (Append.ix 5) contaihing appropriate
antibiotics (10 ug/ml ampicillin, 50 ug/ml tetracycline) •
The minipreparation Was carried out on six colonies picked
from the same agar plate which was incubated with a
plasmidcontaining strain. Approximately 150 ul of the
overnight culture was kept for fUrther plasmid purification
experiments and. the cells of the remaining dulture
harvested. by centrifugation for 5 min at 1200g at 40b in
an Eppendorf. microfuge. The supernatant was then gently
aspirated and. the cells resuspended in 100 1.,111ce ....c01d
lysis bu1;fer solution I (Append.ix 5) by thorough
pipetting. After transfer to sterile 1,5 ml Eppendorf
tUbes (Eppendorf, Germany), incuba.tion at room temperature
fol' 5 minute.s followed and then 200 1.,11of room temperature
solution n; (Append..b::5) was added to the cells. The
suspension was oarefully mixed by invel,~sion of the closed,
tube, The solution turned viscous and partially clarified
and was incubated on ice for 5 minutes. The ad.d.itionof 50
u1. ice~oo1.d Solution III (Appendix 5) and mixing by
vigorous inve;t:'sionresulted in a thick, white preoipitate.
The suspension was stored on ice ·for 5 min and. thereaftet·
cent;t:'ifugedfor 5 minutes at 40C in an Eppendorf
mlcrofuge. ApP;t:'oximately400 1.,11of the supe;t:'natantwas
carefully removed, witbout disturbing the fluffy white
184
pellet, and transferred to a tU!:lecontaining 400 u1
PhOH/CHC13 1;1 (Phenol was equilibrated to a pH of 8.0
with Tris HCl (pH 8.0) accorc3.ingto methods outlined by
Sambrook et al (1989)). After vigorous vortexing and
centrifugation for 5 minutes at 40C in an Eppendorf
microfuge, the aqueous ph.:se waS transferred to another
sterile Eppendorf tube containing 400 ul PhOH/CHC13 1:1
and the extraction repet.ted. The top phaSe (approximately
400 ul) was transferred to a tUbe containing
200 ul CHC13 , vortexed and the suspension centrifuged at
room temperature for 2 min in an Eppendorf microfuge.
After transferral Of the top (aqueous) phase (approximately
400 ul) to a freSh tube, 1 ml ioe·-cold 95% :EtOH was added
and the solutions mix~d by inversion. DNA and RNA was
precip,itated by centrifugation tor 10 minutes at 4°C in
an Eppendorf m.:Lcrofuge. The supern.::ttantwas pouz ed off and
the pellet washed with 1 ml ice-cold 70% EtOH. After
centrifugation for 5 min at 40C in allEppendorf microfuge
and careful aspiration of the supexnatiarrt , the pellet was
dried in a Vacuum centrifuge (SpeedVac Concentrator,
Savant, Hicksville, NJ, USA) for 5 min. Thereafter, the
ON.li.-RNApe;J.letwas dissolved in 25 ul TE/RNase A
(Appendix 5) and the RNA destroyed by heat.-inactivation at
600C for 10 min. After thorough mixing and
recentrifugation at room tempe;t;'aturefor 1 min in an
Eppendorf microfuge the DNA solutions were stored at
-200C until needed.
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plasmid DNA was digested with appropriate restriction
enzymes (Ta.ble 6.1) and the entire digested sample r~n on a
1,5% agarose minigel (Hoeffer Scientific Instr~l':lents,San
Francisco, CA, USA). A series of digestions with different
restriction enzy:rnes(Ba:rnHI, Hinc III, Pst I) were ~sed
~ntil the correct insert as assessed by molecular weight
markar's (Boehringer Mannheim, Hannheim, Ger:rnany)was found
and this pla.smid DNA minipreparation was used for further
purification.
PLASMID PURIFICATION
Approximately five hundred microlitres of an overnight
culture of E.cQli, containing plasmids (Table 6.1) was
grown at 370C in 5ml LB medi~m (Appendix 5) supplemented
with appropriate antibiotics (Table 6.1). The culture was
innoculated into 500 ml LB medium (Appendix $) supplemented
with appropriate antibiotics (Table 6.1) (if plasmids
exhibited tetr, cultUres were kept in the dark) and grown
with vigorous Shaking (300 rpm) until the optical density
(00) at 600 nm was 0.5. When this 00 was reached (ie cells
were in ll1idlog'phase), 2,4 ml of a chloramphenicol
(34 mg/ml) solution waG added to amplify copy number of the
plasmid while inhibiting bacterial replication. The
culture was grO\<Thfor not longer than 16 hours at 37°C
with Shaking (120 rpm). Cells were pelleted for 15 min at
3000g at 4°C in the JA20 rotor and resuspended in -.1 ml
solution I (Appendix 5). The soluti.on was transfer;l:'edto
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a clean t.ube and .1 m l, of a freshly made up lysosome (60
mg/ml) solution added (Boehringer Mannheim, Mannheim,
Germany). After gentle swirling, the suspension was
inCubated at room temperature for 5 min. Ten ml of
solution II (Appendix 5) Was added, the trube gently
inverted and then incubated on ice for 10 min. After
addition of 7,6 ml solution III (Appendix 6), the tube was
inverted sharply .fourtimes and the suspension incubateo. on
ice for 10 minutes. The resulting white precipitate was
centrifuged at 10000g for 15 min and the supernatant
transferred to a clean ttlbe. Twelve ml of room temperatUre
isopropyl alcohol was added, the suspension gently mixed
and stored at l;'oomtemperature for 1$ min. Centrifugation
at room temperature at 10000g for 15 min recovered tl;le
nucleic acid pellet and the supernatant was discarded. The
pellet was; vacuum dried and resuspended completely in
exactlY 4,2 ml TE (Appendix 3) and transferred to a
polyalloner quick-seal centrifuge tUbe (Beckman, Palo Alto,
CA, USA (.13x 5.1mm). To the so]'ution was added 4,8g csc]'
(Boehringer Hannheim, Mannheim, Germany) and 0,42 m],
ethidium bromide (10 mg/ ml). Thel;'eafterthe tube W"lS kept
in the dark. The tubes were sealed after weighing (Tube
topper for quick seal tubes, Beckman Instruments) and spun
in a Beckman VTI 50 vertical rotor at 150000g for 18 hours
at 150C. After centrifugation, the upper band containing
plasmid DNA was removed using a 23'"'gaugesyringe needle
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attached to a syringe and disposed into a 1,5 ml eppendorf
""tube. An equal volume of butanol (equilibrated with
20 x SSC (Appendix 6) in a ratio of 1:1) was added to
remove ethidium bromide. Extraction of the dye was
repeated until the upper phase WaS completely colourless"
'·'helower phase containing plasmid DNA was transferred to
polycarbonate ultraclear centrifuge tUbes (Beckman), two
volumes TE and 2,5 volumes 95% EtOH were added and the DNA
pellet collected by centrifugation for 15 min at 1500.0g at
room temperatura in the JA20 rotor, The pellet was
vacuum-dried, resuspended in 500 ul TE buffer (Appendix 4)
and the OD at 260 nm and 280 nrnmeasured to determine the
DNA concentration and its purity.
ELECTRO ELUTION OF ISOLATED cDNA PROBES
Electroelution was carried out using a level unidit'ecti()hal
electroeluter (International Biotechnologies Inc1 N.aw
HaVen, connet.acut, USA) using a low salt elect,:oelution
buffer (Appendix 5). After excision of the agarose
containing the corl;'ectinsert from a 115% aga:r:osegel at
75 mv and 120rnA for 120 min (11inniesubmarine aga.r0se
unit, Hoefer Scientific Instruments, San Fra!1disco, CA,
USA) thegel slice was loaded onto a trough containing 100
ul high salt }Juffer (Appendix 6) DNA was electroeluted
(100V, 50mA) for 30 minutes and 400 ul withdrawn from the
trough. Ethidium bromide and the loading dye were
extracted three times using 300 u1 saturated }Jutanol
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(butanol:20 x SSC:1) (Apperidf.x 6) for every extraction
procedure. DNA was precipitated by addition of 1ml ice-cold
95% EtOH and incubation fOr 60 min at -20°C. After
centrifugation at 4°C for 30 min, the supernatant
discarded and the DNA pellet vacuunt dried (SpeedVac
ConcentratOr, salant, Hicksville, l-TJ USA). The purified
cDNA was dissolved in 50 Ul TE (Appendix 4) and stored at
-200C until needed.
PREPARATION OF RNA FROM tICC,RAJI AND K562 CELL
LINES
Total RNA was isolated by the guanidine thiocyanate Il\ethods
of Chirgwin at al, (1979). Approxintately 5>::106cell/ntl
6.2.3.4
were harvested according to cell culture methods outlined
in Section 2.4.; and washed twice with PBS (Ap'pendix 1).
The cell pellet was resuspended in 3.2 ml of 4M guanidine
thiocyanate solution (Appendix 5) and the su::;pension
vortexed for 20 seconds. The lysate Was carefUlly layered
onto 1.2 ml of a 5.7M CsCI solution (Appandix 6) in a 5 ml
centrifuge tube (Beckman Instruments Inc, Palo Alto, CA,
USA) and centrifuged for 18 hours at 110000g at 20°C in a
SW55 rotor (Beckman). The supernatant was carP-fully
removed and the RNA pellet resuspended in a total of 400 ul
of diethyl pyrocarbonate (DEPC) treated water (Appendix
5). .rheRNA solution Was transferred. to a 1.5 ml eppendorf
tube (Eppendorf, Germany) and 40 ul of 3 M sodium aceta-t:.e
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(pH 6) added to the RNA mixture fcllowed by ~OO ul 95%
ethanol. The suspension was thoroughly mixed by
vortexing. After precipitation at -20oC overnight, the
nucleic acid suspension was recovered by centrifugation in
an Eppendorf microfuge for 30 min at 4oC. The
supernatant waS discarded and the RNA pellet dried in a
vacuum centrifuge (Savant Instrul11:.mtsI Hicksville, NY I
USA). The pellet was resuspended in 50 ul of DEPC-treated
water, the RNA concentration determined by OD at 260 nm and
the RNA ~olution stored at -20°C until needed.
6.2.3.5 EIJECTROPHORETIC SEPARATION OF RNA.
Total RNA extracted by the guanidine thiocyant.ite:,lethodwas
resolved by agarose gel electrophoresis in the presGnce of
formaldehyde according to the method of Lehrach et al
(1977). Two grams of agarose (Bio-Rad Laboratories,
Richmond, CA, USA) was dissolved by heating in 160 ml
distilled water and cooled to 50°C before addition of 20
ml of 10 x MOPS bUffer (Appendix 6) and 20 ml of 37%
formaldehyde. A horizontal minigel electrophoresis
apparatus was uSed (Hoefer Scientific Instruments, San
Francisco, CA, USA). RNA was denatured in 9-12 ul of
loading buffer (Appendix 6) by heating to 56°C for 15
min. Equal amounts of each RNA sample (4 ug) were applied
t.o \1e11s in 5 mm thick agarose formaldehyde gels.
Electrophoretic resolution was carried out using 1 x M()PS
as the running buffer at 4°C for 18-20 hr at 35-40 V per
gel.
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6.2.3.6 PRELIMINARY FINDINGS
Preparation of competent E.C()lj.JM10l cells using the
alkaline lysis method and their subsequent transf'o"';i\atiun
was successfully performed. Initial isolation of the cDl!A
probes 8-ABC-5 (anti-HLA-A,B,C), MCFI~lB (anti-HLA-DRB) and
p-gamma-2 (anti-Ii) using a rapid plasmid DNA
minipreparation was achieved. Figure 6.2 shows the
restriction fragments of the cDNA 8-ABC-5 that was obtained
after subsequent digestion with the appropriate restriction
enzyme, :Pst I. In Figure 6.2, the probe 8-ABC",S
(anti-HLA-A,B,C) is visualised with ethidium bromide using
agarose gel electrophoresis. The insert of 693 bp is also
shown. The plasmid and its insert were of reasonable
purity. According to the restriction map shown in Fig
6.1a, the eDNA probe 8-ABC-5 is 669bp long.
After it was ascertained that the plasmid containing the
correct insert had been isolate~, the three plasmids were
purified on a larger scale using a CsCl gradient. The
plasmid was again digested with the appropriate restriction
enzymes and the correct insert further purified by
electroelution. Figure 6.3 shows the restriction fragments
obtained after digestion of the plasmids from the large
~cale plasmid preparation. In this figure, the eDNA probes
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FIGURE $.1 RESTRICTION MAPS.
FIGURE 6.1a
Schematic; map Of recombinant plasmid pHtA-A containing 669
bp long lnsert of tb.e eDNA probe S"'ABC"o. The nUmbers
refer to base-pa.irs (Redrawn from Trowsdale et al lSS4).
Haem Pst 1 Haem Mbo I
Pst 1 ••_LII. kdiillllfll•• '_'_II'=_WlIll _·IJ!!;II$!IIiiI.r-'- ..-·----------..., .., Pst 1
IS' Coding 351 Non-coding 3,669 bp
FIGTJRE 6.1b
Restriqtian map Of the p-gamma"2 eDNA l:ll;'obeco11taining the.
Pst! 1487bp insert. The 6' end of thea cod.ing st.J;andis
close ttl the F.:co:R!site in pBR:J22. The thick line
J."spresants the translated portion. (R<o)drawn :from C:laesstln
-- 'C... c:III
~.n.
! !
....A.·S::::-,--.MlfIlII -IIIIiIIIa!D1'•••••u.1 _IIIIM_i._VIl I. iMDlIIinI-+- ...··...-+I---I--J'---II--_,__A. ~
V ; -:3' V
200 400 aoo 000 1000 1:1.00 bl)
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693 ....
bp
:E'IGURE 6.4
E~ample ot' :t"apid plasmid. l?:t"spl;u:'ation of re.combinant plasmid.
pULA-A (lane 2). The Pst :t insert ot 69:>bp is shown in
lanes 1 and 4. 'X'hemolecular wei9ht standards are SO,CJwn in
lane 8.
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Lane
bp
950
540
450
bp
-2176
-1766
-1230
...1033
-653
-5il
...453
...394
-298
-234
..1$4
FIGU~E 6,3
Example 0:1; plasmid pl:'eparationof recom")inant plasmid
p-gamma"'2 (lane :n showing two Pst I inserts (lanes 1 arid
j) of Sl50 and 330 bp each. The plasmid )?reparation of
recombinant plasmid MCFX"lB (lane 6) shows two Pst I
inserts (lanes 5 and 7) of.540 and 450 bp each. The
molecular weight standards are shown in lanes 4 and 8.
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p-gamma-:a ano. MCFI-1B whioh were successfully isolateo. Were
visualiseo. using ethio.iultlbromide. Their size in bp Was
assessed using molecular weight standards. In this figura,
two restrictiort t'ragmertts of 950 and 330 bp each were
obtia.Lned after Plirt :t digestion. It is possible to use both
restriction fragrrlents for fUrther experiments such as Ln
Northern blotting. This is suggested by the restriction
map of p ....gamma ....2 which irtdicates the 1287 bJ:>insert
containing r.':n,lrdifferent pst l'. sites (Figul:e 6.l.b). Also
shown in FigUre 6.3 is the plasmi(;1preparation of the
recombinant plasmid MOFt-1B. THO Pst I digests of 450 ano
540 bp each Were obtained. It i.spossil:'>leto Use both
fragments for fUrther eDNA prol:'>,i,ngc:(ccoro.ingto the
restriction msp , Al.though unpublishE!d, this was given via a
personal communication of Dr J Lee (ICRF, :London, UK).
'rotal cytoplasmic RNA Was prepared frOll\+.he Raj i, I\Sp~ and
the Hec cell lines that were examirtec;lin this studY.
Formalde.hyde gel electrophoresis sapare:ted the intact RNA
into the 18S and 28S rRNA spec.ies. As shown in E'igure 6.4,
the 18S and ;ass r~NA species of the HA59T/VCH, P'.A22'r/VGH,
TONG PB:C, Pr."C/PRE'/5and Hep 3B were visuali:;;sc.'lunder
fluorescence usirt9'the irlter¢."latinc·'agent, ethidium
l:'>~C)mide.
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Lane 1 3 52 4
Lana 11 HA69TIVGH
2.1 HA2.2T /VGH
3, Tong PHC
41 PLC/PRrls
5.1 Hap 38
F!GURE 6.4
-288
-188
Example of fo:rmaldehy(:l.e ac;,ra:t:osec;,reJ.sepa:t:ation of RNA
isolated from fiVe different HCC O~ll lines (lanes 1~5)
showing 18S and 288 rRNA spe-oiall!.
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6.3 DISCUSSION
The isolation and purification of eDNA prcbes was achieved
by alkaline lysis according to methods outlined by Sambrook
et al (19139). This .;..ethod allows for quick and clean
minipreparations of plasmid DNA. figure 4.2 shows the
restriction fragment of approximately 693bp obtained ·after
Pst I digestion of a representative cDNA probe, 8-ABC-$ ..
The Pst I insert is well separated and of a reasonable
purity. Although the running of a CsCl gradient is long
and expensive (lEI hours at 150 OOOg). The large scale
plasmid preparation results in olean. and well-resolved
plasmids. These plasmids werp. of a good purity and free of
protein contaminant: (Figure 6.3). In Figure 6.3, both the
probes McFI-1B (550 bp insert) anCl p-gamma-2 (1280 bp
insert) where digested bY Pst t. Each probe was resolved.
into two well-separateCl restriction fragments by agaror:::;e
qel eleotrophoresis. Visuali?ation using ethidium bromide
o=.r;owedthat MCfI-iB (anti-liLA-ORB) was digested into two
Pst I fragments' of approximately 540 and 450 bp each (as
assesed by molecular weight standards). This 1-1 possible
according restriction map of this eDNA probe ol:>tainedvia a
personal connnunication of Dr J Lee, lCRF, London 1 u!\. The
two digests obtained from the Pst 1: restriction of
p"'gamma-2 were confirmed by refer:ral to the restriction map
of this cDNA probe (Fig 6.1b). This map Clet;.ils . 't:' Pst I
:rest:dction sites which would give rise t,o three fragments
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ef an estimated 940, 330 and 120 bp each. subtractien ef
the 95 bp initiation ceden described by Claessen et al
(1983) results in a Pst I insert of appreximately 1295
bp. Figure 6.3 Shewed two pst :r digests ef 950 and 330 bp
each. The smaller restrictien fragment ef appreximately
120 bp was not visible. There are two possible reasens fer
this. FirstlY, be(",use of its small number ef base pairs,
this fragment "V'asnet,resel~·.J in the 1,5% agarr',d gel used
in this stucly (that is, a higher concentration of agarese
was needed to reseHve this band) or seccndly, the
cencentration ef DNA leaded in the well WaS tee weak for
this fragment to.be observed at the frent of the band. The
absence ef this band dees net affect the probing ability of
p-gamma-2 since beth the visible fragments are suitable ;far
Narthern blatting.
FigUre 6.4 shews a representative fermalo.ehyde agarase gel
separ acfon of total RNA iselated fretn five ace cell lines.
The resalutien ef RNA into. 18S and ~8S rRNA species implied
that RNA was intact ie undeqraded , Degraded RNA, which
appearS as a smear on the formaldehyde al1arose gel is
unsuitable fer Nerthern bletting and hybridizatiol'l
experiments. It is essential to extract RNA under sterile
conditiens. The labil.ity ef the 3 '-hydroxyl group on
uracil easily caU.:ieSdegradation of thtf\RNA sample by
hydro.lysis. For this reason, all methods and reagents
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which inhibit ribonuclease activity are favoured when
extracting RNA from cells with high activity of this enzyme
(Sambrook et al :1.989). In tllis stUdy. the method of
chirg,..in et. al (1979) was employed for the preparation of
biologically fUnc.tional RNA. This method employs two
poWerful RNase inhibitors: diethylpyrocarbonate and
guanidium thiocyanate. It was initially determined that
RNase had a ha.lf",Ufe of 10 sec in 4M gUanidium
hydro.chloride. However I later it was demonstrated that
guanidium thiocyanate has a much more rapid denaturant of
RNase, permitting the isolation of intact RNA (Chirgwin et
al 1979) as demonstrated by the preSence of intact 28S and
18S rRNA species (Fig 15.4). Total RNA preparations had an.
00 260/00 280 ratio of between 1,8 and 2,2. indicating ldW
proteia cont.amdriat.Lon, The use of a CsCl. gradiet1t improved
the purity of the RNA preparation. RNh prepared with
guanidium thiocyanate was shown to retain the information
content of the starting RNA and was fully active in
translation, hybridization and recombinant ONA experiments
(Chirgwin at a.1.1979). Thus this method of extr, ctinq
~)iologically active RNA i.ssuitable for further
hybrid;i.zat:i.onexperiments with cONA probes. Northern
blotting and subaequant; hybridization expel'iments u:sing the
eDNA probes purH:Led and the RNA extracted from the HCC
cell lines will be performed at a later date.
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APPENDIX 1
MATERIAIJS FOR ENZYME-LINKED IMMUNOASSAY ELISA
Sodium Carbonate Buffer (coating buffer) O,05Ivf
NaC02 (BDH, Pcole, England)
NaH003 (BDH, Poole, England)
Make up to 900m3. with distilled H:aO
Adjust pH to 9.6
Make up to 1 litre with distilled H20
Store in 100 ml aliql..\otsat -2000.
1· Litre
1.590g'
2.g30g
0;5% Bovine Seruln.Albumin (BSA)
Dissolve 0.5g BSA (Seravac, l?enta:l{Products, Illinois, USA)
in 100ml sodium. carbonate buffer
Adjust to pH 9.6.
store at --:aooe.
Phosphate Buffered Saline (PBS)
0.15M ,lOx concentration)
Nael (Univar, South Africa)
Kel (Univar, South Africa)
Na2HP04.2H20 (BDH, Poole, England)
KH2P04 (BDH, poole, England)
Dissolve in 900ml distilled H20.
1 litre
80g
2g
11.5g
2g
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Adjust the pH to 7.2.
Make up to 1 litre with distilled H20.
sterilise by a1,ltoclaving.
PSS-Tweeh 0.05%
Add 0.5 lUI TWeen-:20 (polY':lxyethelene sorbitan monol·"I.urate,
sigma Chemical co , , st Louis, Missouri. USA) to 1 1it:t',~
PBS.
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APP'ENDIX 2
PEROXIDASE S'OBS'l'RATE FOR ELISA
$Ubsb:'ute Buffer
citric acid (BDH, Peole,England)
Na2HP04 (BDH, Poole, England)
Dissolve in distilled H20'
Adj.ust t.opH 5.0
store in the dark
Make u.pfresh daily
1.029g/100Illl
1.448g/100ml
Immediately prior to use ad("
chemicals .Ltd., Poo].e, England) anu 34mSi J~phenylenediamine
(Sigma Chern. co ,, St Louis, MO, USA) to.100ml substrate
puffer.
Keep the substrate solution entirely covered until used.
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APPENDIX 3
eEL:;:"CULTURE PROCEDURES
Preparatitlll of RPMr-1640 med:i.uma
Per litre:
RPMI-1640 (lOX)
L-Glutamine
NaRC03 (7,5%)
Repes (;J..M)
res (heat inactivated) b
Gentamycin
Pen:i.cill.inI streptolT,ycin, Fungizone (100X)
sterile, autoclaved H20
Add ingredients togetherd and sterilise
by autoclaving. store complete medium (RPMI....1640
SiJ,qplemented with PCS) <it 4°C until needed.
£t;eparation ot DMEM.mediuma.
per litre.:
J)MEM (5~)
Nafic03 (7,5%)
Hepes (1M)
FCS (heat-inactivated)b
Gentamycin (1%)
Penicillin, streptomycin, Fungizone (100:X:)
L-Glutamine
Sterile autoclaved H20
100 ml
2 mM
2200 mg/l
20 mM
100 mle
0,1%
.1.%
900 ml
200 ml
3700 mg/l
20 mN
100 ml
0,1%
1%
4mM
800 ml
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Add ingredients togetherd and sterilise by autoclaving.
store compLetie DMEM(DMEMsupp l emerrced 'l'tith rCS) at 4°C
uhti1 needed.
a) alJ. media ingredients ·...ere obtained sterile from
Highveld Biologicals, Johannesburg, SA.
b) Fetal oalf serum (FCS) was heat-inactivated for 30 min
at 560e ahd stored at -20°C in So ml aliquots.
CelJ.s gr'o~/l in suspension were g'rowh in RPMI"'l,$40
medium supplemented with 5% FOS ($0 mIll). RCC cells
were grown in DMEMsuppleme,nted with 10% FCS
(100m1/1).
e) MediUlnwas used at a pH of between 7/2 ana 7 I 4 and was
adjusted ""ith IN NaOH.
Procedure for the preservation of'ee1ls
rrypsination of.cel1s
Cells were preserved oy freezing in liquid nitrogen in the
presence of the cryoproteoti v« agent I g1yoe1:'01.
Glycerol.
FCS
10%
40%
50%Liquid medium
r yeerol was sterilised by autoclav:(,hg and added ':'0 FeS
and liy_uid medium. The mixture was fUter-sterilised
with a 0,22 um filter (Millipore, Seaford, MA., TJSM and
uaed immeaiata1y, Cells that had been ccurrced and thed.r
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viability assessed were suspended in 2 mI glycerol freezing
medium and the mixture transfer:t'eci,to plastic anpout.es
(Cel ....CUI t I Hounslow I El'tgland).JI.mpouleswere stored in
liquid nitrogen.
Procedure for the. thawing of frozen cells
FOI: reconsti tut.ion of frozen cells I ampoules were removed
from liquid nitrogen and immediately transferred to a
370C waterbath. Cells were harvested by centrifugation
at 200 g for l5min after careful. addition of 10 ml complete
medium at 37°C. Viability was assElElsedand the cells
plated out on cell culture flasks.
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APPENDIX 4
STOCl( 80I1UTIONS USED FOR ISOLATION OF eDNA PROBES
O,5M EDTA (pH 801.
Disod:i.um ethyleneC;liamine
tetraacetate.2 H20
deionised H20
stir until dissolved, then adjust pH tQ 8,0
with, NaOR pel.lets.
sterilise by autoclaving.
J,O% Sodium.dQdecyl sulphate (80S)
E:lectrophQres.1.E\-qrade80S
(Flu:k;aBiochemie, switzerland)
deionised H20
Reat until dissolved (7000) then adjust pH
to 7.2 with concentrated HCl. Adjust vcIume to
100 ml. st"\rilise by autoclaving.
Tris-Hel (1M)
Tris (hydro:x:ymethyl) methylamine
(Tria base)
deionised H20
Adjust pH to 7,5 and 8.0 with concentrated
HC1. sterilise by autoclaving.
93,05 CJ
800 :ml
10 g
90 ml
121,;). g
800 ml
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Tris. EDTA (TE)
10 lltH'l'rie.HCl (pH 9.0 1M)
1 toM EDTA (pH a. 0 0 10M)
Ethidium Bromide (10 mg/ml)
Ethidium Bromide. (Boehringer Mannheim,
Mannheim, Germany)
H20
stir overnight at toom temperature.
Hrap container in aluminium foil.
store at 4°0.
Potassium Acetate (5M)
CH3COOI< (BDH ;Lt\1,poole, England)
deio -;1 sed H20
Adjust pH to 7.5 with aoetic acid (2M).
Make up ~ 250 ml with H20.
steri1.is_ y autoclaving.
lrris-,Acetate f1'A:El
50X stock solution:
'l'~:isbase (pH a.0 1M)
Glaoi .1 acetio acid
EDTA (pH 8.0, D,S M)
Make, up volume to 1 litre with de Lcnd.eed H20.
1 Sf
100 ml
122,68 g
?'20 m1
242 g
57,.1. ml
100 ml
Working solution (JxTAEl.
a ,04 1'1 TAE
0,001 M EDTA
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APPENDIX 5
SOLUTIONS USEP IN cDNA PREPARATIONS
1) lxM9 Minimal bacterial growth medium
a) M9 salts (5 ~ concentrate)
Na2HP04.7:H20
KH2P04
NaCl
NH4Cl
Dissolve in deionised H20 (900ml) and adjust
to a final voIume of 1 litre with Cl,eicmisedH20
Sterilise by autoclaving, and store at 4cC.
Use 200 ml 5~ M9 salt
b) Glucose (20%)
Glucose
D!!lion;;'sedH20
Filter .:;terilisethrough a 0,45 urn :Ulter
(MiJ.1ipore, ]3eClford,!I.A, USA). Use .20:ml 20% gluoos
Add to 850 rnI sterile, Cleionised B20.
30 g
15 g
2.5 g
5 g
20 g
100 ml
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(2) Luria-Bertani (LB) Medium
Deionised H20
Bacto-tryptone
BClcto-yeast extract:
NaCl
Adjust pH to 7.4 with NaOII (1M). B:dng
volume to 1 litre with deionised IhO and
sterilise by a,utoclaving.
.(3) preparation of Luria Agar (LA) plates
Bacto-tryptone
Bacto-yeast extract
NaCl
Bacto-'agar
Dissolve in 1 litre deionised H20
Aliquot into 200 lnJ.portion and st.erilise
i'?yauboc Lavd.riq , When agar has coo Led to 50PC
add antibiotics (oO lng/ml t.etracycJ.ine.. ..
light sensitive, 10 mg/lnl ampicillin).
950 ml
8 9
5 9
5 9
8 9
5 9
5 9
15 9
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Rapid plasmid DNA preparation
Alkaline lysis method
Solution 1
50 mM Glucose (0,5 M)
25 mM Tris-HCI (pH 8.0)
10 mM EDTA (pH 8. O)
Made up to 100 ml with deionised, sterile H20.
Solution II
4ml NaOH
20 lUI SDS
176 ml H20
Make up to 100 mi with sterile, deionised H20.
Solution III
(10 M)
(10%)
60 lUl CH3COOK (5 M)
11,5 ml glacial acetic acid
28,5 ml ste~ilef deionised H20
Prep~~ation of TE/RNaseA
Dissc,lve pancreatic RNaseA (Boehringer Mannheim,
Mannheim, Germany) at a concentration of 2 mg/lUl in 10 mM
Tris-HCl (pH 7,0 1M) and 15 mM NaCl (5 M). Heat at
100°c for 15 minutes. After cooling until roam
temperatura, aliquot and store at -20°C.
DNase-free RNase ~l. (2 mg/ml)
TE
Final concentration of RNAseA
4 ul
156 ul
50 Uq/lUl.
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Gel-loading buffer (6x)
Bromophenol Blue
Xylene cyanol FF
Ficoll (Type 400, l?harmacia) in water
store at roo~ temperature.
Electroelution buffer
High salt buffer
Ammonium acetate (7,5 M)
Bromophenol blue (0,1%)
Dissolve salt in 8 ml sterile deionised H20
and add dye. Adjust final volume to 10ml
with sterile, deionised H20.
RUnnin9 buffer (low salt)
Tris HCI (pH 8 •.0)
EDTA
Nf.ICl
Adjust final volume to 1 Utre ~lith sterile,
deionised H20. Sterilise by autoclaving.
0,25%
0,25%
,15%
5/8 g
1 ml
20 roM
0.2 roM
5 roM
212
APPENDIX 6
RNA PROCEPURES
~iethylpyrocaTbonate (DEPC) treated water
Add 1ml DEPC (Fluka chemf.s , S\-1itzerland)to
1 litre deionised, steril~ H20. Mix thoroughly
and autoclaVe. DEPC is light sensitive so bottle is
stored in dark.
Guanidine thiocyanate (pH 7.9. 4 M)
GUanidine thiocyanate (4 M)
(Merck Chemicals, Darmstadt, Germany)
Sodium N-lauroylsarcosine (sarkosyl)
(Sigma Chemicals, st Louis MO, USA)
2-~ercaptoethanol (BPH Chemicals Ltd,
:8.001eI England)
sodium citrate (pH 7.0, 1 M)
After dissolution of solutes in 80 ml DEPC-
treated H20, filter-sterilise the solution
(0,45 um filter, Millipore Bedford, MA, USA)
Adjust pH to 7.0 with NaOH (1M), bring final
volume to 100 ml and refilter through a 0,45 um
filter. store solution at room temperature in the. dark.
(GTC is light sensitive).
50 g
0,5%
n,l M
25 mM
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Cesiur,lChloride (5.7 M)
Cesium r.hlo:dde {Boehringer Mannheim
Mannheim, Germany)
Sodinm acetate (pH 6.0, 3 M)
Adjust volume to 100 ml with DEPC-treated
water. sterilise by autoclaving.
95,97 g
0,83 ml
Morpholinopropane~sulfonic acid (MOPS) buffer (10 xL
MoPS (Boehringer Mannheim, Mannheim
Germany)
Sodium acetate. (pH 7. 0)
EDTA
0,2 M
0,05 M
0,01 M
Loading. dye
Formaldehyde (deionised uS described
in Samb;cook et al. 1989)
10 x MoPS buffer
Formaldehyde (37 %)
OEPC H20
Brc)mophenol blue (saturated so l.utiLen)
glycerol
t , 2 ml
1,6 ml
2,6 ml
1,8 ml
0,8 l'l\l
1.0 ml
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175,3 g
88,2 g
800 ml
100X D"mhardts
Ficoll 400 10 g
Polyvinylpyrrolidine (PVP) 10 g
BSA (Pentax Fraction V) 10 g
Adjust final volume to 500 ml with sterile
deionised H20, Filter sterilise (0;45 um
Millipore, Bedford MA, USA) and store at ,.-20°0.
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